data_1ho0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ho0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 CA-C-O 118.949 -0.917 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.3 p -76.03 -32.99 59.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -55.05 -48.56 73.3 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 121.59 1.995 . . . . 0.0 114.474 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.9 tp -63.37 -70.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 116.202 -1.856 . . . . 0.0 109.633 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -48.66 -27.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.971 0 C-N-CA 126.738 2.015 . . . . 0.0 114.06 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -74.33 -60.7 2.15 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 114.445 -2.693 . . . . 0.0 106.847 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.53 -36.51 0.11 Allowed 'General case' 0 N--CA 1.506 2.356 1 N-CA-C 123.182 4.512 . . . . 0.0 123.182 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.419 ' H ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.55 -31.26 59.98 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.802 2.89 . . . . 0.0 118.802 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.31 -29.71 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 175.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.4 -54.66 5.5 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.241 2.616 . . . . 0.0 113.172 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 99.3 t -80.51 -59.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 116.859 -1.543 . . . . 0.0 108.056 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.3 m -68.72 -46.29 69.32 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.26 177.58 51.95 Favored Glycine 0 C--N 1.36 1.868 0 CA-C-N 120.464 1.483 . . . . 0.0 114.552 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.24 72.46 1.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 123.627 1.679 . . . . 0.0 112.158 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -164.99 -41.64 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 128.043 2.537 . . . . 0.0 108.974 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.3 82.27 1.68 Allowed Glycine 0 C--N 1.368 2.332 0 CA-C-N 120.288 1.404 . . . . 0.0 113.873 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -143.89 117.12 8.98 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 116.785 -1.578 . . . . 0.0 111.427 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 CA-C-O 118.761 -1.022 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.5 p -70.38 -31.01 68.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 118.262 2.69 . . . . 0.0 118.262 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -58.12 -49.56 76.55 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 121.417 1.917 . . . . 0.0 114.126 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.6 -72.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 115.389 -2.243 . . . . 0.0 108.869 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 12.6 m -48.42 -28.02 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 11.7 mm-40 -80.09 -27.34 39.28 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 114.195 -2.812 . . . . 0.0 112.819 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.11 72.15 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.28 -30.84 66.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.692 3.219 . . . . 0.0 119.692 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.345 0.0 OUTLIER -39.34 -29.85 0.05 Allowed 'General case' 0 CA--C 1.59 2.483 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 176.495 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.35 -53.45 6.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 129.046 2.938 . . . . 0.0 114.344 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.21 -55.78 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 116.613 -1.66 . . . . 0.0 109.187 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -63.24 -47.35 82.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.61 148.55 4.92 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 120.41 1.459 . . . . 0.0 112.437 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -42.01 -36.71 1.18 Allowed 'General case' 0 N--CA 1.511 2.597 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -71.91 -42.22 66.97 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 116.486 -1.721 . . . . 0.0 113.593 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.66 -178.09 53.83 Favored Glycine 0 C--N 1.36 1.898 0 CA-C-N 120.208 1.367 . . . . 0.0 114.67 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -126.95 -31.33 2.64 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . 0.338 90.6 m-85 . . . . . 0 N--CA 1.504 2.27 0 C-N-CA 126.72 2.008 . . . . 0.0 111.935 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.5 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.3 m -74.17 -33.8 63.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -54.74 -49.22 71.36 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 121.756 2.071 . . . . 0.0 114.699 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.28 -72.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 115.283 -2.294 . . . . 0.0 108.964 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 11.4 m -47.85 -28.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.2 -27.51 38.83 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 114.216 -2.802 . . . . 0.0 112.6 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.15 -36.58 72.1 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 120.134 3.383 . . . . 0.0 120.134 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.431 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.12 -30.34 64.96 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.482 3.141 . . . . 0.0 119.482 -178.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.3 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.588 2.416 0 N-CA-C 120.35 3.463 . . . . 0.0 120.35 176.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.96 -54.87 5.2 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 128.847 2.859 . . . . 0.0 114.013 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -80.39 -54.2 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 116.716 -1.612 . . . . 0.0 109.452 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -60.99 -48.17 83.06 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.1 101.19 0.18 Allowed Glycine 0 C--N 1.36 1.865 0 CA-C-N 120.757 1.617 . . . . 0.0 111.711 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -38.92 -45.48 1.19 Allowed 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -120.04 66.65 0.82 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.47 -80.95 0.06 OUTLIER Glycine 0 C--N 1.359 1.837 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.2 t80 63.89 96.75 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 126.676 1.991 . . . . 0.0 111.553 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.493 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 CA-C-O 121.899 0.721 . . . . 0.0 114.252 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -77.53 -31.71 53.56 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -58.66 -51.27 70.66 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 121.727 2.058 . . . . 0.0 113.679 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 tp -56.67 -43.04 80.03 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 116.877 -1.535 . . . . 0.0 114.865 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.6 -41.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 115.476 -2.202 . . . . 0.0 109.742 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.298 39.7 mt-10 -64.9 -29.21 70.15 Favored 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 123.053 2.66 . . . . 0.0 113.826 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.85 63.15 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -29.8 62.05 Favored 'General case' 0 N--CA 1.485 1.309 1 N-CA-C 124.499 4.999 . . . . 0.0 124.499 -176.49 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -61.07 -29.9 70.02 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 mt -72.47 -46.95 52.46 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 126.646 1.978 . . . . 0.0 113.721 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.256 95.6 t -80.44 -59.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.269 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -65.63 -45.7 82.04 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 117.026 2.232 . . . . 0.0 117.026 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.59 114.94 1.7 Allowed Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.609 1.55 . . . . 0.0 110.066 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -40.49 -41.09 1.36 Allowed 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 117.649 2.462 . . . . 0.0 117.649 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -73.04 -38.15 66.61 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 116.333 -1.794 . . . . 0.0 114.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 89.53 1.28 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 120.519 1.509 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -97.47 105.57 17.74 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 t80 . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 179.849 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.347 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 m -71.3 -30.57 66.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -58.87 -51.64 69.16 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 121.616 2.007 . . . . 0.0 113.57 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.09 -54.79 43.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 116.201 -1.857 . . . . 0.0 112.873 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.4 m -70.14 -30.21 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 CA-C-O 115.736 -2.078 . . . . 0.0 114.749 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.292 40.5 mt-10 -75.53 -29.85 59.58 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 122.342 2.337 . . . . 0.0 112.469 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.6 65.39 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -29.62 62.51 Favored 'General case' 0 N--CA 1.487 1.409 1 N-CA-C 124.665 5.061 . . . . 0.0 124.665 -176.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -61.06 -29.4 69.71 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.3 mt -72.77 -54.05 9.94 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 126.762 2.025 . . . . 0.0 112.497 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.274 93.1 t -81.14 -62.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-O 117.069 -1.444 . . . . 0.0 107.913 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -70.84 -53.48 15.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.16 169.85 12.41 Favored Glycine 0 C--N 1.361 1.919 0 CA-C-N 120.618 1.554 . . . . 0.0 114.095 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -37.64 -36.43 0.17 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 119.182 3.03 . . . . 0.0 119.182 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -65.0 -43.92 90.96 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 116.43 -1.748 . . . . 0.0 115.164 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.0 -129.18 8.88 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-N 120.201 1.364 . . . . 0.0 113.191 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.27 134.42 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.474 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.38 0 CA-C-O 118.924 -0.931 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -80.01 -37.04 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -58.39 -53.53 57.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.483 1.947 . . . . 0.0 113.62 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.21 -50.9 72.27 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 124.943 1.297 . . . . 0.0 113.664 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.292 14.9 t -69.18 -26.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 115.209 -2.329 . . . . 0.0 112.49 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 47.3 mt-10 -80.76 -58.39 3.12 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 123.415 2.825 . . . . 0.0 108.237 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . 0.41 . . -33.6 -34.3 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 1 N-CA-C 125.167 5.247 . . . . 0.0 125.167 -178.351 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.438 HD11 ' H ' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -77.37 -37.76 51.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 119.785 3.254 . . . . 0.0 119.785 -176.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.361 0.1 OUTLIER -39.53 -33.62 0.18 Allowed 'General case' 0 CA--C 1.591 2.553 0 N-CA-C 119.822 3.267 . . . . 0.0 119.822 174.879 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.1 -55.22 4.9 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 128.906 2.882 . . . . 0.0 113.938 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.264 99.2 t -80.04 -60.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 CA-C-O 116.947 -1.501 . . . . 0.0 107.813 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -65.11 -45.93 83.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.31 169.0 41.31 Favored Glycine 0 C--N 1.359 1.852 0 CA-C-N 120.117 1.326 . . . . 0.0 114.846 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -39.65 -41.58 1.08 Allowed 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.57 60.82 0.94 Allowed 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 123.704 0.802 . . . . 0.0 109.452 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.34 -122.17 3.83 Favored Glycine 0 C--N 1.359 1.857 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -88.71 135.55 33.45 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.841 0.856 . . . . 0.0 110.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 CA-C-O 121.788 0.66 . . . . 0.0 114.208 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -74.17 -35.82 64.03 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -53.32 -48.69 68.22 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 121.377 1.899 . . . . 0.0 115.874 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -63.77 -71.02 0.18 Allowed 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 116.309 -1.805 . . . . 0.0 109.307 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t -47.76 -27.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 C-N-CA 126.886 2.074 . . . . 0.0 114.298 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.74 -62.58 1.49 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 114.245 -2.788 . . . . 0.0 106.359 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.45 -34.94 0.07 Allowed 'General case' 0 N--CA 1.506 2.357 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -31.72 60.54 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.331 0.1 OUTLIER -38.72 -34.73 0.16 Allowed 'General case' 0 CA--C 1.589 2.466 0 N-CA-C 120.183 3.401 . . . . 0.0 120.183 175.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.32 -55.05 4.97 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 128.661 2.785 . . . . 0.0 113.941 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 98.9 t -80.06 -60.07 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-O 116.912 -1.518 . . . . 0.0 108.104 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m -63.3 -44.41 95.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.64 135.95 4.37 Favored Glycine 0 C--N 1.361 1.932 0 CA-C-N 120.325 1.42 . . . . 0.0 111.912 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -41.35 -37.0 0.91 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.65 -39.47 67.13 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.963 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.06 87.18 0.55 Allowed Glycine 0 C--N 1.36 1.879 0 CA-C-N 120.496 1.498 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -99.12 96.69 7.96 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.861 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 CA-C-O 118.896 -0.946 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -79.89 -39.6 30.11 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 116.37 -1.776 . . . . 0.0 115.509 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -55.44 -46.36 76.75 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 121.403 1.911 . . . . 0.0 114.447 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.1 -70.69 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 116.235 -1.84 . . . . 0.0 109.414 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 t -48.52 -27.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 126.75 2.02 . . . . 0.0 114.08 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.03 -60.9 2.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 114.423 -2.703 . . . . 0.0 106.914 173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.54 -36.85 0.11 Allowed 'General case' 0 N--CA 1.507 2.389 1 N-CA-C 123.118 4.488 . . . . 0.0 123.118 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.422 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 -31.27 61.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.18 -30.52 0.06 Allowed 'General case' 0 CA--C 1.59 2.51 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -51.71 8.42 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 128.44 2.696 . . . . 0.0 113.807 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.252 86.2 t -80.29 -58.2 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 CA-C-O 116.691 -1.623 . . . . 0.0 108.525 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.9 m -63.64 -42.24 98.16 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.84 165.14 14.31 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 120.36 1.436 . . . . 0.0 113.701 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.279 12.7 pt-20 -33.6 -43.94 0.14 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.05 66.41 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.28 159.28 6.38 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 119.448 1.022 . . . . 0.0 115.313 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -89.6 137.39 32.37 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.906 0.882 . . . . 0.0 110.239 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 . . . . . 0 N--CA 1.493 1.679 0 C-N-CA 123.78 0.832 . . . . 0.0 109.253 -179.688 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.278 0 CA-C-O 118.915 -0.936 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 m -76.03 -36.48 59.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -52.09 -48.82 64.54 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 121.547 1.976 . . . . 0.0 115.943 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.54 -70.91 0.2 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 116.211 -1.852 . . . . 0.0 109.361 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -48.51 -27.81 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.941 0 C-N-CA 126.83 2.052 . . . . 0.0 114.12 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.24 -62.58 1.47 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 114.346 -2.74 . . . . 0.0 106.493 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.38 -35.09 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.81 -32.24 61.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.33 0.1 OUTLIER -38.56 -35.01 0.16 Allowed 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 120.222 3.416 . . . . 0.0 120.222 175.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.52 -53.81 5.96 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 128.626 2.771 . . . . 0.0 114.802 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 86.3 t -77.88 -57.13 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 116.753 -1.594 . . . . 0.0 109.168 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -60.26 -42.2 94.82 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.12 161.97 12.92 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 120.181 1.355 . . . . 0.0 113.217 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -39.86 -38.36 0.67 Allowed 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -75.5 -39.79 58.0 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.99 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.81 146.32 6.24 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 120.637 1.562 . . . . 0.0 113.209 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -84.7 147.14 27.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.025 0.93 . . . . 0.0 111.545 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 . . . . . 0 N--CA 1.493 1.711 0 C-N-CA 124.024 0.93 . . . . 0.0 109.241 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 CA-C-O 118.702 -1.055 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -69.95 -38.07 76.04 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.259 31.8 p80 -57.56 -51.32 69.96 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-N 121.76 2.073 . . . . 0.0 114.675 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.7 tp -59.23 -71.38 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 115.808 -2.044 . . . . 0.0 108.723 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 t -48.94 -28.55 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.883 0 C-N-CA 126.429 1.892 . . . . 0.0 113.987 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -78.93 -27.07 43.66 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 114.377 -2.725 . . . . 0.0 113.148 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.42 -37.46 71.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 119.837 3.273 . . . . 0.0 119.837 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.65 -31.11 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -178.178 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.339 0.0 OUTLIER -38.86 -28.98 0.03 OUTLIER 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 176.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.8 -52.56 7.76 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.816 2.846 . . . . 0.0 113.12 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.37 -55.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 117.111 -1.423 . . . . 0.0 107.542 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.2 p -56.12 -41.48 75.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 118.873 2.916 . . . . 0.0 118.873 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.05 122.29 2.41 Favored Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -36.02 -43.12 0.31 Allowed 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -125.98 66.78 1.19 Allowed 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 92.07 0.1 OUTLIER Glycine 0 C--N 1.358 1.774 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -92.98 109.45 20.9 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.8 p90 . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 179.396 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.611 0 N-CA-C 112.096 -0.401 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.1 m -73.6 -34.23 64.96 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -52.54 -48.59 66.01 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 121.641 2.019 . . . . 0.0 114.483 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.88 -71.53 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 115.83 -2.033 . . . . 0.0 109.289 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -49.7 -28.44 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 C-N-CA 126.346 1.858 . . . . 0.0 114.127 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.67 -27.22 45.14 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 114.442 -2.694 . . . . 0.0 112.869 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.94 70.86 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 120.055 3.354 . . . . 0.0 120.055 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.447 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.25 -29.97 64.42 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.476 3.139 . . . . 0.0 119.476 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.342 0.1 OUTLIER -39.22 -29.55 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.495 0 N-CA-C 120.345 3.461 . . . . 0.0 120.345 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.88 -53.79 6.16 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 128.963 2.905 . . . . 0.0 113.681 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 95.8 t -80.31 -59.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 116.825 -1.56 . . . . 0.0 107.916 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 64.7 m -68.46 -44.33 75.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.36 171.82 38.16 Favored Glycine 0 C--N 1.36 1.874 0 CA-C-N 120.355 1.434 . . . . 0.0 114.775 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -36.2 -42.41 0.31 Allowed 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -122.59 65.04 0.95 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.05 88.89 0.12 Allowed Glycine 0 C--N 1.359 1.85 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -134.96 119.67 18.27 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.96 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 CA-C-O 118.877 -0.957 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -72.18 -31.52 66.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -56.55 -49.88 73.53 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.449 1.932 . . . . 0.0 114.198 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.53 -70.78 0.19 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 116.177 -1.868 . . . . 0.0 109.431 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -48.61 -28.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 C-N-CA 126.823 2.049 . . . . 0.0 113.959 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.05 -60.7 2.14 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 114.319 -2.753 . . . . 0.0 107.18 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.6 0.11 Allowed 'General case' 0 N--CA 1.506 2.362 1 N-CA-C 123.048 4.462 . . . . 0.0 123.048 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.41 -31.38 60.37 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.32 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.516 0 N-CA-C 120.67 3.582 . . . . 0.0 120.67 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.22 -51.79 8.52 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 128.269 2.628 . . . . 0.0 113.597 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -80.1 -55.71 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-O 117.038 -1.458 . . . . 0.0 107.968 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 94.1 p -51.36 -35.2 37.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.777 3.251 . . . . 0.0 119.777 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.76 103.48 1.55 Allowed Glycine 0 C--N 1.358 1.804 0 CA-C-N 120.071 1.305 . . . . 0.0 110.186 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -38.94 -38.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.457 2.762 . . . . 0.0 118.457 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -74.2 -39.88 62.84 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 116.462 -1.733 . . . . 0.0 113.948 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.45 93.72 0.98 Allowed Glycine 0 C--N 1.361 1.928 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -91.49 117.91 30.11 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.76 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 CA-C-O 118.906 -0.941 . . . . 0.0 113.333 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -61.69 -29.92 70.4 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -57.7 -50.56 72.8 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 121.296 1.862 . . . . 0.0 114.117 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.0 tp -62.46 -72.44 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 115.27 -2.3 . . . . 0.0 108.998 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 12.0 m -47.96 -28.1 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.17 -27.5 38.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 114.035 -2.888 . . . . 0.0 112.585 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -36.82 72.8 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.095 3.369 . . . . 0.0 120.095 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.17 -30.1 64.66 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.4 -29.65 0.05 Allowed 'General case' 0 CA--C 1.589 2.444 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 176.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.9 -53.2 6.67 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 129.034 2.934 . . . . 0.0 114.181 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -80.3 -55.4 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 116.714 -1.612 . . . . 0.0 108.98 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.5 t -59.42 -40.46 86.78 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.32 101.49 2.42 Favored Glycine 0 C--N 1.357 1.727 0 CA-C-N 120.342 1.428 . . . . 0.0 110.191 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -40.2 -36.22 0.49 Allowed 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -70.81 -39.72 72.91 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 116.395 -1.764 . . . . 0.0 114.382 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.94 84.02 0.35 Allowed Glycine 0 C--N 1.36 1.903 0 CA-C-N 120.644 1.566 . . . . 0.0 110.844 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.02 120.95 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.835 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -77.17 -38.03 52.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -57.39 -47.94 80.36 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 121.428 1.922 . . . . 0.0 114.144 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.91 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 116.262 -1.828 . . . . 0.0 109.204 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -47.95 -27.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 C-N-CA 126.826 2.05 . . . . 0.0 114.04 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -74.3 -61.01 2.01 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 114.434 -2.698 . . . . 0.0 107.156 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.55 0.11 Allowed 'General case' 0 N--CA 1.507 2.375 1 N-CA-C 123.129 4.492 . . . . 0.0 123.129 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.413 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.23 -31.59 60.9 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.757 2.873 . . . . 0.0 118.757 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.24 -29.98 0.05 Allowed 'General case' 0 CA--C 1.59 2.482 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 175.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.32 5.79 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.247 2.619 . . . . 0.0 113.546 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.253 87.0 t -80.32 -57.41 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-O 116.802 -1.57 . . . . 0.0 108.468 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -64.75 -47.21 79.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.63 136.97 4.13 Favored Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.279 1.4 . . . . 0.0 112.363 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -42.47 -35.79 1.15 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -69.13 -38.59 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 116.348 -1.787 . . . . 0.0 114.966 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.66 86.04 0.42 Allowed Glycine 0 C--N 1.36 1.88 0 CA-C-N 120.393 1.451 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -99.18 119.64 38.2 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.6 t80 . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.708 0 CA-C-O 119.316 -0.713 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.9 p -70.01 -32.82 71.18 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -59.9 -48.67 80.75 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 121.437 1.926 . . . . 0.0 113.75 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.67 -50.24 74.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 116.603 -1.665 . . . . 0.0 113.415 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.3 m -73.84 -31.46 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 CA-C-O 115.961 -1.971 . . . . 0.0 113.908 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 48.1 mt-10 -73.82 -29.75 62.32 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 122.081 2.219 . . . . 0.0 112.36 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.62 62.54 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -29.86 68.61 Favored 'General case' 0 N--CA 1.486 1.362 1 N-CA-C 123.941 4.793 . . . . 0.0 123.941 -176.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.258 0.9 OUTLIER -61.32 -28.62 69.34 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.22 -50.81 62.52 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 126.213 1.805 . . . . 0.0 113.192 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.262 88.8 t -80.37 -60.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.281 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.8 m -66.67 -41.72 87.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.94 133.14 5.54 Favored Glycine 0 C--N 1.358 1.802 0 CA-C-N 120.335 1.425 . . . . 0.0 111.169 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.26 14.3 pt-20 -33.18 -41.04 0.07 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.58 -41.75 59.95 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.824 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.19 86.49 1.16 Allowed Glycine 0 C--N 1.361 1.951 0 CA-C-N 120.579 1.536 . . . . 0.0 110.848 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -100.55 114.65 28.47 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 t80 . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.894 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 CA-C-O 118.77 -1.016 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.6 m -70.82 -37.55 73.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -57.81 -48.17 80.49 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 121.515 1.961 . . . . 0.0 113.975 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.16 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 116.117 -1.896 . . . . 0.0 109.279 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -47.95 -28.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 126.785 2.034 . . . . 0.0 114.106 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.5 -60.76 2.13 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.34 -2.743 . . . . 0.0 106.783 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.63 -36.35 0.11 Allowed 'General case' 0 N--CA 1.507 2.407 1 N-CA-C 123.238 4.532 . . . . 0.0 123.238 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' H ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.97 -30.82 58.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.02 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.35 -30.14 0.06 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.319 3.451 . . . . 0.0 120.319 175.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 -53.9 6.07 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.256 2.622 . . . . 0.0 113.938 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -80.47 -54.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.743 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.4 m -58.88 -47.14 85.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.3 88.33 0.09 OUTLIER Glycine 0 C--N 1.359 1.832 0 CA-C-N 120.654 1.57 . . . . 0.0 111.251 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -42.57 -42.02 3.23 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -65.93 -33.75 76.54 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -154.7 92.0 0.13 Allowed Glycine 0 C--N 1.356 1.678 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -127.1 115.34 19.0 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 p90 . . . . . 0 N--CA 1.492 1.641 0 C-N-CA 124.29 1.036 . . . . 0.0 108.636 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -77.71 -29.97 51.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.254 41.2 p-80 -50.31 -52.0 40.45 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 121.862 2.119 . . . . 0.0 116.647 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.65 -71.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 115.749 -2.072 . . . . 0.0 109.456 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.299 10.4 m -48.47 -27.22 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.084 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -75.89 -60.24 2.41 Favored 'General case' 0 CA--C 1.573 1.835 0 CA-C-O 114.432 -2.699 . . . . 0.0 106.689 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.43 -37.41 0.12 Allowed 'General case' 0 N--CA 1.507 2.401 1 N-CA-C 122.845 4.387 . . . . 0.0 122.845 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.42 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.22 -29.72 60.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.332 0.1 OUTLIER -39.06 -35.87 0.25 Allowed 'General case' 0 CA--C 1.595 2.686 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 175.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -52.07 7.8 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 128.926 2.89 . . . . 0.0 111.667 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 11.5 m -70.92 -56.71 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 125.544 1.538 . . . . 0.0 112.518 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.9 m -74.57 -43.42 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.83 110.09 3.46 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -35.61 -40.76 0.18 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.85 -41.5 59.74 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 116.481 -1.723 . . . . 0.0 113.61 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.04 91.44 1.3 Allowed Glycine 0 C--N 1.361 1.938 0 CA-C-N 120.447 1.476 . . . . 0.0 109.763 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -94.47 116.44 28.79 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 179.833 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.685 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.8 p -80.33 -39.51 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -54.55 -48.46 71.99 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 121.491 1.95 . . . . 0.0 114.239 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.7 tp -58.12 -71.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 115.793 -2.051 . . . . 0.0 109.244 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -49.23 -28.59 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 C-N-CA 126.39 1.876 . . . . 0.0 114.272 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.06 -27.39 43.08 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 114.411 -2.709 . . . . 0.0 112.774 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.68 70.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 120.18 3.4 . . . . 0.0 120.18 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.446 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.95 -30.53 65.39 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.347 0.1 OUTLIER -39.26 -29.79 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.273 3.434 . . . . 0.0 120.273 176.263 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.33 -53.21 6.52 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 129.077 2.951 . . . . 0.0 114.408 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.24 -54.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 CA-C-O 116.634 -1.65 . . . . 0.0 109.451 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.0 m -60.08 -45.34 93.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.48 91.24 0.39 Allowed Glycine 0 C--N 1.359 1.829 0 CA-C-N 120.533 1.515 . . . . 0.0 110.586 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -35.78 -42.36 0.25 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.97 -42.47 69.67 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.88 -128.57 4.01 Favored Glycine 0 C--N 1.358 1.75 0 CA-C-N 119.194 0.907 . . . . 0.0 111.081 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 56.51 92.09 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.723 2.009 . . . . 0.0 112.457 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.3 t -79.9 -41.51 26.02 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 116.392 -1.766 . . . . 0.0 115.242 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -54.84 -45.2 74.45 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.366 1.894 . . . . 0.0 114.588 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.4 tp -63.52 -70.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 116.134 -1.889 . . . . 0.0 109.254 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 t -48.04 -28.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 C-N-CA 126.805 2.042 . . . . 0.0 114.094 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.39 -60.83 2.09 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 114.55 -2.643 . . . . 0.0 106.841 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -36.52 0.11 Allowed 'General case' 0 N--CA 1.505 2.307 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.415 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.34 -31.11 60.46 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.32 -31.51 0.08 Allowed 'General case' 0 CA--C 1.591 2.537 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 175.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.6 -53.45 6.54 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 128.33 2.652 . . . . 0.0 114.039 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.27 -55.85 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 116.691 -1.623 . . . . 0.0 109.31 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -61.74 -48.04 82.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.73 2.492 . . . . 0.0 117.73 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.68 108.53 0.25 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 120.667 1.576 . . . . 0.0 111.312 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -36.73 -44.8 0.49 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -126.69 66.01 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 89.73 0.08 OUTLIER Glycine 0 C--N 1.359 1.808 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.66 126.42 37.73 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.9 t80 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.675 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 CA-C-O 119.185 -0.786 . . . . 0.0 114.579 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.3 p -46.28 -29.33 1.58 Allowed 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 121.893 4.035 . . . . 0.0 121.893 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -45.74 -48.55 15.26 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.36 -72.62 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 116.283 -1.817 . . . . 0.0 110.359 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.385 4.8 p -51.39 -26.8 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.1 -60.26 2.37 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 114.488 -2.672 . . . . 0.0 106.753 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.46 -37.47 0.13 Allowed 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 122.952 4.427 . . . . 0.0 122.952 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.42 ' H ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.52 -31.06 62.03 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.324 0.1 OUTLIER -39.32 -30.01 0.05 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.618 3.562 . . . . 0.0 120.618 175.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.1 5.99 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 128.25 2.62 . . . . 0.0 113.53 -177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 93.1 t -80.32 -58.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 CA-C-O 116.881 -1.533 . . . . 0.0 108.271 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 t -65.02 -43.08 93.61 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.71 127.71 4.06 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 120.292 1.406 . . . . 0.0 110.546 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -39.72 -37.87 0.58 Allowed 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -73.38 -40.29 64.46 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 116.468 -1.729 . . . . 0.0 113.845 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 91.78 1.04 Allowed Glycine 0 C--N 1.361 1.95 0 CA-C-N 120.47 1.486 . . . . 0.0 109.463 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -94.73 99.33 11.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 179.897 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.5 p -78.87 -46.94 17.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.531 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -46.35 -45.11 17.46 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 121.71 2.05 . . . . 0.0 115.472 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -63.65 -70.9 0.19 Allowed 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.161 -1.876 . . . . 0.0 109.626 177.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.263 4.8 t -47.43 -28.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.919 0 CA-C-O 115.85 -2.024 . . . . 0.0 114.282 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.1 -60.3 2.35 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.248 -2.787 . . . . 0.0 106.872 173.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -35.1 0.08 Allowed 'General case' 0 N--CA 1.508 2.428 1 N-CA-C 123.476 4.621 . . . . 0.0 123.476 -178.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -31.74 57.46 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.333 0.1 OUTLIER -39.09 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.488 0 N-CA-C 120.724 3.602 . . . . 0.0 120.724 175.851 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.93 -52.39 7.92 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 128.235 2.614 . . . . 0.0 113.342 -177.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -80.31 -56.25 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-O 117.053 -1.451 . . . . 0.0 107.96 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.7 p -51.81 -35.1 42.96 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 119.912 3.301 . . . . 0.0 119.912 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.99 110.96 2.41 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -39.86 -37.3 0.54 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -72.9 -39.4 66.38 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 116.306 -1.807 . . . . 0.0 114.162 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.42 87.66 1.27 Allowed Glycine 0 C--N 1.36 1.904 0 CA-C-N 120.562 1.528 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -112.95 113.86 26.09 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 179.812 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.23 103.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 1 N-CA-C 99.868 -4.123 . . . . 0.0 99.868 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -96.41 123.0 39.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -132.87 108.57 9.04 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -141.28 118.07 11.06 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.4 mt -139.81 -55.17 0.55 Allowed 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 124.376 1.07 . . . . 0.0 112.734 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.4 p -136.22 132.98 36.58 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.2 1.4 . . . . 0.0 109.598 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.42 86.95 0.13 Allowed Glycine 0 N--CA 1.48 1.625 0 CA-C-O 118.949 -0.917 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.3 p -76.03 -32.99 59.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -55.05 -48.56 73.3 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 121.59 1.995 . . . . 0.0 114.474 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.9 tp -63.37 -70.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 116.202 -1.856 . . . . 0.0 109.633 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -48.66 -27.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.971 0 C-N-CA 126.738 2.015 . . . . 0.0 114.06 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -74.33 -60.7 2.15 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 114.445 -2.693 . . . . 0.0 106.847 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.53 -36.51 0.11 Allowed 'General case' 0 N--CA 1.506 2.356 1 N-CA-C 123.182 4.512 . . . . 0.0 123.182 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.419 ' H ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.55 -31.26 59.98 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.802 2.89 . . . . 0.0 118.802 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.31 -29.71 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 175.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.4 -54.66 5.5 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.241 2.616 . . . . 0.0 113.172 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 99.3 t -80.51 -59.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 116.859 -1.543 . . . . 0.0 108.056 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.3 m -68.72 -46.29 69.32 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.26 177.58 51.95 Favored Glycine 0 C--N 1.36 1.868 0 CA-C-N 120.464 1.483 . . . . 0.0 114.552 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.24 72.46 1.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 123.627 1.679 . . . . 0.0 112.158 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -164.99 -41.64 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 128.043 2.537 . . . . 0.0 108.974 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.3 82.27 1.68 Allowed Glycine 0 C--N 1.368 2.332 0 CA-C-N 120.288 1.404 . . . . 0.0 113.873 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -143.89 117.12 8.98 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -126.63 -58.28 1.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 116.785 -1.578 . . . . 0.0 111.427 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -82.05 136.8 35.17 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.607 1.549 . . . . 0.0 111.599 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.1 p 64.41 124.19 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.419 0 CA-C-O 112.956 -3.402 . . . . 0.0 111.802 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.59 144.95 28.94 Favored 'Trans proline' 0 C--N 1.394 2.943 0 CA-C-N 127.491 3.711 . . . . 0.0 113.415 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -130.49 113.24 14.03 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.205 0 O-C-N 124.128 0.893 . . . . 0.0 111.007 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 23.4 t80 . . . . . 0 CA--C 1.563 1.468 0 CA-C-O 116.604 -1.665 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.363 55.3 t -98.63 -96.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -97.89 118.71 35.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.515 1.126 . . . . 0.0 108.509 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -100.57 114.82 28.79 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -134.87 107.05 7.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.3 mt -138.45 -53.33 0.61 Allowed 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 124.358 1.063 . . . . 0.0 113.098 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 84.5 p -113.18 128.57 56.52 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.937 1.295 . . . . 0.0 109.497 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.84 90.03 0.08 OUTLIER Glycine 0 N--CA 1.474 1.224 0 CA-C-O 118.761 -1.022 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.5 p -70.38 -31.01 68.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 118.262 2.69 . . . . 0.0 118.262 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -58.12 -49.56 76.55 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 121.417 1.917 . . . . 0.0 114.126 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.6 -72.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 115.389 -2.243 . . . . 0.0 108.869 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 12.6 m -48.42 -28.02 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 11.7 mm-40 -80.09 -27.34 39.28 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 114.195 -2.812 . . . . 0.0 112.819 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.11 72.15 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.28 -30.84 66.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.692 3.219 . . . . 0.0 119.692 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.345 0.0 OUTLIER -39.34 -29.85 0.05 Allowed 'General case' 0 CA--C 1.59 2.483 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 176.495 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.35 -53.45 6.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 129.046 2.938 . . . . 0.0 114.344 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.21 -55.78 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 116.613 -1.66 . . . . 0.0 109.187 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -63.24 -47.35 82.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.61 148.55 4.92 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 120.41 1.459 . . . . 0.0 112.437 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -42.01 -36.71 1.18 Allowed 'General case' 0 N--CA 1.511 2.597 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -71.91 -42.22 66.97 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 116.486 -1.721 . . . . 0.0 113.593 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.66 -178.09 53.83 Favored Glycine 0 C--N 1.36 1.898 0 CA-C-N 120.208 1.367 . . . . 0.0 114.67 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -126.95 -31.33 2.64 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . 0.338 90.6 m-85 69.96 -68.22 0.21 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 126.72 2.008 . . . . 0.0 111.935 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -157.68 128.96 6.7 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 36.8 p -81.76 129.18 66.21 Favored Pre-proline 0 CA--C 1.584 2.256 0 CA-C-O 114.142 -2.837 . . . . 0.0 110.006 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.4 -28.3 34.78 Favored 'Trans proline' 0 C--N 1.392 2.832 0 N-CA-C 122.067 3.833 . . . . 0.0 122.067 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -143.02 120.09 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.869 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 . . . . . 0 CA--C 1.563 1.471 0 CA-C-O 116.693 -1.623 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 m -94.24 93.61 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 t30 56.96 115.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 126.973 2.109 . . . . 0.0 112.924 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -126.83 -65.9 0.93 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.8 -1.572 . . . . 0.0 109.516 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -92.48 128.81 38.47 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 120.626 1.557 . . . . 0.0 108.232 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 pp -133.31 140.37 47.39 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.34 1.056 . . . . 0.0 109.909 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.9 m -78.21 -45.51 22.82 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.59 -123.31 7.89 Favored Glycine 0 C--N 1.36 1.884 0 CA-C-N 120.568 1.531 . . . . 0.0 110.114 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.3 m -74.17 -33.8 63.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -54.74 -49.22 71.36 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 121.756 2.071 . . . . 0.0 114.699 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.28 -72.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 115.283 -2.294 . . . . 0.0 108.964 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 11.4 m -47.85 -28.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.2 -27.51 38.83 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 114.216 -2.802 . . . . 0.0 112.6 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.15 -36.58 72.1 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 120.134 3.383 . . . . 0.0 120.134 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.431 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.12 -30.34 64.96 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.482 3.141 . . . . 0.0 119.482 -178.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.3 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.588 2.416 0 N-CA-C 120.35 3.463 . . . . 0.0 120.35 176.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.96 -54.87 5.2 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 128.847 2.859 . . . . 0.0 114.013 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -80.39 -54.2 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 116.716 -1.612 . . . . 0.0 109.452 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -60.99 -48.17 83.06 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.1 101.19 0.18 Allowed Glycine 0 C--N 1.36 1.865 0 CA-C-N 120.757 1.617 . . . . 0.0 111.711 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -38.92 -45.48 1.19 Allowed 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -120.04 66.65 0.82 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.47 -80.95 0.06 OUTLIER Glycine 0 C--N 1.359 1.837 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.2 t80 63.89 96.75 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 126.676 1.991 . . . . 0.0 111.553 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -137.28 111.97 8.79 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -134.26 119.8 19.19 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.2 m -95.88 114.23 63.68 Favored Pre-proline 0 CA--C 1.588 2.404 0 CA-C-O 113.967 -2.92 . . . . 0.0 105.539 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.27 135.0 18.03 Favored 'Trans proline' 0 C--N 1.395 3.018 0 CA-C-N 126.908 3.503 . . . . 0.0 112.931 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -86.5 -64.1 1.21 Allowed 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 116.677 -1.63 . . . . 0.0 110.485 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 CA-C-N 120.418 1.463 . . . . 0.0 109.907 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 CA--C 1.563 1.476 0 CA-C-O 116.71 -1.614 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 m -148.72 94.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 59.46 117.93 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 126.764 2.026 . . . . 0.0 112.351 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -135.26 116.39 14.35 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -133.35 111.86 11.14 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.4 mt -144.55 120.99 10.99 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.3 m -93.6 125.72 38.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.755 0.822 . . . . 0.0 109.007 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.1 179.12 32.31 Favored Glycine 0 N--CA 1.484 1.885 0 O-C-N 124.021 0.825 . . . . 0.0 114.252 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -77.53 -31.71 53.56 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -58.66 -51.27 70.66 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 121.727 2.058 . . . . 0.0 113.679 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 tp -56.67 -43.04 80.03 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 116.877 -1.535 . . . . 0.0 114.865 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.6 -41.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 115.476 -2.202 . . . . 0.0 109.742 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.298 39.7 mt-10 -64.9 -29.21 70.15 Favored 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 123.053 2.66 . . . . 0.0 113.826 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.85 63.15 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -29.8 62.05 Favored 'General case' 0 N--CA 1.485 1.309 1 N-CA-C 124.499 4.999 . . . . 0.0 124.499 -176.49 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -61.07 -29.9 70.02 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 mt -72.47 -46.95 52.46 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 126.646 1.978 . . . . 0.0 113.721 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.256 95.6 t -80.44 -59.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.269 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -65.63 -45.7 82.04 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 117.026 2.232 . . . . 0.0 117.026 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.59 114.94 1.7 Allowed Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.609 1.55 . . . . 0.0 110.066 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -40.49 -41.09 1.36 Allowed 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 117.649 2.462 . . . . 0.0 117.649 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -73.04 -38.15 66.61 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 116.333 -1.794 . . . . 0.0 114.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 89.53 1.28 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 120.519 1.509 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -97.47 105.57 17.74 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -137.88 115.65 11.44 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -99.54 114.28 27.2 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.3 m -98.43 107.78 44.01 Favored Pre-proline 0 CA--C 1.585 2.313 0 CA-C-O 114.033 -2.889 . . . . 0.0 104.885 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -79.3 121.81 4.94 Favored 'Trans proline' 0 C--N 1.395 2.986 0 CA-C-N 126.596 3.392 . . . . 0.0 111.801 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.07 -57.5 2.94 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 116.696 -1.621 . . . . 0.0 111.209 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.365 1.251 0 CA-C-N 120.844 1.656 . . . . 0.0 109.784 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . 0.266 45.8 p90 . . . . . 0 CA--C 1.562 1.441 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.716 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -92.24 93.08 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -136.17 121.74 19.55 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.18 0.992 . . . . 0.0 108.561 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -128.31 113.53 15.73 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -81.74 -62.44 1.64 Allowed 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 116.669 -1.634 . . . . 0.0 112.243 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 tp -138.67 117.41 12.28 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.2 p -93.42 129.73 39.47 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 124.256 0.972 . . . . 0.0 109.434 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.88 92.69 0.1 Allowed Glycine 0 N--CA 1.476 1.347 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 m -71.3 -30.57 66.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -58.87 -51.64 69.16 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 121.616 2.007 . . . . 0.0 113.57 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.09 -54.79 43.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 116.201 -1.857 . . . . 0.0 112.873 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.4 m -70.14 -30.21 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 CA-C-O 115.736 -2.078 . . . . 0.0 114.749 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.292 40.5 mt-10 -75.53 -29.85 59.58 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 122.342 2.337 . . . . 0.0 112.469 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.6 65.39 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -29.62 62.51 Favored 'General case' 0 N--CA 1.487 1.409 1 N-CA-C 124.665 5.061 . . . . 0.0 124.665 -176.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -61.06 -29.4 69.71 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.3 mt -72.77 -54.05 9.94 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 126.762 2.025 . . . . 0.0 112.497 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.274 93.1 t -81.14 -62.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-O 117.069 -1.444 . . . . 0.0 107.913 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -70.84 -53.48 15.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.16 169.85 12.41 Favored Glycine 0 C--N 1.361 1.919 0 CA-C-N 120.618 1.554 . . . . 0.0 114.095 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -37.64 -36.43 0.17 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 119.182 3.03 . . . . 0.0 119.182 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -65.0 -43.92 90.96 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 116.43 -1.748 . . . . 0.0 115.164 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.0 -129.18 8.88 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-N 120.201 1.364 . . . . 0.0 113.191 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.27 134.42 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -93.13 114.92 27.55 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -79.44 -45.48 19.36 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.2 m -92.94 118.38 67.85 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-O 113.889 -2.958 . . . . 0.0 106.408 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.29 145.76 39.16 Favored 'Trans proline' 0 C--N 1.394 2.944 0 CA-C-N 126.942 3.515 . . . . 0.0 113.635 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.06 127.66 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 126.518 1.927 . . . . 0.0 111.25 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 O-C-N 124.481 1.113 . . . . 0.0 110.814 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 CA--C 1.564 1.5 0 CA-C-O 116.68 -1.628 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.8 t -145.46 103.72 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 1 N-CA-C 99.761 -4.162 . . . . 0.0 99.761 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -138.88 121.47 16.26 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -103.01 119.79 39.48 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -134.18 114.83 13.51 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.4 tp -134.95 109.48 8.49 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -136.68 130.93 32.87 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.218 1.007 . . . . 0.0 108.97 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.65 84.36 0.07 OUTLIER Glycine 0 N--CA 1.477 1.38 0 O-C-N 124.272 0.983 . . . . 0.0 111.915 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -80.01 -37.04 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -58.39 -53.53 57.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.483 1.947 . . . . 0.0 113.62 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.21 -50.9 72.27 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 124.943 1.297 . . . . 0.0 113.664 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.292 14.9 t -69.18 -26.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 115.209 -2.329 . . . . 0.0 112.49 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 47.3 mt-10 -80.76 -58.39 3.12 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 123.415 2.825 . . . . 0.0 108.237 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . 0.41 . . -33.6 -34.3 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 1 N-CA-C 125.167 5.247 . . . . 0.0 125.167 -178.351 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.438 HD11 ' H ' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -77.37 -37.76 51.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 119.785 3.254 . . . . 0.0 119.785 -176.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.361 0.1 OUTLIER -39.53 -33.62 0.18 Allowed 'General case' 0 CA--C 1.591 2.553 0 N-CA-C 119.822 3.267 . . . . 0.0 119.822 174.879 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.1 -55.22 4.9 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 128.906 2.882 . . . . 0.0 113.938 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.264 99.2 t -80.04 -60.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 CA-C-O 116.947 -1.501 . . . . 0.0 107.813 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -65.11 -45.93 83.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.31 169.0 41.31 Favored Glycine 0 C--N 1.359 1.852 0 CA-C-N 120.117 1.326 . . . . 0.0 114.846 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -39.65 -41.58 1.08 Allowed 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.57 60.82 0.94 Allowed 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 123.704 0.802 . . . . 0.0 109.452 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.34 -122.17 3.83 Favored Glycine 0 C--N 1.359 1.857 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -88.71 135.55 33.45 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.841 0.856 . . . . 0.0 110.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -93.28 124.56 37.35 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -79.42 -56.99 3.92 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.8 p -90.7 124.3 62.71 Favored Pre-proline 0 CA--C 1.583 2.218 0 CA-C-O 114.253 -2.784 . . . . 0.0 107.952 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.79 142.08 68.26 Favored 'Trans proline' 0 C--N 1.397 3.106 0 CA-C-N 127.089 3.567 . . . . 0.0 114.903 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -120.85 -66.7 1.03 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 117.166 -1.397 . . . . 0.0 109.104 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.079 0 C-N-CA 126.774 2.03 . . . . 0.0 115.187 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 CA--C 1.564 1.508 0 CA-C-O 116.756 -1.592 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -92.98 119.22 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -94.14 124.79 38.38 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -96.67 123.93 40.5 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -136.49 104.09 5.47 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 pp -88.58 140.44 29.46 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.002 0.921 . . . . 0.0 110.68 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -133.73 120.8 21.03 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.19 -177.11 49.87 Favored Glycine 0 N--CA 1.482 1.727 0 O-C-N 124.111 0.882 . . . . 0.0 114.208 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -74.17 -35.82 64.03 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -53.32 -48.69 68.22 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 121.377 1.899 . . . . 0.0 115.874 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -63.77 -71.02 0.18 Allowed 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 116.309 -1.805 . . . . 0.0 109.307 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 t -47.76 -27.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 C-N-CA 126.886 2.074 . . . . 0.0 114.298 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.74 -62.58 1.49 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 114.245 -2.788 . . . . 0.0 106.359 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.45 -34.94 0.07 Allowed 'General case' 0 N--CA 1.506 2.357 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -31.72 60.54 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.331 0.1 OUTLIER -38.72 -34.73 0.16 Allowed 'General case' 0 CA--C 1.589 2.466 0 N-CA-C 120.183 3.401 . . . . 0.0 120.183 175.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.32 -55.05 4.97 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 128.661 2.785 . . . . 0.0 113.941 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 98.9 t -80.06 -60.07 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-O 116.912 -1.518 . . . . 0.0 108.104 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m -63.3 -44.41 95.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.64 135.95 4.37 Favored Glycine 0 C--N 1.361 1.932 0 CA-C-N 120.325 1.42 . . . . 0.0 111.912 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -41.35 -37.0 0.91 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.65 -39.47 67.13 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.963 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.06 87.18 0.55 Allowed Glycine 0 C--N 1.36 1.879 0 CA-C-N 120.496 1.498 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -99.12 96.69 7.96 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -145.02 121.65 11.12 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -133.2 116.81 16.67 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p 65.07 125.43 0.02 OUTLIER Pre-proline 0 N--CA 1.508 2.461 0 CA-C-O 112.982 -3.39 . . . . 0.0 111.619 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.85 121.43 6.25 Favored 'Trans proline' 0 C--N 1.395 2.984 0 CA-C-N 127.631 3.761 . . . . 0.0 112.246 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.04 113.71 11.72 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 O-C-N 124.115 0.885 . . . . 0.0 110.758 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 t80 . . . . . 0 CA--C 1.565 1.537 0 CA-C-O 116.862 -1.542 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.358 9.7 p -76.71 -59.23 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 CA-C-N 120.623 1.556 . . . . 0.0 113.01 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -92.49 122.56 35.04 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -140.24 126.54 19.96 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -79.36 -56.95 3.96 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 116.807 -1.568 . . . . 0.0 112.781 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.7 mt -92.9 124.79 37.14 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 120.419 1.463 . . . . 0.0 107.772 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.0 p -75.43 -46.1 34.78 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.68 84.01 1.39 Allowed Glycine 0 C--N 1.36 1.902 0 CA-C-N 120.535 1.516 . . . . 0.0 112.24 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -79.89 -39.6 30.11 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 116.37 -1.776 . . . . 0.0 115.509 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -55.44 -46.36 76.75 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 121.403 1.911 . . . . 0.0 114.447 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.1 -70.69 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 116.235 -1.84 . . . . 0.0 109.414 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.5 t -48.52 -27.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 126.75 2.02 . . . . 0.0 114.08 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.03 -60.9 2.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 114.423 -2.703 . . . . 0.0 106.914 173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.54 -36.85 0.11 Allowed 'General case' 0 N--CA 1.507 2.389 1 N-CA-C 123.118 4.488 . . . . 0.0 123.118 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.422 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 -31.27 61.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.18 -30.52 0.06 Allowed 'General case' 0 CA--C 1.59 2.51 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -51.71 8.42 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 128.44 2.696 . . . . 0.0 113.807 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.252 86.2 t -80.29 -58.2 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 CA-C-O 116.691 -1.623 . . . . 0.0 108.525 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.9 m -63.64 -42.24 98.16 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.84 165.14 14.31 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 120.36 1.436 . . . . 0.0 113.701 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.279 12.7 pt-20 -33.6 -43.94 0.14 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.05 66.41 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.28 159.28 6.38 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 119.448 1.022 . . . . 0.0 115.313 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -89.6 137.39 32.37 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.906 0.882 . . . . 0.0 110.239 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -86.48 128.06 34.92 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.78 0.832 . . . . 0.0 109.253 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -73.45 -44.56 57.85 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.9 m -90.48 117.37 67.94 Favored Pre-proline 0 CA--C 1.59 2.492 0 CA-C-O 113.802 -2.999 . . . . 0.0 106.823 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.72 144.21 31.04 Favored 'Trans proline' 0 C--N 1.394 2.931 0 CA-C-N 126.894 3.498 . . . . 0.0 113.596 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -85.91 -63.11 1.37 Allowed 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 116.694 -1.622 . . . . 0.0 110.805 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 CA-C-N 120.48 1.491 . . . . 0.0 110.819 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.305 40.7 t 85.23 96.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -136.05 120.94 18.63 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -138.46 -61.99 0.58 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 116.723 -1.608 . . . . 0.0 110.516 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.252 28.4 p80 -89.78 -57.95 2.68 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 121.17 1.805 . . . . 0.0 113.797 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.6 tp -92.29 121.13 33.5 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 119.874 1.215 . . . . 0.0 107.822 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.3 p -120.24 -50.43 2.24 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 116.442 -1.742 . . . . 0.0 114.419 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.83 87.72 0.07 OUTLIER Glycine 0 C--N 1.359 1.856 0 CA-C-N 120.595 1.543 . . . . 0.0 110.859 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 m -76.03 -36.48 59.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -52.09 -48.82 64.54 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 121.547 1.976 . . . . 0.0 115.943 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.54 -70.91 0.2 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 116.211 -1.852 . . . . 0.0 109.361 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 t -48.51 -27.81 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.941 0 C-N-CA 126.83 2.052 . . . . 0.0 114.12 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.24 -62.58 1.47 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 114.346 -2.74 . . . . 0.0 106.493 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.38 -35.09 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.81 -32.24 61.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.33 0.1 OUTLIER -38.56 -35.01 0.16 Allowed 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 120.222 3.416 . . . . 0.0 120.222 175.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.52 -53.81 5.96 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 128.626 2.771 . . . . 0.0 114.802 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 86.3 t -77.88 -57.13 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 116.753 -1.594 . . . . 0.0 109.168 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -60.26 -42.2 94.82 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.12 161.97 12.92 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 120.181 1.355 . . . . 0.0 113.217 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -39.86 -38.36 0.67 Allowed 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -75.5 -39.79 58.0 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.99 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.81 146.32 6.24 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 120.637 1.562 . . . . 0.0 113.209 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -84.7 147.14 27.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.025 0.93 . . . . 0.0 111.545 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -83.12 129.88 35.06 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.024 0.93 . . . . 0.0 109.241 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -84.77 136.71 33.58 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.052 0.941 . . . . 0.0 110.317 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 t -133.91 121.75 16.04 Favored Pre-proline 0 CA--C 1.58 2.111 0 CA-C-O 112.962 -3.399 . . . . 0.0 109.099 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -63.86 140.26 72.48 Favored 'Trans proline' 0 C--N 1.396 3.066 0 CA-C-N 127.93 3.868 . . . . 0.0 115.063 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -121.02 114.73 21.93 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.897 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.564 1.518 0 CA-C-O 116.657 -1.64 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 m -148.11 112.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -95.09 121.42 36.7 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -91.54 111.18 22.59 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.027 0.931 . . . . 0.0 108.696 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -85.17 141.87 29.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 124.267 0.979 . . . . 0.0 111.581 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.2 mt 64.44 136.64 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 126.324 1.85 . . . . 0.0 111.86 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -80.66 136.27 36.18 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.942 0.897 . . . . 0.0 112.183 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.01 -82.29 0.04 OUTLIER Glycine 0 N--CA 1.481 1.694 0 CA-C-O 118.702 -1.055 . . . . 0.0 111.805 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -69.95 -38.07 76.04 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.259 31.8 p80 -57.56 -51.32 69.96 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-N 121.76 2.073 . . . . 0.0 114.675 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.7 tp -59.23 -71.38 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 115.808 -2.044 . . . . 0.0 108.723 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 t -48.94 -28.55 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.883 0 C-N-CA 126.429 1.892 . . . . 0.0 113.987 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -78.93 -27.07 43.66 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 114.377 -2.725 . . . . 0.0 113.148 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.42 -37.46 71.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 119.837 3.273 . . . . 0.0 119.837 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.456 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.65 -31.11 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -178.178 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.339 0.0 OUTLIER -38.86 -28.98 0.03 OUTLIER 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 176.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.8 -52.56 7.76 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.816 2.846 . . . . 0.0 113.12 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.37 -55.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 117.111 -1.423 . . . . 0.0 107.542 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.2 p -56.12 -41.48 75.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 118.873 2.916 . . . . 0.0 118.873 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.05 122.29 2.41 Favored Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -36.02 -43.12 0.31 Allowed 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -125.98 66.78 1.19 Allowed 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 92.07 0.1 OUTLIER Glycine 0 C--N 1.358 1.774 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -92.98 109.45 20.9 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -144.28 102.28 3.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -97.4 92.67 6.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.8 m -142.34 114.89 6.31 Favored Pre-proline 0 CA--C 1.586 2.336 0 CA-C-O 114.202 -2.809 . . . . 0.0 104.827 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -70.15 135.44 29.53 Favored 'Trans proline' 0 C--N 1.394 2.956 0 CA-C-N 126.825 3.473 . . . . 0.0 113.731 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp 64.51 129.22 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 126.397 1.879 . . . . 0.0 111.086 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 O-C-N 124.174 0.921 . . . . 0.0 111.054 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 93.9 t -114.68 103.95 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 1 N-CA-C 99.981 -4.081 . . . . 0.0 99.981 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -118.92 126.38 51.63 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -79.08 -50.89 10.32 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 117.195 -1.383 . . . . 0.0 113.063 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 63.21 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 126.584 1.954 . . . . 0.0 111.716 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . 0.255 13.1 tp 60.11 82.32 0.16 Allowed 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.657 1.983 . . . . 0.0 112.354 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 t -97.98 131.97 43.96 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.892 0.877 . . . . 0.0 109.156 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.1 139.69 4.29 Favored Glycine 0 CA--C 1.54 1.611 0 O-C-N 124.23 0.956 . . . . 0.0 112.096 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.1 m -73.6 -34.23 64.96 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -52.54 -48.59 66.01 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 121.641 2.019 . . . . 0.0 114.483 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.88 -71.53 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 115.83 -2.033 . . . . 0.0 109.289 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -49.7 -28.44 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 C-N-CA 126.346 1.858 . . . . 0.0 114.127 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.67 -27.22 45.14 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 114.442 -2.694 . . . . 0.0 112.869 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.94 70.86 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 120.055 3.354 . . . . 0.0 120.055 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.447 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.25 -29.97 64.42 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.476 3.139 . . . . 0.0 119.476 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.342 0.1 OUTLIER -39.22 -29.55 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.495 0 N-CA-C 120.345 3.461 . . . . 0.0 120.345 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.88 -53.79 6.16 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 128.963 2.905 . . . . 0.0 113.681 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 95.8 t -80.31 -59.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 116.825 -1.56 . . . . 0.0 107.916 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 64.7 m -68.46 -44.33 75.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.36 171.82 38.16 Favored Glycine 0 C--N 1.36 1.874 0 CA-C-N 120.355 1.434 . . . . 0.0 114.775 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -36.2 -42.41 0.31 Allowed 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -122.59 65.04 0.95 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.05 88.89 0.12 Allowed Glycine 0 C--N 1.359 1.85 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -134.96 119.67 18.27 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -121.73 120.52 34.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -124.81 -60.91 1.34 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.289 1.035 . . . . 0.0 111.955 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.8 p -86.92 131.92 43.51 Favored Pre-proline 0 CA--C 1.582 2.196 0 CA-C-O 114.186 -2.816 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.67 145.19 32.52 Favored 'Trans proline' 0 C--N 1.394 2.958 0 CA-C-N 126.678 3.421 . . . . 0.0 113.678 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -83.7 -60.95 1.96 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 116.705 -1.617 . . . . 0.0 111.804 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 CA-C-N 120.403 1.456 . . . . 0.0 110.905 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 m -96.15 99.59 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -93.19 127.4 38.74 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -95.52 112.77 24.42 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -134.76 122.45 22.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -89.85 111.88 23.05 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.133 0.973 . . . . 0.0 108.705 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.5 m -90.79 131.06 36.67 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.369 1.043 . . . . 0.0 110.238 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.13 -85.14 1.43 Allowed Glycine 0 N--CA 1.481 1.683 0 O-C-N 124.26 0.975 . . . . 0.0 111.188 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -72.18 -31.52 66.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -56.55 -49.88 73.53 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.449 1.932 . . . . 0.0 114.198 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.53 -70.78 0.19 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 116.177 -1.868 . . . . 0.0 109.431 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -48.61 -28.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 C-N-CA 126.823 2.049 . . . . 0.0 113.959 178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.05 -60.7 2.14 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 114.319 -2.753 . . . . 0.0 107.18 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.6 0.11 Allowed 'General case' 0 N--CA 1.506 2.362 1 N-CA-C 123.048 4.462 . . . . 0.0 123.048 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.41 -31.38 60.37 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.32 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.516 0 N-CA-C 120.67 3.582 . . . . 0.0 120.67 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.22 -51.79 8.52 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 128.269 2.628 . . . . 0.0 113.597 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -80.1 -55.71 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-O 117.038 -1.458 . . . . 0.0 107.968 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 94.1 p -51.36 -35.2 37.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.777 3.251 . . . . 0.0 119.777 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.76 103.48 1.55 Allowed Glycine 0 C--N 1.358 1.804 0 CA-C-N 120.071 1.305 . . . . 0.0 110.186 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -38.94 -38.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.457 2.762 . . . . 0.0 118.457 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -74.2 -39.88 62.84 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 116.462 -1.733 . . . . 0.0 113.948 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.45 93.72 0.98 Allowed Glycine 0 C--N 1.361 1.928 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -91.49 117.91 30.11 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -142.61 118.07 10.3 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -95.87 116.05 28.34 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.9 m -134.75 114.65 12.11 Favored Pre-proline 0 CA--C 1.587 2.396 0 CA-C-O 114.048 -2.882 . . . . 0.0 105.13 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.15 145.13 34.56 Favored 'Trans proline' 0 C--N 1.394 2.966 0 CA-C-N 126.857 3.485 . . . . 0.0 113.497 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -140.54 122.48 15.54 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.892 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 44.4 t80 . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.371 8.0 p -133.04 -64.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 C-N-CA 124.484 1.114 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -92.57 130.2 38.29 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.799 1.239 . . . . 0.0 108.352 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -93.14 117.92 30.63 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -93.16 132.94 36.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 124.401 1.063 . . . . 0.0 108.657 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.5 mt -92.62 122.32 34.92 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.4 t -75.23 -49.13 20.32 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.39 -78.03 0.11 Allowed Glycine 0 C--N 1.36 1.862 0 CA-C-N 120.789 1.632 . . . . 0.0 113.333 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -61.69 -29.92 70.4 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -57.7 -50.56 72.8 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 121.296 1.862 . . . . 0.0 114.117 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.0 tp -62.46 -72.44 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 115.27 -2.3 . . . . 0.0 108.998 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 12.0 m -47.96 -28.1 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.17 -27.5 38.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 114.035 -2.888 . . . . 0.0 112.585 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -36.82 72.8 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.095 3.369 . . . . 0.0 120.095 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.17 -30.1 64.66 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.4 -29.65 0.05 Allowed 'General case' 0 CA--C 1.589 2.444 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 176.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.9 -53.2 6.67 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 129.034 2.934 . . . . 0.0 114.181 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -80.3 -55.4 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 116.714 -1.612 . . . . 0.0 108.98 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.5 t -59.42 -40.46 86.78 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.32 101.49 2.42 Favored Glycine 0 C--N 1.357 1.727 0 CA-C-N 120.342 1.428 . . . . 0.0 110.191 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -40.2 -36.22 0.49 Allowed 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -70.81 -39.72 72.91 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 116.395 -1.764 . . . . 0.0 114.382 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.94 84.02 0.35 Allowed Glycine 0 C--N 1.36 1.903 0 CA-C-N 120.644 1.566 . . . . 0.0 110.844 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.02 120.95 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.85 96.75 3.86 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.254 48.9 t80 -124.45 -65.17 1.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 124.423 1.089 . . . . 0.0 110.989 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -85.84 122.17 72.97 Favored Pre-proline 0 CA--C 1.58 2.125 0 CA-C-O 112.81 -3.471 . . . . 0.0 110.231 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -65.06 140.26 64.8 Favored 'Trans proline' 0 C--N 1.395 2.975 0 CA-C-N 127.794 3.819 . . . . 0.0 114.9 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -97.03 116.66 29.62 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 O-C-N 124.297 0.998 . . . . 0.0 110.993 -179.988 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.304 26.9 t 83.26 95.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.706 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -140.66 122.1 15.04 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 64.89 128.72 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 C-N-CA 126.484 1.914 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -93.15 122.54 35.64 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.1 mt -94.0 123.9 37.66 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.2 p -87.97 132.03 34.39 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.155 0.909 . . . . 0.0 110.964 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.06 85.88 1.34 Allowed Glycine 0 N--CA 1.482 1.707 0 O-C-N 124.356 1.035 . . . . 0.0 111.506 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -77.17 -38.03 52.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -57.39 -47.94 80.36 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 121.428 1.922 . . . . 0.0 114.144 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.91 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 116.262 -1.828 . . . . 0.0 109.204 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -47.95 -27.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 C-N-CA 126.826 2.05 . . . . 0.0 114.04 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -74.3 -61.01 2.01 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 114.434 -2.698 . . . . 0.0 107.156 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.55 0.11 Allowed 'General case' 0 N--CA 1.507 2.375 1 N-CA-C 123.129 4.492 . . . . 0.0 123.129 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.413 ' H ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.23 -31.59 60.9 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.757 2.873 . . . . 0.0 118.757 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.24 -29.98 0.05 Allowed 'General case' 0 CA--C 1.59 2.482 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 175.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.32 5.79 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.247 2.619 . . . . 0.0 113.546 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.253 87.0 t -80.32 -57.41 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-O 116.802 -1.57 . . . . 0.0 108.468 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -64.75 -47.21 79.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.63 136.97 4.13 Favored Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.279 1.4 . . . . 0.0 112.363 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -42.47 -35.79 1.15 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -69.13 -38.59 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 116.348 -1.787 . . . . 0.0 114.966 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.66 86.04 0.42 Allowed Glycine 0 C--N 1.36 1.88 0 CA-C-N 120.393 1.451 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -99.18 119.64 38.2 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -130.61 114.88 15.99 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.26 46.4 t80 -124.03 -64.6 1.12 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 124.342 1.057 . . . . 0.0 111.264 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.5 p -89.1 131.17 41.77 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 114.258 -2.782 . . . . 0.0 108.939 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -65.42 138.01 53.35 Favored 'Trans proline' 0 C--N 1.395 3.014 0 CA-C-N 126.939 3.514 . . . . 0.0 114.829 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -98.71 122.13 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.939 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 84.5 t -109.81 104.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 1 N-CA-C 100.047 -4.057 . . . . 0.0 100.047 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -73.35 -47.13 44.82 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -88.68 116.26 26.8 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.826 1.25 . . . . 0.0 109.111 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -136.71 114.34 11.09 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.1 mt -142.75 116.0 8.96 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.2 p -88.12 134.25 33.81 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.899 0.88 . . . . 0.0 111.266 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.66 132.02 10.95 Favored Glycine 0 CA--C 1.541 1.708 0 O-C-N 124.268 0.98 . . . . 0.0 111.76 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.9 p -70.01 -32.82 71.18 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -59.9 -48.67 80.75 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 121.437 1.926 . . . . 0.0 113.75 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.67 -50.24 74.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 116.603 -1.665 . . . . 0.0 113.415 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.3 m -73.84 -31.46 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 CA-C-O 115.961 -1.971 . . . . 0.0 113.908 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 48.1 mt-10 -73.82 -29.75 62.32 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 122.081 2.219 . . . . 0.0 112.36 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.62 62.54 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -29.86 68.61 Favored 'General case' 0 N--CA 1.486 1.362 1 N-CA-C 123.941 4.793 . . . . 0.0 123.941 -176.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.258 0.9 OUTLIER -61.32 -28.62 69.34 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.22 -50.81 62.52 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 126.213 1.805 . . . . 0.0 113.192 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.262 88.8 t -80.37 -60.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.281 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.8 m -66.67 -41.72 87.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.94 133.14 5.54 Favored Glycine 0 C--N 1.358 1.802 0 CA-C-N 120.335 1.425 . . . . 0.0 111.169 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.26 14.3 pt-20 -33.18 -41.04 0.07 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.58 -41.75 59.95 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.824 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.19 86.49 1.16 Allowed Glycine 0 C--N 1.361 1.951 0 CA-C-N 120.579 1.536 . . . . 0.0 110.848 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -100.55 114.65 28.47 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -138.03 115.91 11.54 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.261 47.0 t80 -127.64 -66.3 0.88 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.399 1.08 . . . . 0.0 110.701 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.4 p -89.12 132.74 36.9 Favored Pre-proline 0 CA--C 1.581 2.163 0 CA-C-O 114.296 -2.764 . . . . 0.0 109.271 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.77 148.52 41.43 Favored 'Trans proline' 0 C--N 1.395 2.979 0 CA-C-N 126.671 3.418 . . . . 0.0 113.634 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.328 49.2 mtpt 69.26 -58.37 0.51 Allowed 'General case' 0 N--CA 1.51 2.549 0 C-N-CA 125.95 1.7 . . . . 0.0 113.703 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.27 0 CA-C-N 120.223 1.374 . . . . 0.0 110.491 179.925 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 p90 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.45 111.63 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 t30 57.79 115.82 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 126.799 2.04 . . . . 0.0 112.467 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -133.76 119.36 19.17 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -88.45 99.87 12.61 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.954 0.902 . . . . 0.0 109.142 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -86.57 138.41 31.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.115 0.966 . . . . 0.0 111.048 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -88.22 133.09 34.12 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.809 0.844 . . . . 0.0 110.186 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.57 -84.46 0.05 OUTLIER Glycine 0 N--CA 1.479 1.514 0 O-C-N 124.328 1.017 . . . . 0.0 111.616 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.6 m -70.82 -37.55 73.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -57.81 -48.17 80.49 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 121.515 1.961 . . . . 0.0 113.975 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.16 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 116.117 -1.896 . . . . 0.0 109.279 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -47.95 -28.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 126.785 2.034 . . . . 0.0 114.106 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.5 -60.76 2.13 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.34 -2.743 . . . . 0.0 106.783 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.63 -36.35 0.11 Allowed 'General case' 0 N--CA 1.507 2.407 1 N-CA-C 123.238 4.532 . . . . 0.0 123.238 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' H ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.97 -30.82 58.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.02 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.35 -30.14 0.06 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.319 3.451 . . . . 0.0 120.319 175.607 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 -53.9 6.07 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.256 2.622 . . . . 0.0 113.938 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -80.47 -54.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.743 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.4 m -58.88 -47.14 85.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.3 88.33 0.09 OUTLIER Glycine 0 C--N 1.359 1.832 0 CA-C-N 120.654 1.57 . . . . 0.0 111.251 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -42.57 -42.02 3.23 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -65.93 -33.75 76.54 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -154.7 92.0 0.13 Allowed Glycine 0 C--N 1.356 1.678 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -127.1 115.34 19.0 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -138.46 123.57 19.12 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.29 1.036 . . . . 0.0 108.636 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -134.81 118.17 16.73 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.8 m -130.02 109.64 16.82 Favored Pre-proline 0 CA--C 1.586 2.349 0 CA-C-O 114.003 -2.903 . . . . 0.0 104.559 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.81 137.04 17.45 Favored 'Trans proline' 0 C--N 1.394 2.956 0 CA-C-N 126.733 3.44 . . . . 0.0 112.682 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? 62.29 129.69 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 C-N-CA 126.481 1.912 . . . . 0.0 111.765 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 O-C-N 124.297 0.998 . . . . 0.0 110.841 179.891 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -137.04 94.38 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.93 124.69 40.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -91.74 141.03 29.13 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.008 0.923 . . . . 0.0 109.388 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.6 t60 62.21 95.08 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 126.993 2.117 . . . . 0.0 112.733 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.3 mt -153.24 120.39 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.9 m -80.9 -56.68 3.96 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 116.609 -1.662 . . . . 0.0 113.324 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.58 177.03 46.12 Favored Glycine 0 C--N 1.362 1.997 0 CA-C-N 120.559 1.527 . . . . 0.0 115.679 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -77.71 -29.97 51.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.254 41.2 p-80 -50.31 -52.0 40.45 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 121.862 2.119 . . . . 0.0 116.647 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.65 -71.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 115.749 -2.072 . . . . 0.0 109.456 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.299 10.4 m -48.47 -27.22 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.084 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -75.89 -60.24 2.41 Favored 'General case' 0 CA--C 1.573 1.835 0 CA-C-O 114.432 -2.699 . . . . 0.0 106.689 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.43 -37.41 0.12 Allowed 'General case' 0 N--CA 1.507 2.401 1 N-CA-C 122.845 4.387 . . . . 0.0 122.845 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.42 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.22 -29.72 60.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.332 0.1 OUTLIER -39.06 -35.87 0.25 Allowed 'General case' 0 CA--C 1.595 2.686 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 175.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -52.07 7.8 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 128.926 2.89 . . . . 0.0 111.667 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 11.5 m -70.92 -56.71 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 125.544 1.538 . . . . 0.0 112.518 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.9 m -74.57 -43.42 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.83 110.09 3.46 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -35.61 -40.76 0.18 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.85 -41.5 59.74 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 116.481 -1.723 . . . . 0.0 113.61 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.04 91.44 1.3 Allowed Glycine 0 C--N 1.361 1.938 0 CA-C-N 120.447 1.476 . . . . 0.0 109.763 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -94.47 116.44 28.79 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -141.95 113.21 7.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.273 45.5 t80 -94.52 -68.38 0.8 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.93 0.892 . . . . 0.0 110.845 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.6 p -146.48 117.4 4.75 Favored Pre-proline 0 CA--C 1.581 2.164 0 CA-C-O 114.306 -2.759 . . . . 0.0 106.437 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.45 133.49 11.86 Favored 'Trans proline' 0 C--N 1.396 3.055 0 CA-C-N 126.908 3.503 . . . . 0.0 112.396 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.426 17.1 ptpt 64.12 -61.55 0.18 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-N 119.218 0.917 . . . . 0.0 111.142 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 44.0 t80 . . . . . 0 CA--C 1.566 1.561 0 CA-C-O 116.85 -1.547 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.41 114.55 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.75 120.79 33.49 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -94.62 130.49 41.05 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -76.07 -51.57 11.99 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 116.669 -1.634 . . . . 0.0 113.844 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.0 mt -96.88 115.97 28.36 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.4 m -106.02 130.64 53.9 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.833 0.853 . . . . 0.0 109.789 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.53 75.85 1.13 Allowed Glycine 0 N--CA 1.482 1.734 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.685 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.8 p -80.33 -39.51 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -54.55 -48.46 71.99 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 121.491 1.95 . . . . 0.0 114.239 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.7 tp -58.12 -71.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 115.793 -2.051 . . . . 0.0 109.244 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -49.23 -28.59 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 C-N-CA 126.39 1.876 . . . . 0.0 114.272 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.06 -27.39 43.08 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 114.411 -2.709 . . . . 0.0 112.774 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.68 70.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 120.18 3.4 . . . . 0.0 120.18 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.446 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.95 -30.53 65.39 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.347 0.1 OUTLIER -39.26 -29.79 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.273 3.434 . . . . 0.0 120.273 176.263 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.33 -53.21 6.52 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 129.077 2.951 . . . . 0.0 114.408 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.24 -54.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 CA-C-O 116.634 -1.65 . . . . 0.0 109.451 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.0 m -60.08 -45.34 93.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.48 91.24 0.39 Allowed Glycine 0 C--N 1.359 1.829 0 CA-C-N 120.533 1.515 . . . . 0.0 110.586 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -35.78 -42.36 0.25 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.97 -42.47 69.67 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.88 -128.57 4.01 Favored Glycine 0 C--N 1.358 1.75 0 CA-C-N 119.194 0.907 . . . . 0.0 111.081 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 56.51 92.09 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.723 2.009 . . . . 0.0 112.457 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -99.35 118.04 35.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -98.83 118.36 35.42 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.7 m -96.85 111.34 57.22 Favored Pre-proline 0 CA--C 1.587 2.39 0 CA-C-O 113.982 -2.913 . . . . 0.0 105.369 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.48 137.09 18.18 Favored 'Trans proline' 0 C--N 1.394 2.971 0 CA-C-N 126.697 3.428 . . . . 0.0 112.82 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -85.87 -64.01 1.22 Allowed 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 116.708 -1.615 . . . . 0.0 110.633 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.106 0 CA-C-N 120.354 1.434 . . . . 0.0 110.766 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 52.6 t80 . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.373 8.5 p -137.34 -64.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.398 0 C-N-CA 124.588 1.155 . . . . 0.0 110.724 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -72.76 -38.57 67.29 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -92.88 118.69 31.41 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -136.16 119.28 16.53 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.6 mt 62.56 129.18 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 126.528 1.931 . . . . 0.0 111.843 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -131.96 126.89 35.15 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.272 0.983 . . . . 0.0 109.242 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.48 82.97 1.13 Allowed Glycine 0 N--CA 1.481 1.662 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.01 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.3 t -79.9 -41.51 26.02 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 116.392 -1.766 . . . . 0.0 115.242 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -54.84 -45.2 74.45 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.366 1.894 . . . . 0.0 114.588 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.4 tp -63.52 -70.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 116.134 -1.889 . . . . 0.0 109.254 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 t -48.04 -28.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 C-N-CA 126.805 2.042 . . . . 0.0 114.094 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.39 -60.83 2.09 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 114.55 -2.643 . . . . 0.0 106.841 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -36.52 0.11 Allowed 'General case' 0 N--CA 1.505 2.307 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.415 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.34 -31.11 60.46 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.32 -31.51 0.08 Allowed 'General case' 0 CA--C 1.591 2.537 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 175.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.6 -53.45 6.54 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 128.33 2.652 . . . . 0.0 114.039 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.27 -55.85 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 116.691 -1.623 . . . . 0.0 109.31 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -61.74 -48.04 82.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.73 2.492 . . . . 0.0 117.73 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.68 108.53 0.25 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 120.667 1.576 . . . . 0.0 111.312 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -36.73 -44.8 0.49 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -126.69 66.01 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 89.73 0.08 OUTLIER Glycine 0 C--N 1.359 1.808 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.66 126.42 37.73 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -129.18 105.27 8.05 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -128.27 -57.06 1.23 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 124.408 1.083 . . . . 0.0 112.579 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.1 t -137.69 126.26 14.57 Favored Pre-proline 0 CA--C 1.583 2.215 0 CA-C-O 113.115 -3.326 . . . . 0.0 109.928 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -64.46 141.22 73.08 Favored 'Trans proline' 0 C--N 1.395 2.988 0 CA-C-N 127.683 3.78 . . . . 0.0 114.89 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -129.14 114.59 16.52 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.985 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.7 t80 . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.0 m -149.64 110.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.263 20.1 t-20 -122.6 -66.0 1.06 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.204 1.002 . . . . 0.0 111.211 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -125.72 -67.2 0.9 Allowed 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 116.73 -1.605 . . . . 0.0 109.259 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -94.41 123.71 37.98 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.594 1.543 . . . . 0.0 107.355 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -132.38 103.25 6.1 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.1 t -132.16 126.1 32.83 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.1 -74.7 1.28 Allowed Glycine 0 N--CA 1.483 1.786 0 O-C-N 124.07 0.856 . . . . 0.0 114.579 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.3 p -46.28 -29.33 1.58 Allowed 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 121.893 4.035 . . . . 0.0 121.893 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -45.74 -48.55 15.26 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.36 -72.62 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 116.283 -1.817 . . . . 0.0 110.359 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.385 4.8 p -51.39 -26.8 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.1 -60.26 2.37 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 114.488 -2.672 . . . . 0.0 106.753 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.46 -37.47 0.13 Allowed 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 122.952 4.427 . . . . 0.0 122.952 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.42 ' H ' HD11 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.52 -31.06 62.03 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.324 0.1 OUTLIER -39.32 -30.01 0.05 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.618 3.562 . . . . 0.0 120.618 175.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.1 5.99 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 128.25 2.62 . . . . 0.0 113.53 -177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 93.1 t -80.32 -58.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 CA-C-O 116.881 -1.533 . . . . 0.0 108.271 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 t -65.02 -43.08 93.61 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.71 127.71 4.06 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 120.292 1.406 . . . . 0.0 110.546 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -39.72 -37.87 0.58 Allowed 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -73.38 -40.29 64.46 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 116.468 -1.729 . . . . 0.0 113.845 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 91.78 1.04 Allowed Glycine 0 C--N 1.361 1.95 0 CA-C-N 120.47 1.486 . . . . 0.0 109.463 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -94.73 99.33 11.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -143.33 120.09 11.2 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -98.35 115.16 27.86 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 m -136.57 113.4 10.13 Favored Pre-proline 0 CA--C 1.587 2.371 0 CA-C-O 114.039 -2.886 . . . . 0.0 105.006 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.31 142.68 27.23 Favored 'Trans proline' 0 C--N 1.395 2.993 0 CA-C-N 126.842 3.479 . . . . 0.0 113.205 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm 59.93 135.96 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 126.874 2.07 . . . . 0.0 112.201 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.782 179.991 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . 0.268 43.1 p90 . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 117.111 -1.424 . . . . 0.0 113.358 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 m -94.5 109.8 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -129.83 -48.65 1.14 Allowed 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 69.26 126.78 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 127.264 2.225 . . . . 0.0 110.017 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 61.48 123.59 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 126.637 1.975 . . . . 0.0 111.836 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.4 mt -98.37 118.37 34.88 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.5 m -108.39 127.52 53.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.923 0.889 . . . . 0.0 108.791 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.72 -91.54 0.08 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.5 p -78.87 -46.94 17.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.531 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -46.35 -45.11 17.46 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 121.71 2.05 . . . . 0.0 115.472 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -63.65 -70.9 0.19 Allowed 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.161 -1.876 . . . . 0.0 109.626 177.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.263 4.8 t -47.43 -28.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.919 0 CA-C-O 115.85 -2.024 . . . . 0.0 114.282 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.1 -60.3 2.35 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.248 -2.787 . . . . 0.0 106.872 173.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -35.1 0.08 Allowed 'General case' 0 N--CA 1.508 2.428 1 N-CA-C 123.476 4.621 . . . . 0.0 123.476 -178.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -31.74 57.46 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -179.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.333 0.1 OUTLIER -39.09 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.488 0 N-CA-C 120.724 3.602 . . . . 0.0 120.724 175.851 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.93 -52.39 7.92 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 128.235 2.614 . . . . 0.0 113.342 -177.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -80.31 -56.25 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-O 117.053 -1.451 . . . . 0.0 107.96 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.7 p -51.81 -35.1 42.96 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 119.912 3.301 . . . . 0.0 119.912 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.99 110.96 2.41 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -39.86 -37.3 0.54 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -72.9 -39.4 66.38 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 116.306 -1.807 . . . . 0.0 114.162 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.42 87.66 1.27 Allowed Glycine 0 C--N 1.36 1.904 0 CA-C-N 120.562 1.528 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -112.95 113.86 26.09 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -143.02 118.4 10.27 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -134.36 119.35 18.53 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 26.7 m -132.17 113.31 14.65 Favored Pre-proline 0 CA--C 1.587 2.367 0 CA-C-O 114.112 -2.851 . . . . 0.0 104.974 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -68.71 140.74 47.69 Favored 'Trans proline' 0 C--N 1.395 3.006 0 CA-C-N 126.771 3.454 . . . . 0.0 114.395 -176.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -83.16 -62.44 1.59 Allowed 'General case' 0 CA--C 1.572 1.824 0 CA-C-O 116.722 -1.608 . . . . 0.0 111.39 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 CA-C-N 120.376 1.444 . . . . 0.0 109.916 -179.857 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 CA-C-O 118.949 -0.917 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.3 p -76.03 -32.99 59.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -55.05 -48.56 73.3 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 121.59 1.995 . . . . 0.0 114.474 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.9 tp -63.37 -70.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 116.202 -1.856 . . . . 0.0 109.633 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.1 t -48.66 -27.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.971 0 C-N-CA 126.738 2.015 . . . . 0.0 114.06 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -74.33 -60.7 2.15 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 114.445 -2.693 . . . . 0.0 106.847 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.53 -36.51 0.11 Allowed 'General case' 0 N--CA 1.506 2.356 1 N-CA-C 123.182 4.512 . . . . 0.0 123.182 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.55 -31.26 59.98 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.802 2.89 . . . . 0.0 118.802 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.31 -29.71 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 175.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.4 -54.66 5.5 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.241 2.616 . . . . 0.0 113.172 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 99.3 t -80.51 -59.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 116.859 -1.543 . . . . 0.0 108.056 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.3 m -68.72 -46.29 69.32 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.26 177.58 51.95 Favored Glycine 0 C--N 1.36 1.868 0 CA-C-N 120.464 1.483 . . . . 0.0 114.552 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.24 72.46 1.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 123.627 1.679 . . . . 0.0 112.158 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -164.99 -41.64 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 128.043 2.537 . . . . 0.0 108.974 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.3 82.27 1.68 Allowed Glycine 0 C--N 1.368 2.332 0 CA-C-N 120.288 1.404 . . . . 0.0 113.873 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -143.89 117.12 8.98 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 116.785 -1.578 . . . . 0.0 111.427 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 CA-C-O 118.761 -1.022 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.5 p -70.38 -31.01 68.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 118.262 2.69 . . . . 0.0 118.262 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -58.12 -49.56 76.55 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 121.417 1.917 . . . . 0.0 114.126 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.6 -72.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 115.389 -2.243 . . . . 0.0 108.869 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 12.6 m -48.42 -28.02 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 11.7 mm-40 -80.09 -27.34 39.28 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 114.195 -2.812 . . . . 0.0 112.819 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.11 72.15 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.28 -30.84 66.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.692 3.219 . . . . 0.0 119.692 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.345 0.0 OUTLIER -39.34 -29.85 0.05 Allowed 'General case' 0 CA--C 1.59 2.483 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 176.495 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.35 -53.45 6.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 129.046 2.938 . . . . 0.0 114.344 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.21 -55.78 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 116.613 -1.66 . . . . 0.0 109.187 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -63.24 -47.35 82.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.61 148.55 4.92 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 120.41 1.459 . . . . 0.0 112.437 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -42.01 -36.71 1.18 Allowed 'General case' 0 N--CA 1.511 2.597 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -71.91 -42.22 66.97 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 116.486 -1.721 . . . . 0.0 113.593 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.66 -178.09 53.83 Favored Glycine 0 C--N 1.36 1.898 0 CA-C-N 120.208 1.367 . . . . 0.0 114.67 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -126.95 -31.33 2.64 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . 0.338 90.6 m-85 . . . . . 0 N--CA 1.504 2.27 0 C-N-CA 126.72 2.008 . . . . 0.0 111.935 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.5 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.3 m -74.17 -33.8 63.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -54.74 -49.22 71.36 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 121.756 2.071 . . . . 0.0 114.699 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.28 -72.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 115.283 -2.294 . . . . 0.0 108.964 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 11.4 m -47.85 -28.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.2 -27.51 38.83 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 114.216 -2.802 . . . . 0.0 112.6 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.15 -36.58 72.1 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 120.134 3.383 . . . . 0.0 120.134 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.12 -30.34 64.96 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.482 3.141 . . . . 0.0 119.482 -178.064 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.3 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.588 2.416 0 N-CA-C 120.35 3.463 . . . . 0.0 120.35 176.358 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.96 -54.87 5.2 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 128.847 2.859 . . . . 0.0 114.013 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -80.39 -54.2 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 116.716 -1.612 . . . . 0.0 109.452 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -60.99 -48.17 83.06 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.1 101.19 0.18 Allowed Glycine 0 C--N 1.36 1.865 0 CA-C-N 120.757 1.617 . . . . 0.0 111.711 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -38.92 -45.48 1.19 Allowed 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -120.04 66.65 0.82 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.47 -80.95 0.06 OUTLIER Glycine 0 C--N 1.359 1.837 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.2 t80 63.89 96.75 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 126.676 1.991 . . . . 0.0 111.553 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.493 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 CA-C-O 121.899 0.721 . . . . 0.0 114.252 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -77.53 -31.71 53.56 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -58.66 -51.27 70.66 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 121.727 2.058 . . . . 0.0 113.679 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 tp -56.67 -43.04 80.03 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 116.877 -1.535 . . . . 0.0 114.865 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.6 -41.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 115.476 -2.202 . . . . 0.0 109.742 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.298 39.7 mt-10 -64.9 -29.21 70.15 Favored 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 123.053 2.66 . . . . 0.0 113.826 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.85 63.15 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.461 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.08 -29.8 62.05 Favored 'General case' 0 N--CA 1.485 1.309 1 N-CA-C 124.499 4.999 . . . . 0.0 124.499 -176.49 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -61.07 -29.9 70.02 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 mt -72.47 -46.95 52.46 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 126.646 1.978 . . . . 0.0 113.721 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.256 95.6 t -80.44 -59.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.269 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -65.63 -45.7 82.04 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 117.026 2.232 . . . . 0.0 117.026 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.59 114.94 1.7 Allowed Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.609 1.55 . . . . 0.0 110.066 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -40.49 -41.09 1.36 Allowed 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 117.649 2.462 . . . . 0.0 117.649 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -73.04 -38.15 66.61 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 116.333 -1.794 . . . . 0.0 114.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 89.53 1.28 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 120.519 1.509 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -97.47 105.57 17.74 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 t80 . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 179.849 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.347 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 m -71.3 -30.57 66.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -58.87 -51.64 69.16 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 121.616 2.007 . . . . 0.0 113.57 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.09 -54.79 43.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 116.201 -1.857 . . . . 0.0 112.873 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.4 m -70.14 -30.21 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 CA-C-O 115.736 -2.078 . . . . 0.0 114.749 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.292 40.5 mt-10 -75.53 -29.85 59.58 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 122.342 2.337 . . . . 0.0 112.469 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.6 65.39 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.448 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.59 -29.62 62.51 Favored 'General case' 0 N--CA 1.487 1.409 1 N-CA-C 124.665 5.061 . . . . 0.0 124.665 -176.573 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -61.06 -29.4 69.71 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.3 mt -72.77 -54.05 9.94 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 126.762 2.025 . . . . 0.0 112.497 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.274 93.1 t -81.14 -62.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-O 117.069 -1.444 . . . . 0.0 107.913 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -70.84 -53.48 15.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.16 169.85 12.41 Favored Glycine 0 C--N 1.361 1.919 0 CA-C-N 120.618 1.554 . . . . 0.0 114.095 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -37.64 -36.43 0.17 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 119.182 3.03 . . . . 0.0 119.182 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -65.0 -43.92 90.96 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 116.43 -1.748 . . . . 0.0 115.164 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.0 -129.18 8.88 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-N 120.201 1.364 . . . . 0.0 113.191 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.27 134.42 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.474 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.38 0 CA-C-O 118.924 -0.931 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -80.01 -37.04 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -58.39 -53.53 57.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.483 1.947 . . . . 0.0 113.62 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.21 -50.9 72.27 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 124.943 1.297 . . . . 0.0 113.664 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.292 14.9 t -69.18 -26.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 115.209 -2.329 . . . . 0.0 112.49 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 47.3 mt-10 -80.76 -58.39 3.12 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 123.415 2.825 . . . . 0.0 108.237 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . 0.41 . . -33.6 -34.3 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 1 N-CA-C 125.167 5.247 . . . . 0.0 125.167 -178.351 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -77.37 -37.76 51.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 119.785 3.254 . . . . 0.0 119.785 -176.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.361 0.1 OUTLIER -39.53 -33.62 0.18 Allowed 'General case' 0 CA--C 1.591 2.553 0 N-CA-C 119.822 3.267 . . . . 0.0 119.822 174.879 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.1 -55.22 4.9 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 128.906 2.882 . . . . 0.0 113.938 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.264 99.2 t -80.04 -60.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 CA-C-O 116.947 -1.501 . . . . 0.0 107.813 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -65.11 -45.93 83.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.31 169.0 41.31 Favored Glycine 0 C--N 1.359 1.852 0 CA-C-N 120.117 1.326 . . . . 0.0 114.846 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -39.65 -41.58 1.08 Allowed 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.57 60.82 0.94 Allowed 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 123.704 0.802 . . . . 0.0 109.452 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.34 -122.17 3.83 Favored Glycine 0 C--N 1.359 1.857 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -88.71 135.55 33.45 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.841 0.856 . . . . 0.0 110.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 CA-C-O 121.788 0.66 . . . . 0.0 114.208 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -74.17 -35.82 64.03 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -53.32 -48.69 68.22 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 121.377 1.899 . . . . 0.0 115.874 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -63.77 -71.02 0.18 Allowed 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 116.309 -1.805 . . . . 0.0 109.307 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.0 t -47.76 -27.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 C-N-CA 126.886 2.074 . . . . 0.0 114.298 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.74 -62.58 1.49 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 114.245 -2.788 . . . . 0.0 106.359 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.45 -34.94 0.07 Allowed 'General case' 0 N--CA 1.506 2.357 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.39 -31.72 60.54 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.472 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.331 0.1 OUTLIER -38.72 -34.73 0.16 Allowed 'General case' 0 CA--C 1.589 2.466 0 N-CA-C 120.183 3.401 . . . . 0.0 120.183 175.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.32 -55.05 4.97 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 128.661 2.785 . . . . 0.0 113.941 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 98.9 t -80.06 -60.07 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-O 116.912 -1.518 . . . . 0.0 108.104 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m -63.3 -44.41 95.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.64 135.95 4.37 Favored Glycine 0 C--N 1.361 1.932 0 CA-C-N 120.325 1.42 . . . . 0.0 111.912 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -41.35 -37.0 0.91 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.65 -39.47 67.13 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.963 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.06 87.18 0.55 Allowed Glycine 0 C--N 1.36 1.879 0 CA-C-N 120.496 1.498 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -99.12 96.69 7.96 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.861 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 CA-C-O 118.896 -0.946 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -79.89 -39.6 30.11 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 116.37 -1.776 . . . . 0.0 115.509 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -55.44 -46.36 76.75 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 121.403 1.911 . . . . 0.0 114.447 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.1 -70.69 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 116.235 -1.84 . . . . 0.0 109.414 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.5 t -48.52 -27.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 126.75 2.02 . . . . 0.0 114.08 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.03 -60.9 2.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 114.423 -2.703 . . . . 0.0 106.914 173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.54 -36.85 0.11 Allowed 'General case' 0 N--CA 1.507 2.389 1 N-CA-C 123.118 4.488 . . . . 0.0 123.118 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 -31.27 61.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.18 -30.52 0.06 Allowed 'General case' 0 CA--C 1.59 2.51 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.659 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -51.71 8.42 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 128.44 2.696 . . . . 0.0 113.807 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.252 86.2 t -80.29 -58.2 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 CA-C-O 116.691 -1.623 . . . . 0.0 108.525 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.9 m -63.64 -42.24 98.16 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.84 165.14 14.31 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 120.36 1.436 . . . . 0.0 113.701 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.279 12.7 pt-20 -33.6 -43.94 0.14 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.05 66.41 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.28 159.28 6.38 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 119.448 1.022 . . . . 0.0 115.313 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -89.6 137.39 32.37 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.906 0.882 . . . . 0.0 110.239 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 . . . . . 0 N--CA 1.493 1.679 0 C-N-CA 123.78 0.832 . . . . 0.0 109.253 -179.688 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.278 0 CA-C-O 118.915 -0.936 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 m -76.03 -36.48 59.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -52.09 -48.82 64.54 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 121.547 1.976 . . . . 0.0 115.943 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.54 -70.91 0.2 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 116.211 -1.852 . . . . 0.0 109.361 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.0 t -48.51 -27.81 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.941 0 C-N-CA 126.83 2.052 . . . . 0.0 114.12 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.24 -62.58 1.47 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 114.346 -2.74 . . . . 0.0 106.493 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.38 -35.09 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.454 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.81 -32.24 61.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.33 0.1 OUTLIER -38.56 -35.01 0.16 Allowed 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 120.222 3.416 . . . . 0.0 120.222 175.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.52 -53.81 5.96 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 128.626 2.771 . . . . 0.0 114.802 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 86.3 t -77.88 -57.13 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 116.753 -1.594 . . . . 0.0 109.168 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -60.26 -42.2 94.82 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.12 161.97 12.92 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 120.181 1.355 . . . . 0.0 113.217 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -39.86 -38.36 0.67 Allowed 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -75.5 -39.79 58.0 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.99 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.81 146.32 6.24 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 120.637 1.562 . . . . 0.0 113.209 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -84.7 147.14 27.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.025 0.93 . . . . 0.0 111.545 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 . . . . . 0 N--CA 1.493 1.711 0 C-N-CA 124.024 0.93 . . . . 0.0 109.241 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 CA-C-O 118.702 -1.055 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -69.95 -38.07 76.04 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.259 31.8 p80 -57.56 -51.32 69.96 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-N 121.76 2.073 . . . . 0.0 114.675 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.7 tp -59.23 -71.38 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 115.808 -2.044 . . . . 0.0 108.723 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 t -48.94 -28.55 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.883 0 C-N-CA 126.429 1.892 . . . . 0.0 113.987 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -78.93 -27.07 43.66 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 114.377 -2.725 . . . . 0.0 113.148 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.42 -37.46 71.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 119.837 3.273 . . . . 0.0 119.837 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.65 -31.11 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -178.178 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.339 0.0 OUTLIER -38.86 -28.98 0.03 OUTLIER 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 176.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.8 -52.56 7.76 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.816 2.846 . . . . 0.0 113.12 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.37 -55.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 117.111 -1.423 . . . . 0.0 107.542 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.2 p -56.12 -41.48 75.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 118.873 2.916 . . . . 0.0 118.873 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.05 122.29 2.41 Favored Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -36.02 -43.12 0.31 Allowed 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -125.98 66.78 1.19 Allowed 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 92.07 0.1 OUTLIER Glycine 0 C--N 1.358 1.774 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -92.98 109.45 20.9 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.8 p90 . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 179.396 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.611 0 N-CA-C 112.096 -0.401 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.1 m -73.6 -34.23 64.96 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -52.54 -48.59 66.01 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 121.641 2.019 . . . . 0.0 114.483 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.88 -71.53 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 115.83 -2.033 . . . . 0.0 109.289 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -49.7 -28.44 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 C-N-CA 126.346 1.858 . . . . 0.0 114.127 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.67 -27.22 45.14 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 114.442 -2.694 . . . . 0.0 112.869 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.94 70.86 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 120.055 3.354 . . . . 0.0 120.055 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.488 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.25 -29.97 64.42 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.476 3.139 . . . . 0.0 119.476 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.342 0.1 OUTLIER -39.22 -29.55 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.495 0 N-CA-C 120.345 3.461 . . . . 0.0 120.345 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.88 -53.79 6.16 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 128.963 2.905 . . . . 0.0 113.681 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 95.8 t -80.31 -59.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 116.825 -1.56 . . . . 0.0 107.916 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 64.7 m -68.46 -44.33 75.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.36 171.82 38.16 Favored Glycine 0 C--N 1.36 1.874 0 CA-C-N 120.355 1.434 . . . . 0.0 114.775 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -36.2 -42.41 0.31 Allowed 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -122.59 65.04 0.95 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.05 88.89 0.12 Allowed Glycine 0 C--N 1.359 1.85 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -134.96 119.67 18.27 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.96 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 CA-C-O 118.877 -0.957 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -72.18 -31.52 66.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -56.55 -49.88 73.53 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.449 1.932 . . . . 0.0 114.198 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.53 -70.78 0.19 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 116.177 -1.868 . . . . 0.0 109.431 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HA ' HD11 ' A' ' 15' ' ' LEU . 5.6 t -48.61 -28.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 C-N-CA 126.823 2.049 . . . . 0.0 113.959 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.05 -60.7 2.14 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 114.319 -2.753 . . . . 0.0 107.18 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.6 0.11 Allowed 'General case' 0 N--CA 1.506 2.362 1 N-CA-C 123.048 4.462 . . . . 0.0 123.048 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.483 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.41 -31.38 60.37 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.32 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.516 0 N-CA-C 120.67 3.582 . . . . 0.0 120.67 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.22 -51.79 8.52 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 128.269 2.628 . . . . 0.0 113.597 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -80.1 -55.71 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-O 117.038 -1.458 . . . . 0.0 107.968 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 94.1 p -51.36 -35.2 37.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.777 3.251 . . . . 0.0 119.777 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.76 103.48 1.55 Allowed Glycine 0 C--N 1.358 1.804 0 CA-C-N 120.071 1.305 . . . . 0.0 110.186 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -38.94 -38.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.457 2.762 . . . . 0.0 118.457 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -74.2 -39.88 62.84 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 116.462 -1.733 . . . . 0.0 113.948 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.45 93.72 0.98 Allowed Glycine 0 C--N 1.361 1.928 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -91.49 117.91 30.11 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.76 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 CA-C-O 118.906 -0.941 . . . . 0.0 113.333 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -61.69 -29.92 70.4 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -57.7 -50.56 72.8 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 121.296 1.862 . . . . 0.0 114.117 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.0 tp -62.46 -72.44 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 115.27 -2.3 . . . . 0.0 108.998 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 12.0 m -47.96 -28.1 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.17 -27.5 38.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 114.035 -2.888 . . . . 0.0 112.585 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -36.82 72.8 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.095 3.369 . . . . 0.0 120.095 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.484 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.17 -30.1 64.66 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.4 -29.65 0.05 Allowed 'General case' 0 CA--C 1.589 2.444 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 176.291 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.9 -53.2 6.67 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 129.034 2.934 . . . . 0.0 114.181 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -80.3 -55.4 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 116.714 -1.612 . . . . 0.0 108.98 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.5 t -59.42 -40.46 86.78 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.32 101.49 2.42 Favored Glycine 0 C--N 1.357 1.727 0 CA-C-N 120.342 1.428 . . . . 0.0 110.191 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -40.2 -36.22 0.49 Allowed 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -70.81 -39.72 72.91 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 116.395 -1.764 . . . . 0.0 114.382 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.94 84.02 0.35 Allowed Glycine 0 C--N 1.36 1.903 0 CA-C-N 120.644 1.566 . . . . 0.0 110.844 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.02 120.95 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.835 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -77.17 -38.03 52.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -57.39 -47.94 80.36 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 121.428 1.922 . . . . 0.0 114.144 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.91 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 116.262 -1.828 . . . . 0.0 109.204 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.413 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.1 t -47.95 -27.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 C-N-CA 126.826 2.05 . . . . 0.0 114.04 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -74.3 -61.01 2.01 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 114.434 -2.698 . . . . 0.0 107.156 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.55 0.11 Allowed 'General case' 0 N--CA 1.507 2.375 1 N-CA-C 123.129 4.492 . . . . 0.0 123.129 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.467 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.23 -31.59 60.9 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.757 2.873 . . . . 0.0 118.757 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.24 -29.98 0.05 Allowed 'General case' 0 CA--C 1.59 2.482 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 175.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.32 5.79 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.247 2.619 . . . . 0.0 113.546 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.253 87.0 t -80.32 -57.41 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-O 116.802 -1.57 . . . . 0.0 108.468 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -64.75 -47.21 79.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.63 136.97 4.13 Favored Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.279 1.4 . . . . 0.0 112.363 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -42.47 -35.79 1.15 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -69.13 -38.59 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 116.348 -1.787 . . . . 0.0 114.966 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.66 86.04 0.42 Allowed Glycine 0 C--N 1.36 1.88 0 CA-C-N 120.393 1.451 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -99.18 119.64 38.2 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.6 t80 . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.708 0 CA-C-O 119.316 -0.713 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.9 p -70.01 -32.82 71.18 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -59.9 -48.67 80.75 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 121.437 1.926 . . . . 0.0 113.75 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.67 -50.24 74.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 116.603 -1.665 . . . . 0.0 113.415 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.3 m -73.84 -31.46 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 CA-C-O 115.961 -1.971 . . . . 0.0 113.908 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 48.1 mt-10 -73.82 -29.75 62.32 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 122.081 2.219 . . . . 0.0 112.36 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.62 62.54 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.461 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -68.44 -29.86 68.61 Favored 'General case' 0 N--CA 1.486 1.362 1 N-CA-C 123.941 4.793 . . . . 0.0 123.941 -176.81 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.258 0.9 OUTLIER -61.32 -28.62 69.34 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.22 -50.81 62.52 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 126.213 1.805 . . . . 0.0 113.192 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.262 88.8 t -80.37 -60.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.281 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.8 m -66.67 -41.72 87.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.94 133.14 5.54 Favored Glycine 0 C--N 1.358 1.802 0 CA-C-N 120.335 1.425 . . . . 0.0 111.169 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.26 14.3 pt-20 -33.18 -41.04 0.07 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.58 -41.75 59.95 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.824 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.19 86.49 1.16 Allowed Glycine 0 C--N 1.361 1.951 0 CA-C-N 120.579 1.536 . . . . 0.0 110.848 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -100.55 114.65 28.47 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 t80 . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.894 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 CA-C-O 118.77 -1.016 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.6 m -70.82 -37.55 73.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -57.81 -48.17 80.49 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 121.515 1.961 . . . . 0.0 113.975 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.16 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 116.117 -1.896 . . . . 0.0 109.279 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.8 t -47.95 -28.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 126.785 2.034 . . . . 0.0 114.106 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.5 -60.76 2.13 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.34 -2.743 . . . . 0.0 106.783 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.63 -36.35 0.11 Allowed 'General case' 0 N--CA 1.507 2.407 1 N-CA-C 123.238 4.532 . . . . 0.0 123.238 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.97 -30.82 58.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.02 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.35 -30.14 0.06 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.319 3.451 . . . . 0.0 120.319 175.607 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 -53.9 6.07 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.256 2.622 . . . . 0.0 113.938 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -80.47 -54.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.743 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.4 m -58.88 -47.14 85.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.3 88.33 0.09 OUTLIER Glycine 0 C--N 1.359 1.832 0 CA-C-N 120.654 1.57 . . . . 0.0 111.251 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -42.57 -42.02 3.23 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -65.93 -33.75 76.54 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -154.7 92.0 0.13 Allowed Glycine 0 C--N 1.356 1.678 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -127.1 115.34 19.0 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 p90 . . . . . 0 N--CA 1.492 1.641 0 C-N-CA 124.29 1.036 . . . . 0.0 108.636 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -77.71 -29.97 51.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.254 41.2 p-80 -50.31 -52.0 40.45 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 121.862 2.119 . . . . 0.0 116.647 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.65 -71.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 115.749 -2.072 . . . . 0.0 109.456 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.431 ' HA ' HD11 ' A' ' 15' ' ' LEU 0.299 10.4 m -48.47 -27.22 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.084 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 177.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -75.89 -60.24 2.41 Favored 'General case' 0 CA--C 1.573 1.835 0 CA-C-O 114.432 -2.699 . . . . 0.0 106.689 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.43 -37.41 0.12 Allowed 'General case' 0 N--CA 1.507 2.401 1 N-CA-C 122.845 4.387 . . . . 0.0 122.845 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.474 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.22 -29.72 60.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.332 0.1 OUTLIER -39.06 -35.87 0.25 Allowed 'General case' 0 CA--C 1.595 2.686 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 175.673 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -52.07 7.8 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 128.926 2.89 . . . . 0.0 111.667 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 11.5 m -70.92 -56.71 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 125.544 1.538 . . . . 0.0 112.518 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.9 m -74.57 -43.42 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.83 110.09 3.46 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -35.61 -40.76 0.18 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.85 -41.5 59.74 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 116.481 -1.723 . . . . 0.0 113.61 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.04 91.44 1.3 Allowed Glycine 0 C--N 1.361 1.938 0 CA-C-N 120.447 1.476 . . . . 0.0 109.763 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -94.47 116.44 28.79 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 179.833 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.685 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.8 p -80.33 -39.51 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -54.55 -48.46 71.99 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 121.491 1.95 . . . . 0.0 114.239 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.7 tp -58.12 -71.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 115.793 -2.051 . . . . 0.0 109.244 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -49.23 -28.59 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 C-N-CA 126.39 1.876 . . . . 0.0 114.272 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.06 -27.39 43.08 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 114.411 -2.709 . . . . 0.0 112.774 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.68 70.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 120.18 3.4 . . . . 0.0 120.18 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.95 -30.53 65.39 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.347 0.1 OUTLIER -39.26 -29.79 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.273 3.434 . . . . 0.0 120.273 176.263 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.33 -53.21 6.52 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 129.077 2.951 . . . . 0.0 114.408 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.24 -54.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 CA-C-O 116.634 -1.65 . . . . 0.0 109.451 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.0 m -60.08 -45.34 93.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.48 91.24 0.39 Allowed Glycine 0 C--N 1.359 1.829 0 CA-C-N 120.533 1.515 . . . . 0.0 110.586 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -35.78 -42.36 0.25 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.97 -42.47 69.67 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.88 -128.57 4.01 Favored Glycine 0 C--N 1.358 1.75 0 CA-C-N 119.194 0.907 . . . . 0.0 111.081 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 56.51 92.09 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.723 2.009 . . . . 0.0 112.457 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.973 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.3 t -79.9 -41.51 26.02 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 116.392 -1.766 . . . . 0.0 115.242 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -54.84 -45.2 74.45 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.366 1.894 . . . . 0.0 114.588 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.4 tp -63.52 -70.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 116.134 -1.889 . . . . 0.0 109.254 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.7 t -48.04 -28.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 C-N-CA 126.805 2.042 . . . . 0.0 114.094 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.39 -60.83 2.09 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 114.55 -2.643 . . . . 0.0 106.841 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -36.52 0.11 Allowed 'General case' 0 N--CA 1.505 2.307 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.34 -31.11 60.46 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.32 -31.51 0.08 Allowed 'General case' 0 CA--C 1.591 2.537 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 175.743 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.6 -53.45 6.54 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 128.33 2.652 . . . . 0.0 114.039 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.27 -55.85 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 116.691 -1.623 . . . . 0.0 109.31 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -61.74 -48.04 82.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.73 2.492 . . . . 0.0 117.73 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.68 108.53 0.25 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 120.667 1.576 . . . . 0.0 111.312 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -36.73 -44.8 0.49 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -126.69 66.01 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 89.73 0.08 OUTLIER Glycine 0 C--N 1.359 1.808 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.66 126.42 37.73 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.9 t80 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.675 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 CA-C-O 119.185 -0.786 . . . . 0.0 114.579 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.3 p -46.28 -29.33 1.58 Allowed 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 121.893 4.035 . . . . 0.0 121.893 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -45.74 -48.55 15.26 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.36 -72.62 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 116.283 -1.817 . . . . 0.0 110.359 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.385 4.8 p -51.39 -26.8 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.1 -60.26 2.37 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 114.488 -2.672 . . . . 0.0 106.753 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.46 -37.47 0.13 Allowed 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 122.952 4.427 . . . . 0.0 122.952 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.47 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.52 -31.06 62.03 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.324 0.1 OUTLIER -39.32 -30.01 0.05 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.618 3.562 . . . . 0.0 120.618 175.759 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.1 5.99 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 128.25 2.62 . . . . 0.0 113.53 -177.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 93.1 t -80.32 -58.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 CA-C-O 116.881 -1.533 . . . . 0.0 108.271 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 t -65.02 -43.08 93.61 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.71 127.71 4.06 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 120.292 1.406 . . . . 0.0 110.546 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -39.72 -37.87 0.58 Allowed 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -73.38 -40.29 64.46 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 116.468 -1.729 . . . . 0.0 113.845 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 91.78 1.04 Allowed Glycine 0 C--N 1.361 1.95 0 CA-C-N 120.47 1.486 . . . . 0.0 109.463 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -94.73 99.33 11.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 179.897 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.5 p -78.87 -46.94 17.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.531 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -46.35 -45.11 17.46 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 121.71 2.05 . . . . 0.0 115.472 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -63.65 -70.9 0.19 Allowed 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.161 -1.876 . . . . 0.0 109.626 177.052 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.402 ' HA ' HD11 ' A' ' 15' ' ' LEU 0.263 4.8 t -47.43 -28.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.919 0 CA-C-O 115.85 -2.024 . . . . 0.0 114.282 179.473 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.1 -60.3 2.35 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.248 -2.787 . . . . 0.0 106.872 173.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -35.1 0.08 Allowed 'General case' 0 N--CA 1.508 2.428 1 N-CA-C 123.476 4.621 . . . . 0.0 123.476 -178.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.44 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -76.68 -31.74 57.46 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -179.015 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.333 0.1 OUTLIER -39.09 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.488 0 N-CA-C 120.724 3.602 . . . . 0.0 120.724 175.851 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.93 -52.39 7.92 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 128.235 2.614 . . . . 0.0 113.342 -177.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -80.31 -56.25 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-O 117.053 -1.451 . . . . 0.0 107.96 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.7 p -51.81 -35.1 42.96 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 119.912 3.301 . . . . 0.0 119.912 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.99 110.96 2.41 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -39.86 -37.3 0.54 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -72.9 -39.4 66.38 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 116.306 -1.807 . . . . 0.0 114.162 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.42 87.66 1.27 Allowed Glycine 0 C--N 1.36 1.904 0 CA-C-N 120.562 1.528 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -112.95 113.86 26.09 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 179.812 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.23 103.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 1 N-CA-C 99.868 -4.123 . . . . 0.0 99.868 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -96.41 123.0 39.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -132.87 108.57 9.04 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -141.28 118.07 11.06 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.4 mt -139.81 -55.17 0.55 Allowed 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 124.376 1.07 . . . . 0.0 112.734 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.4 p -136.22 132.98 36.58 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.2 1.4 . . . . 0.0 109.598 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.42 86.95 0.13 Allowed Glycine 0 N--CA 1.48 1.625 0 CA-C-O 118.949 -0.917 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.3 p -76.03 -32.99 59.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -55.05 -48.56 73.3 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 121.59 1.995 . . . . 0.0 114.474 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.9 tp -63.37 -70.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 116.202 -1.856 . . . . 0.0 109.633 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.1 t -48.66 -27.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.971 0 C-N-CA 126.738 2.015 . . . . 0.0 114.06 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -74.33 -60.7 2.15 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 114.445 -2.693 . . . . 0.0 106.847 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.53 -36.51 0.11 Allowed 'General case' 0 N--CA 1.506 2.356 1 N-CA-C 123.182 4.512 . . . . 0.0 123.182 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.55 -31.26 59.98 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.802 2.89 . . . . 0.0 118.802 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.31 -29.71 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 175.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.4 -54.66 5.5 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.241 2.616 . . . . 0.0 113.172 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 99.3 t -80.51 -59.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 116.859 -1.543 . . . . 0.0 108.056 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.3 m -68.72 -46.29 69.32 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.26 177.58 51.95 Favored Glycine 0 C--N 1.36 1.868 0 CA-C-N 120.464 1.483 . . . . 0.0 114.552 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.24 72.46 1.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 123.627 1.679 . . . . 0.0 112.158 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -164.99 -41.64 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 128.043 2.537 . . . . 0.0 108.974 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.3 82.27 1.68 Allowed Glycine 0 C--N 1.368 2.332 0 CA-C-N 120.288 1.404 . . . . 0.0 113.873 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -143.89 117.12 8.98 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -126.63 -58.28 1.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 116.785 -1.578 . . . . 0.0 111.427 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -82.05 136.8 35.17 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.607 1.549 . . . . 0.0 111.599 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.1 p 64.41 124.19 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.419 0 CA-C-O 112.956 -3.402 . . . . 0.0 111.802 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.59 144.95 28.94 Favored 'Trans proline' 0 C--N 1.394 2.943 0 CA-C-N 127.491 3.711 . . . . 0.0 113.415 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -130.49 113.24 14.03 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.205 0 O-C-N 124.128 0.893 . . . . 0.0 111.007 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 23.4 t80 . . . . . 0 CA--C 1.563 1.468 0 CA-C-O 116.604 -1.665 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.363 55.3 t -98.63 -96.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -97.89 118.71 35.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.515 1.126 . . . . 0.0 108.509 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -100.57 114.82 28.79 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -134.87 107.05 7.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.3 mt -138.45 -53.33 0.61 Allowed 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 124.358 1.063 . . . . 0.0 113.098 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 84.5 p -113.18 128.57 56.52 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.937 1.295 . . . . 0.0 109.497 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.84 90.03 0.08 OUTLIER Glycine 0 N--CA 1.474 1.224 0 CA-C-O 118.761 -1.022 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.5 p -70.38 -31.01 68.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 118.262 2.69 . . . . 0.0 118.262 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -58.12 -49.56 76.55 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 121.417 1.917 . . . . 0.0 114.126 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.6 -72.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 115.389 -2.243 . . . . 0.0 108.869 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 12.6 m -48.42 -28.02 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 11.7 mm-40 -80.09 -27.34 39.28 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 114.195 -2.812 . . . . 0.0 112.819 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.11 72.15 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.28 -30.84 66.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.692 3.219 . . . . 0.0 119.692 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.345 0.0 OUTLIER -39.34 -29.85 0.05 Allowed 'General case' 0 CA--C 1.59 2.483 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 176.495 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.35 -53.45 6.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 129.046 2.938 . . . . 0.0 114.344 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.21 -55.78 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 116.613 -1.66 . . . . 0.0 109.187 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -63.24 -47.35 82.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.61 148.55 4.92 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 120.41 1.459 . . . . 0.0 112.437 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -42.01 -36.71 1.18 Allowed 'General case' 0 N--CA 1.511 2.597 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -71.91 -42.22 66.97 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 116.486 -1.721 . . . . 0.0 113.593 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.66 -178.09 53.83 Favored Glycine 0 C--N 1.36 1.898 0 CA-C-N 120.208 1.367 . . . . 0.0 114.67 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -126.95 -31.33 2.64 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . 0.338 90.6 m-85 69.96 -68.22 0.21 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 126.72 2.008 . . . . 0.0 111.935 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -157.68 128.96 6.7 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 36.8 p -81.76 129.18 66.21 Favored Pre-proline 0 CA--C 1.584 2.256 0 CA-C-O 114.142 -2.837 . . . . 0.0 110.006 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.4 -28.3 34.78 Favored 'Trans proline' 0 C--N 1.392 2.832 0 N-CA-C 122.067 3.833 . . . . 0.0 122.067 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -143.02 120.09 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.869 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 . . . . . 0 CA--C 1.563 1.471 0 CA-C-O 116.693 -1.623 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 m -94.24 93.61 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 t30 56.96 115.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 126.973 2.109 . . . . 0.0 112.924 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -126.83 -65.9 0.93 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.8 -1.572 . . . . 0.0 109.516 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -92.48 128.81 38.47 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 120.626 1.557 . . . . 0.0 108.232 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 pp -133.31 140.37 47.39 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.34 1.056 . . . . 0.0 109.909 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.9 m -78.21 -45.51 22.82 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.59 -123.31 7.89 Favored Glycine 0 C--N 1.36 1.884 0 CA-C-N 120.568 1.531 . . . . 0.0 110.114 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.3 m -74.17 -33.8 63.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -54.74 -49.22 71.36 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 121.756 2.071 . . . . 0.0 114.699 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.28 -72.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 115.283 -2.294 . . . . 0.0 108.964 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 11.4 m -47.85 -28.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.2 -27.51 38.83 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 114.216 -2.802 . . . . 0.0 112.6 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.15 -36.58 72.1 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 120.134 3.383 . . . . 0.0 120.134 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.12 -30.34 64.96 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.482 3.141 . . . . 0.0 119.482 -178.064 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.3 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.588 2.416 0 N-CA-C 120.35 3.463 . . . . 0.0 120.35 176.358 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.96 -54.87 5.2 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 128.847 2.859 . . . . 0.0 114.013 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -80.39 -54.2 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 116.716 -1.612 . . . . 0.0 109.452 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -60.99 -48.17 83.06 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.1 101.19 0.18 Allowed Glycine 0 C--N 1.36 1.865 0 CA-C-N 120.757 1.617 . . . . 0.0 111.711 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -38.92 -45.48 1.19 Allowed 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -120.04 66.65 0.82 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.47 -80.95 0.06 OUTLIER Glycine 0 C--N 1.359 1.837 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.2 t80 63.89 96.75 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 126.676 1.991 . . . . 0.0 111.553 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -137.28 111.97 8.79 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -134.26 119.8 19.19 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.2 m -95.88 114.23 63.68 Favored Pre-proline 0 CA--C 1.588 2.404 0 CA-C-O 113.967 -2.92 . . . . 0.0 105.539 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.27 135.0 18.03 Favored 'Trans proline' 0 C--N 1.395 3.018 0 CA-C-N 126.908 3.503 . . . . 0.0 112.931 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -86.5 -64.1 1.21 Allowed 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 116.677 -1.63 . . . . 0.0 110.485 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 CA-C-N 120.418 1.463 . . . . 0.0 109.907 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 CA--C 1.563 1.476 0 CA-C-O 116.71 -1.614 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 m -148.72 94.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 59.46 117.93 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 126.764 2.026 . . . . 0.0 112.351 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -135.26 116.39 14.35 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -133.35 111.86 11.14 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.4 mt -144.55 120.99 10.99 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.3 m -93.6 125.72 38.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.755 0.822 . . . . 0.0 109.007 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.1 179.12 32.31 Favored Glycine 0 N--CA 1.484 1.885 0 O-C-N 124.021 0.825 . . . . 0.0 114.252 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -77.53 -31.71 53.56 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -58.66 -51.27 70.66 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 121.727 2.058 . . . . 0.0 113.679 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 tp -56.67 -43.04 80.03 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 116.877 -1.535 . . . . 0.0 114.865 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.6 -41.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 115.476 -2.202 . . . . 0.0 109.742 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.298 39.7 mt-10 -64.9 -29.21 70.15 Favored 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 123.053 2.66 . . . . 0.0 113.826 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.85 63.15 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.461 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.08 -29.8 62.05 Favored 'General case' 0 N--CA 1.485 1.309 1 N-CA-C 124.499 4.999 . . . . 0.0 124.499 -176.49 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -61.07 -29.9 70.02 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 mt -72.47 -46.95 52.46 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 126.646 1.978 . . . . 0.0 113.721 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.256 95.6 t -80.44 -59.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.269 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -65.63 -45.7 82.04 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 117.026 2.232 . . . . 0.0 117.026 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.59 114.94 1.7 Allowed Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.609 1.55 . . . . 0.0 110.066 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -40.49 -41.09 1.36 Allowed 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 117.649 2.462 . . . . 0.0 117.649 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -73.04 -38.15 66.61 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 116.333 -1.794 . . . . 0.0 114.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 89.53 1.28 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 120.519 1.509 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -97.47 105.57 17.74 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -137.88 115.65 11.44 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -99.54 114.28 27.2 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.3 m -98.43 107.78 44.01 Favored Pre-proline 0 CA--C 1.585 2.313 0 CA-C-O 114.033 -2.889 . . . . 0.0 104.885 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -79.3 121.81 4.94 Favored 'Trans proline' 0 C--N 1.395 2.986 0 CA-C-N 126.596 3.392 . . . . 0.0 111.801 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.07 -57.5 2.94 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 116.696 -1.621 . . . . 0.0 111.209 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.365 1.251 0 CA-C-N 120.844 1.656 . . . . 0.0 109.784 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . 0.266 45.8 p90 . . . . . 0 CA--C 1.562 1.441 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.716 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -92.24 93.08 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -136.17 121.74 19.55 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.18 0.992 . . . . 0.0 108.561 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -128.31 113.53 15.73 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -81.74 -62.44 1.64 Allowed 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 116.669 -1.634 . . . . 0.0 112.243 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 tp -138.67 117.41 12.28 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.2 p -93.42 129.73 39.47 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 124.256 0.972 . . . . 0.0 109.434 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.88 92.69 0.1 Allowed Glycine 0 N--CA 1.476 1.347 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 m -71.3 -30.57 66.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -58.87 -51.64 69.16 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 121.616 2.007 . . . . 0.0 113.57 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.09 -54.79 43.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 116.201 -1.857 . . . . 0.0 112.873 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.4 m -70.14 -30.21 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 CA-C-O 115.736 -2.078 . . . . 0.0 114.749 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.292 40.5 mt-10 -75.53 -29.85 59.58 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 122.342 2.337 . . . . 0.0 112.469 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.6 65.39 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.448 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.59 -29.62 62.51 Favored 'General case' 0 N--CA 1.487 1.409 1 N-CA-C 124.665 5.061 . . . . 0.0 124.665 -176.573 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -61.06 -29.4 69.71 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.3 mt -72.77 -54.05 9.94 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 126.762 2.025 . . . . 0.0 112.497 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.274 93.1 t -81.14 -62.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-O 117.069 -1.444 . . . . 0.0 107.913 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -70.84 -53.48 15.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.16 169.85 12.41 Favored Glycine 0 C--N 1.361 1.919 0 CA-C-N 120.618 1.554 . . . . 0.0 114.095 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -37.64 -36.43 0.17 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 119.182 3.03 . . . . 0.0 119.182 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -65.0 -43.92 90.96 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 116.43 -1.748 . . . . 0.0 115.164 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.0 -129.18 8.88 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-N 120.201 1.364 . . . . 0.0 113.191 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.27 134.42 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -93.13 114.92 27.55 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -79.44 -45.48 19.36 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.2 m -92.94 118.38 67.85 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-O 113.889 -2.958 . . . . 0.0 106.408 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.29 145.76 39.16 Favored 'Trans proline' 0 C--N 1.394 2.944 0 CA-C-N 126.942 3.515 . . . . 0.0 113.635 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.06 127.66 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 126.518 1.927 . . . . 0.0 111.25 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 O-C-N 124.481 1.113 . . . . 0.0 110.814 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 CA--C 1.564 1.5 0 CA-C-O 116.68 -1.628 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.8 t -145.46 103.72 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 1 N-CA-C 99.761 -4.162 . . . . 0.0 99.761 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -138.88 121.47 16.26 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -103.01 119.79 39.48 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -134.18 114.83 13.51 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.4 tp -134.95 109.48 8.49 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -136.68 130.93 32.87 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.218 1.007 . . . . 0.0 108.97 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.65 84.36 0.07 OUTLIER Glycine 0 N--CA 1.477 1.38 0 O-C-N 124.272 0.983 . . . . 0.0 111.915 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -80.01 -37.04 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -58.39 -53.53 57.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.483 1.947 . . . . 0.0 113.62 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.21 -50.9 72.27 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 124.943 1.297 . . . . 0.0 113.664 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.292 14.9 t -69.18 -26.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 115.209 -2.329 . . . . 0.0 112.49 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 47.3 mt-10 -80.76 -58.39 3.12 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 123.415 2.825 . . . . 0.0 108.237 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . 0.41 . . -33.6 -34.3 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 1 N-CA-C 125.167 5.247 . . . . 0.0 125.167 -178.351 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -77.37 -37.76 51.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 119.785 3.254 . . . . 0.0 119.785 -176.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.361 0.1 OUTLIER -39.53 -33.62 0.18 Allowed 'General case' 0 CA--C 1.591 2.553 0 N-CA-C 119.822 3.267 . . . . 0.0 119.822 174.879 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.1 -55.22 4.9 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 128.906 2.882 . . . . 0.0 113.938 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.264 99.2 t -80.04 -60.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 CA-C-O 116.947 -1.501 . . . . 0.0 107.813 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -65.11 -45.93 83.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.31 169.0 41.31 Favored Glycine 0 C--N 1.359 1.852 0 CA-C-N 120.117 1.326 . . . . 0.0 114.846 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -39.65 -41.58 1.08 Allowed 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.57 60.82 0.94 Allowed 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 123.704 0.802 . . . . 0.0 109.452 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.34 -122.17 3.83 Favored Glycine 0 C--N 1.359 1.857 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -88.71 135.55 33.45 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.841 0.856 . . . . 0.0 110.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -93.28 124.56 37.35 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -79.42 -56.99 3.92 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.8 p -90.7 124.3 62.71 Favored Pre-proline 0 CA--C 1.583 2.218 0 CA-C-O 114.253 -2.784 . . . . 0.0 107.952 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.79 142.08 68.26 Favored 'Trans proline' 0 C--N 1.397 3.106 0 CA-C-N 127.089 3.567 . . . . 0.0 114.903 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -120.85 -66.7 1.03 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 117.166 -1.397 . . . . 0.0 109.104 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.079 0 C-N-CA 126.774 2.03 . . . . 0.0 115.187 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 CA--C 1.564 1.508 0 CA-C-O 116.756 -1.592 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -92.98 119.22 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -94.14 124.79 38.38 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -96.67 123.93 40.5 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -136.49 104.09 5.47 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 pp -88.58 140.44 29.46 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.002 0.921 . . . . 0.0 110.68 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -133.73 120.8 21.03 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.19 -177.11 49.87 Favored Glycine 0 N--CA 1.482 1.727 0 O-C-N 124.111 0.882 . . . . 0.0 114.208 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -74.17 -35.82 64.03 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -53.32 -48.69 68.22 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 121.377 1.899 . . . . 0.0 115.874 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -63.77 -71.02 0.18 Allowed 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 116.309 -1.805 . . . . 0.0 109.307 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.0 t -47.76 -27.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 C-N-CA 126.886 2.074 . . . . 0.0 114.298 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.74 -62.58 1.49 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 114.245 -2.788 . . . . 0.0 106.359 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.45 -34.94 0.07 Allowed 'General case' 0 N--CA 1.506 2.357 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.39 -31.72 60.54 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.472 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.331 0.1 OUTLIER -38.72 -34.73 0.16 Allowed 'General case' 0 CA--C 1.589 2.466 0 N-CA-C 120.183 3.401 . . . . 0.0 120.183 175.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.32 -55.05 4.97 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 128.661 2.785 . . . . 0.0 113.941 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 98.9 t -80.06 -60.07 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-O 116.912 -1.518 . . . . 0.0 108.104 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m -63.3 -44.41 95.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.64 135.95 4.37 Favored Glycine 0 C--N 1.361 1.932 0 CA-C-N 120.325 1.42 . . . . 0.0 111.912 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -41.35 -37.0 0.91 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.65 -39.47 67.13 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.963 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.06 87.18 0.55 Allowed Glycine 0 C--N 1.36 1.879 0 CA-C-N 120.496 1.498 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -99.12 96.69 7.96 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -145.02 121.65 11.12 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -133.2 116.81 16.67 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p 65.07 125.43 0.02 OUTLIER Pre-proline 0 N--CA 1.508 2.461 0 CA-C-O 112.982 -3.39 . . . . 0.0 111.619 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.85 121.43 6.25 Favored 'Trans proline' 0 C--N 1.395 2.984 0 CA-C-N 127.631 3.761 . . . . 0.0 112.246 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.04 113.71 11.72 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 O-C-N 124.115 0.885 . . . . 0.0 110.758 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 t80 . . . . . 0 CA--C 1.565 1.537 0 CA-C-O 116.862 -1.542 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.358 9.7 p -76.71 -59.23 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 CA-C-N 120.623 1.556 . . . . 0.0 113.01 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -92.49 122.56 35.04 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -140.24 126.54 19.96 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -79.36 -56.95 3.96 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 116.807 -1.568 . . . . 0.0 112.781 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.7 mt -92.9 124.79 37.14 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 120.419 1.463 . . . . 0.0 107.772 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.0 p -75.43 -46.1 34.78 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.68 84.01 1.39 Allowed Glycine 0 C--N 1.36 1.902 0 CA-C-N 120.535 1.516 . . . . 0.0 112.24 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -79.89 -39.6 30.11 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 116.37 -1.776 . . . . 0.0 115.509 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -55.44 -46.36 76.75 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 121.403 1.911 . . . . 0.0 114.447 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.1 -70.69 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 116.235 -1.84 . . . . 0.0 109.414 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.5 t -48.52 -27.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 126.75 2.02 . . . . 0.0 114.08 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.03 -60.9 2.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 114.423 -2.703 . . . . 0.0 106.914 173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.54 -36.85 0.11 Allowed 'General case' 0 N--CA 1.507 2.389 1 N-CA-C 123.118 4.488 . . . . 0.0 123.118 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 -31.27 61.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.18 -30.52 0.06 Allowed 'General case' 0 CA--C 1.59 2.51 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -51.71 8.42 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 128.44 2.696 . . . . 0.0 113.807 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.252 86.2 t -80.29 -58.2 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 CA-C-O 116.691 -1.623 . . . . 0.0 108.525 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.9 m -63.64 -42.24 98.16 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.84 165.14 14.31 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 120.36 1.436 . . . . 0.0 113.701 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.279 12.7 pt-20 -33.6 -43.94 0.14 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.05 66.41 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.28 159.28 6.38 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 119.448 1.022 . . . . 0.0 115.313 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -89.6 137.39 32.37 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.906 0.882 . . . . 0.0 110.239 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -86.48 128.06 34.92 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.78 0.832 . . . . 0.0 109.253 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -73.45 -44.56 57.85 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.9 m -90.48 117.37 67.94 Favored Pre-proline 0 CA--C 1.59 2.492 0 CA-C-O 113.802 -2.999 . . . . 0.0 106.823 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.72 144.21 31.04 Favored 'Trans proline' 0 C--N 1.394 2.931 0 CA-C-N 126.894 3.498 . . . . 0.0 113.596 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -85.91 -63.11 1.37 Allowed 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 116.694 -1.622 . . . . 0.0 110.805 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 CA-C-N 120.48 1.491 . . . . 0.0 110.819 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.305 40.7 t 85.23 96.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -136.05 120.94 18.63 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -138.46 -61.99 0.58 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 116.723 -1.608 . . . . 0.0 110.516 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.252 28.4 p80 -89.78 -57.95 2.68 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 121.17 1.805 . . . . 0.0 113.797 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.6 tp -92.29 121.13 33.5 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 119.874 1.215 . . . . 0.0 107.822 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.3 p -120.24 -50.43 2.24 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 116.442 -1.742 . . . . 0.0 114.419 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.83 87.72 0.07 OUTLIER Glycine 0 C--N 1.359 1.856 0 CA-C-N 120.595 1.543 . . . . 0.0 110.859 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 m -76.03 -36.48 59.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -52.09 -48.82 64.54 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 121.547 1.976 . . . . 0.0 115.943 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.54 -70.91 0.2 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 116.211 -1.852 . . . . 0.0 109.361 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.0 t -48.51 -27.81 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.941 0 C-N-CA 126.83 2.052 . . . . 0.0 114.12 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.24 -62.58 1.47 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 114.346 -2.74 . . . . 0.0 106.493 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.38 -35.09 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.454 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.81 -32.24 61.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.33 0.1 OUTLIER -38.56 -35.01 0.16 Allowed 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 120.222 3.416 . . . . 0.0 120.222 175.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.52 -53.81 5.96 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 128.626 2.771 . . . . 0.0 114.802 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 86.3 t -77.88 -57.13 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 116.753 -1.594 . . . . 0.0 109.168 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -60.26 -42.2 94.82 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.12 161.97 12.92 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 120.181 1.355 . . . . 0.0 113.217 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -39.86 -38.36 0.67 Allowed 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -75.5 -39.79 58.0 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.99 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.81 146.32 6.24 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 120.637 1.562 . . . . 0.0 113.209 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -84.7 147.14 27.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.025 0.93 . . . . 0.0 111.545 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -83.12 129.88 35.06 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.024 0.93 . . . . 0.0 109.241 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -84.77 136.71 33.58 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.052 0.941 . . . . 0.0 110.317 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 t -133.91 121.75 16.04 Favored Pre-proline 0 CA--C 1.58 2.111 0 CA-C-O 112.962 -3.399 . . . . 0.0 109.099 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -63.86 140.26 72.48 Favored 'Trans proline' 0 C--N 1.396 3.066 0 CA-C-N 127.93 3.868 . . . . 0.0 115.063 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -121.02 114.73 21.93 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.897 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.564 1.518 0 CA-C-O 116.657 -1.64 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 m -148.11 112.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -95.09 121.42 36.7 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -91.54 111.18 22.59 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.027 0.931 . . . . 0.0 108.696 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -85.17 141.87 29.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 124.267 0.979 . . . . 0.0 111.581 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.2 mt 64.44 136.64 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 126.324 1.85 . . . . 0.0 111.86 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -80.66 136.27 36.18 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.942 0.897 . . . . 0.0 112.183 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.01 -82.29 0.04 OUTLIER Glycine 0 N--CA 1.481 1.694 0 CA-C-O 118.702 -1.055 . . . . 0.0 111.805 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -69.95 -38.07 76.04 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.259 31.8 p80 -57.56 -51.32 69.96 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-N 121.76 2.073 . . . . 0.0 114.675 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.7 tp -59.23 -71.38 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 115.808 -2.044 . . . . 0.0 108.723 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 t -48.94 -28.55 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.883 0 C-N-CA 126.429 1.892 . . . . 0.0 113.987 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -78.93 -27.07 43.66 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 114.377 -2.725 . . . . 0.0 113.148 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.42 -37.46 71.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 119.837 3.273 . . . . 0.0 119.837 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.65 -31.11 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -178.178 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.339 0.0 OUTLIER -38.86 -28.98 0.03 OUTLIER 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 176.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.8 -52.56 7.76 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.816 2.846 . . . . 0.0 113.12 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.37 -55.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 117.111 -1.423 . . . . 0.0 107.542 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.2 p -56.12 -41.48 75.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 118.873 2.916 . . . . 0.0 118.873 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.05 122.29 2.41 Favored Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -36.02 -43.12 0.31 Allowed 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -125.98 66.78 1.19 Allowed 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 92.07 0.1 OUTLIER Glycine 0 C--N 1.358 1.774 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -92.98 109.45 20.9 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -144.28 102.28 3.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -97.4 92.67 6.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.8 m -142.34 114.89 6.31 Favored Pre-proline 0 CA--C 1.586 2.336 0 CA-C-O 114.202 -2.809 . . . . 0.0 104.827 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -70.15 135.44 29.53 Favored 'Trans proline' 0 C--N 1.394 2.956 0 CA-C-N 126.825 3.473 . . . . 0.0 113.731 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp 64.51 129.22 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 126.397 1.879 . . . . 0.0 111.086 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 O-C-N 124.174 0.921 . . . . 0.0 111.054 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 93.9 t -114.68 103.95 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 1 N-CA-C 99.981 -4.081 . . . . 0.0 99.981 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -118.92 126.38 51.63 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -79.08 -50.89 10.32 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 117.195 -1.383 . . . . 0.0 113.063 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 63.21 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 126.584 1.954 . . . . 0.0 111.716 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . 0.255 13.1 tp 60.11 82.32 0.16 Allowed 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.657 1.983 . . . . 0.0 112.354 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 t -97.98 131.97 43.96 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.892 0.877 . . . . 0.0 109.156 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.1 139.69 4.29 Favored Glycine 0 CA--C 1.54 1.611 0 O-C-N 124.23 0.956 . . . . 0.0 112.096 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.1 m -73.6 -34.23 64.96 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -52.54 -48.59 66.01 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 121.641 2.019 . . . . 0.0 114.483 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.88 -71.53 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 115.83 -2.033 . . . . 0.0 109.289 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -49.7 -28.44 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 C-N-CA 126.346 1.858 . . . . 0.0 114.127 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.67 -27.22 45.14 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 114.442 -2.694 . . . . 0.0 112.869 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.94 70.86 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 120.055 3.354 . . . . 0.0 120.055 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.488 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.25 -29.97 64.42 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.476 3.139 . . . . 0.0 119.476 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.342 0.1 OUTLIER -39.22 -29.55 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.495 0 N-CA-C 120.345 3.461 . . . . 0.0 120.345 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.88 -53.79 6.16 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 128.963 2.905 . . . . 0.0 113.681 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 95.8 t -80.31 -59.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 116.825 -1.56 . . . . 0.0 107.916 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 64.7 m -68.46 -44.33 75.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.36 171.82 38.16 Favored Glycine 0 C--N 1.36 1.874 0 CA-C-N 120.355 1.434 . . . . 0.0 114.775 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -36.2 -42.41 0.31 Allowed 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -122.59 65.04 0.95 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.05 88.89 0.12 Allowed Glycine 0 C--N 1.359 1.85 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -134.96 119.67 18.27 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -121.73 120.52 34.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -124.81 -60.91 1.34 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.289 1.035 . . . . 0.0 111.955 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.8 p -86.92 131.92 43.51 Favored Pre-proline 0 CA--C 1.582 2.196 0 CA-C-O 114.186 -2.816 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.67 145.19 32.52 Favored 'Trans proline' 0 C--N 1.394 2.958 0 CA-C-N 126.678 3.421 . . . . 0.0 113.678 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -83.7 -60.95 1.96 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 116.705 -1.617 . . . . 0.0 111.804 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 CA-C-N 120.403 1.456 . . . . 0.0 110.905 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 m -96.15 99.59 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -93.19 127.4 38.74 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -95.52 112.77 24.42 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -134.76 122.45 22.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -89.85 111.88 23.05 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.133 0.973 . . . . 0.0 108.705 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.5 m -90.79 131.06 36.67 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.369 1.043 . . . . 0.0 110.238 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.13 -85.14 1.43 Allowed Glycine 0 N--CA 1.481 1.683 0 O-C-N 124.26 0.975 . . . . 0.0 111.188 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -72.18 -31.52 66.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -56.55 -49.88 73.53 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.449 1.932 . . . . 0.0 114.198 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.53 -70.78 0.19 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 116.177 -1.868 . . . . 0.0 109.431 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HA ' HD11 ' A' ' 15' ' ' LEU . 5.6 t -48.61 -28.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 C-N-CA 126.823 2.049 . . . . 0.0 113.959 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.05 -60.7 2.14 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 114.319 -2.753 . . . . 0.0 107.18 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.6 0.11 Allowed 'General case' 0 N--CA 1.506 2.362 1 N-CA-C 123.048 4.462 . . . . 0.0 123.048 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.483 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.41 -31.38 60.37 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.32 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.516 0 N-CA-C 120.67 3.582 . . . . 0.0 120.67 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.22 -51.79 8.52 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 128.269 2.628 . . . . 0.0 113.597 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -80.1 -55.71 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-O 117.038 -1.458 . . . . 0.0 107.968 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 94.1 p -51.36 -35.2 37.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.777 3.251 . . . . 0.0 119.777 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.76 103.48 1.55 Allowed Glycine 0 C--N 1.358 1.804 0 CA-C-N 120.071 1.305 . . . . 0.0 110.186 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -38.94 -38.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.457 2.762 . . . . 0.0 118.457 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -74.2 -39.88 62.84 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 116.462 -1.733 . . . . 0.0 113.948 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.45 93.72 0.98 Allowed Glycine 0 C--N 1.361 1.928 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -91.49 117.91 30.11 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -142.61 118.07 10.3 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -95.87 116.05 28.34 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.9 m -134.75 114.65 12.11 Favored Pre-proline 0 CA--C 1.587 2.396 0 CA-C-O 114.048 -2.882 . . . . 0.0 105.13 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.15 145.13 34.56 Favored 'Trans proline' 0 C--N 1.394 2.966 0 CA-C-N 126.857 3.485 . . . . 0.0 113.497 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -140.54 122.48 15.54 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.892 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 44.4 t80 . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.371 8.0 p -133.04 -64.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 C-N-CA 124.484 1.114 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -92.57 130.2 38.29 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.799 1.239 . . . . 0.0 108.352 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -93.14 117.92 30.63 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -93.16 132.94 36.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 124.401 1.063 . . . . 0.0 108.657 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.5 mt -92.62 122.32 34.92 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.4 t -75.23 -49.13 20.32 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.39 -78.03 0.11 Allowed Glycine 0 C--N 1.36 1.862 0 CA-C-N 120.789 1.632 . . . . 0.0 113.333 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -61.69 -29.92 70.4 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -57.7 -50.56 72.8 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 121.296 1.862 . . . . 0.0 114.117 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.0 tp -62.46 -72.44 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 115.27 -2.3 . . . . 0.0 108.998 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 12.0 m -47.96 -28.1 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.17 -27.5 38.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 114.035 -2.888 . . . . 0.0 112.585 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -36.82 72.8 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.095 3.369 . . . . 0.0 120.095 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.484 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.17 -30.1 64.66 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.4 -29.65 0.05 Allowed 'General case' 0 CA--C 1.589 2.444 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 176.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.9 -53.2 6.67 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 129.034 2.934 . . . . 0.0 114.181 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -80.3 -55.4 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 116.714 -1.612 . . . . 0.0 108.98 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.5 t -59.42 -40.46 86.78 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.32 101.49 2.42 Favored Glycine 0 C--N 1.357 1.727 0 CA-C-N 120.342 1.428 . . . . 0.0 110.191 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -40.2 -36.22 0.49 Allowed 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -70.81 -39.72 72.91 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 116.395 -1.764 . . . . 0.0 114.382 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.94 84.02 0.35 Allowed Glycine 0 C--N 1.36 1.903 0 CA-C-N 120.644 1.566 . . . . 0.0 110.844 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.02 120.95 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.85 96.75 3.86 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.254 48.9 t80 -124.45 -65.17 1.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 124.423 1.089 . . . . 0.0 110.989 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -85.84 122.17 72.97 Favored Pre-proline 0 CA--C 1.58 2.125 0 CA-C-O 112.81 -3.471 . . . . 0.0 110.231 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -65.06 140.26 64.8 Favored 'Trans proline' 0 C--N 1.395 2.975 0 CA-C-N 127.794 3.819 . . . . 0.0 114.9 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -97.03 116.66 29.62 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 O-C-N 124.297 0.998 . . . . 0.0 110.993 -179.988 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.304 26.9 t 83.26 95.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.706 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -140.66 122.1 15.04 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 64.89 128.72 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 C-N-CA 126.484 1.914 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -93.15 122.54 35.64 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.1 mt -94.0 123.9 37.66 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.2 p -87.97 132.03 34.39 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.155 0.909 . . . . 0.0 110.964 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.06 85.88 1.34 Allowed Glycine 0 N--CA 1.482 1.707 0 O-C-N 124.356 1.035 . . . . 0.0 111.506 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -77.17 -38.03 52.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -57.39 -47.94 80.36 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 121.428 1.922 . . . . 0.0 114.144 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.91 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 116.262 -1.828 . . . . 0.0 109.204 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.413 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.1 t -47.95 -27.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 C-N-CA 126.826 2.05 . . . . 0.0 114.04 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -74.3 -61.01 2.01 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 114.434 -2.698 . . . . 0.0 107.156 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.55 0.11 Allowed 'General case' 0 N--CA 1.507 2.375 1 N-CA-C 123.129 4.492 . . . . 0.0 123.129 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.467 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.23 -31.59 60.9 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.757 2.873 . . . . 0.0 118.757 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.24 -29.98 0.05 Allowed 'General case' 0 CA--C 1.59 2.482 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 175.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.32 5.79 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.247 2.619 . . . . 0.0 113.546 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.253 87.0 t -80.32 -57.41 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-O 116.802 -1.57 . . . . 0.0 108.468 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -64.75 -47.21 79.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.63 136.97 4.13 Favored Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.279 1.4 . . . . 0.0 112.363 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -42.47 -35.79 1.15 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -69.13 -38.59 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 116.348 -1.787 . . . . 0.0 114.966 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.66 86.04 0.42 Allowed Glycine 0 C--N 1.36 1.88 0 CA-C-N 120.393 1.451 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -99.18 119.64 38.2 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -130.61 114.88 15.99 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.26 46.4 t80 -124.03 -64.6 1.12 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 124.342 1.057 . . . . 0.0 111.264 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.5 p -89.1 131.17 41.77 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 114.258 -2.782 . . . . 0.0 108.939 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -65.42 138.01 53.35 Favored 'Trans proline' 0 C--N 1.395 3.014 0 CA-C-N 126.939 3.514 . . . . 0.0 114.829 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -98.71 122.13 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.939 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 84.5 t -109.81 104.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 1 N-CA-C 100.047 -4.057 . . . . 0.0 100.047 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -73.35 -47.13 44.82 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -88.68 116.26 26.8 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.826 1.25 . . . . 0.0 109.111 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -136.71 114.34 11.09 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.1 mt -142.75 116.0 8.96 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.2 p -88.12 134.25 33.81 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.899 0.88 . . . . 0.0 111.266 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.66 132.02 10.95 Favored Glycine 0 CA--C 1.541 1.708 0 O-C-N 124.268 0.98 . . . . 0.0 111.76 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.9 p -70.01 -32.82 71.18 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -59.9 -48.67 80.75 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 121.437 1.926 . . . . 0.0 113.75 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.67 -50.24 74.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 116.603 -1.665 . . . . 0.0 113.415 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.3 m -73.84 -31.46 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 CA-C-O 115.961 -1.971 . . . . 0.0 113.908 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 48.1 mt-10 -73.82 -29.75 62.32 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 122.081 2.219 . . . . 0.0 112.36 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.62 62.54 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.461 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -68.44 -29.86 68.61 Favored 'General case' 0 N--CA 1.486 1.362 1 N-CA-C 123.941 4.793 . . . . 0.0 123.941 -176.81 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.258 0.9 OUTLIER -61.32 -28.62 69.34 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.22 -50.81 62.52 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 126.213 1.805 . . . . 0.0 113.192 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.262 88.8 t -80.37 -60.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.281 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.8 m -66.67 -41.72 87.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.94 133.14 5.54 Favored Glycine 0 C--N 1.358 1.802 0 CA-C-N 120.335 1.425 . . . . 0.0 111.169 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.26 14.3 pt-20 -33.18 -41.04 0.07 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.58 -41.75 59.95 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.824 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.19 86.49 1.16 Allowed Glycine 0 C--N 1.361 1.951 0 CA-C-N 120.579 1.536 . . . . 0.0 110.848 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -100.55 114.65 28.47 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -138.03 115.91 11.54 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.261 47.0 t80 -127.64 -66.3 0.88 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.399 1.08 . . . . 0.0 110.701 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.4 p -89.12 132.74 36.9 Favored Pre-proline 0 CA--C 1.581 2.163 0 CA-C-O 114.296 -2.764 . . . . 0.0 109.271 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.77 148.52 41.43 Favored 'Trans proline' 0 C--N 1.395 2.979 0 CA-C-N 126.671 3.418 . . . . 0.0 113.634 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.328 49.2 mtpt 69.26 -58.37 0.51 Allowed 'General case' 0 N--CA 1.51 2.549 0 C-N-CA 125.95 1.7 . . . . 0.0 113.703 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.27 0 CA-C-N 120.223 1.374 . . . . 0.0 110.491 179.925 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 p90 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.45 111.63 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 t30 57.79 115.82 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 126.799 2.04 . . . . 0.0 112.467 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -133.76 119.36 19.17 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -88.45 99.87 12.61 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.954 0.902 . . . . 0.0 109.142 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -86.57 138.41 31.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.115 0.966 . . . . 0.0 111.048 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -88.22 133.09 34.12 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.809 0.844 . . . . 0.0 110.186 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.57 -84.46 0.05 OUTLIER Glycine 0 N--CA 1.479 1.514 0 O-C-N 124.328 1.017 . . . . 0.0 111.616 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.6 m -70.82 -37.55 73.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -57.81 -48.17 80.49 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 121.515 1.961 . . . . 0.0 113.975 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.16 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 116.117 -1.896 . . . . 0.0 109.279 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.8 t -47.95 -28.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 126.785 2.034 . . . . 0.0 114.106 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.5 -60.76 2.13 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.34 -2.743 . . . . 0.0 106.783 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.63 -36.35 0.11 Allowed 'General case' 0 N--CA 1.507 2.407 1 N-CA-C 123.238 4.532 . . . . 0.0 123.238 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.97 -30.82 58.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.02 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.35 -30.14 0.06 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.319 3.451 . . . . 0.0 120.319 175.607 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 -53.9 6.07 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.256 2.622 . . . . 0.0 113.938 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -80.47 -54.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.743 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.4 m -58.88 -47.14 85.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.3 88.33 0.09 OUTLIER Glycine 0 C--N 1.359 1.832 0 CA-C-N 120.654 1.57 . . . . 0.0 111.251 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -42.57 -42.02 3.23 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -65.93 -33.75 76.54 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -154.7 92.0 0.13 Allowed Glycine 0 C--N 1.356 1.678 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -127.1 115.34 19.0 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -138.46 123.57 19.12 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.29 1.036 . . . . 0.0 108.636 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -134.81 118.17 16.73 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.8 m -130.02 109.64 16.82 Favored Pre-proline 0 CA--C 1.586 2.349 0 CA-C-O 114.003 -2.903 . . . . 0.0 104.559 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.81 137.04 17.45 Favored 'Trans proline' 0 C--N 1.394 2.956 0 CA-C-N 126.733 3.44 . . . . 0.0 112.682 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? 62.29 129.69 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 C-N-CA 126.481 1.912 . . . . 0.0 111.765 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 O-C-N 124.297 0.998 . . . . 0.0 110.841 179.891 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -137.04 94.38 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.93 124.69 40.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -91.74 141.03 29.13 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.008 0.923 . . . . 0.0 109.388 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.6 t60 62.21 95.08 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 126.993 2.117 . . . . 0.0 112.733 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.3 mt -153.24 120.39 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.9 m -80.9 -56.68 3.96 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 116.609 -1.662 . . . . 0.0 113.324 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.58 177.03 46.12 Favored Glycine 0 C--N 1.362 1.997 0 CA-C-N 120.559 1.527 . . . . 0.0 115.679 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -77.71 -29.97 51.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.254 41.2 p-80 -50.31 -52.0 40.45 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 121.862 2.119 . . . . 0.0 116.647 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.65 -71.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 115.749 -2.072 . . . . 0.0 109.456 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.431 ' HA ' HD11 ' A' ' 15' ' ' LEU 0.299 10.4 m -48.47 -27.22 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.084 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 177.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -75.89 -60.24 2.41 Favored 'General case' 0 CA--C 1.573 1.835 0 CA-C-O 114.432 -2.699 . . . . 0.0 106.689 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.43 -37.41 0.12 Allowed 'General case' 0 N--CA 1.507 2.401 1 N-CA-C 122.845 4.387 . . . . 0.0 122.845 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.474 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.22 -29.72 60.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.332 0.1 OUTLIER -39.06 -35.87 0.25 Allowed 'General case' 0 CA--C 1.595 2.686 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 175.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -52.07 7.8 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 128.926 2.89 . . . . 0.0 111.667 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 11.5 m -70.92 -56.71 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 125.544 1.538 . . . . 0.0 112.518 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.9 m -74.57 -43.42 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.83 110.09 3.46 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -35.61 -40.76 0.18 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.85 -41.5 59.74 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 116.481 -1.723 . . . . 0.0 113.61 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.04 91.44 1.3 Allowed Glycine 0 C--N 1.361 1.938 0 CA-C-N 120.447 1.476 . . . . 0.0 109.763 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -94.47 116.44 28.79 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -141.95 113.21 7.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.273 45.5 t80 -94.52 -68.38 0.8 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.93 0.892 . . . . 0.0 110.845 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.6 p -146.48 117.4 4.75 Favored Pre-proline 0 CA--C 1.581 2.164 0 CA-C-O 114.306 -2.759 . . . . 0.0 106.437 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.45 133.49 11.86 Favored 'Trans proline' 0 C--N 1.396 3.055 0 CA-C-N 126.908 3.503 . . . . 0.0 112.396 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.426 17.1 ptpt 64.12 -61.55 0.18 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-N 119.218 0.917 . . . . 0.0 111.142 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 44.0 t80 . . . . . 0 CA--C 1.566 1.561 0 CA-C-O 116.85 -1.547 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.41 114.55 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.75 120.79 33.49 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -94.62 130.49 41.05 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -76.07 -51.57 11.99 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 116.669 -1.634 . . . . 0.0 113.844 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.0 mt -96.88 115.97 28.36 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.4 m -106.02 130.64 53.9 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.833 0.853 . . . . 0.0 109.789 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.53 75.85 1.13 Allowed Glycine 0 N--CA 1.482 1.734 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.685 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.8 p -80.33 -39.51 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -54.55 -48.46 71.99 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 121.491 1.95 . . . . 0.0 114.239 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.7 tp -58.12 -71.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 115.793 -2.051 . . . . 0.0 109.244 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -49.23 -28.59 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 C-N-CA 126.39 1.876 . . . . 0.0 114.272 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.06 -27.39 43.08 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 114.411 -2.709 . . . . 0.0 112.774 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.68 70.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 120.18 3.4 . . . . 0.0 120.18 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.95 -30.53 65.39 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.347 0.1 OUTLIER -39.26 -29.79 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.273 3.434 . . . . 0.0 120.273 176.263 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.33 -53.21 6.52 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 129.077 2.951 . . . . 0.0 114.408 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.24 -54.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 CA-C-O 116.634 -1.65 . . . . 0.0 109.451 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.0 m -60.08 -45.34 93.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.48 91.24 0.39 Allowed Glycine 0 C--N 1.359 1.829 0 CA-C-N 120.533 1.515 . . . . 0.0 110.586 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -35.78 -42.36 0.25 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.97 -42.47 69.67 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.88 -128.57 4.01 Favored Glycine 0 C--N 1.358 1.75 0 CA-C-N 119.194 0.907 . . . . 0.0 111.081 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 56.51 92.09 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.723 2.009 . . . . 0.0 112.457 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -99.35 118.04 35.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -98.83 118.36 35.42 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.7 m -96.85 111.34 57.22 Favored Pre-proline 0 CA--C 1.587 2.39 0 CA-C-O 113.982 -2.913 . . . . 0.0 105.369 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.48 137.09 18.18 Favored 'Trans proline' 0 C--N 1.394 2.971 0 CA-C-N 126.697 3.428 . . . . 0.0 112.82 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -85.87 -64.01 1.22 Allowed 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 116.708 -1.615 . . . . 0.0 110.633 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.106 0 CA-C-N 120.354 1.434 . . . . 0.0 110.766 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 52.6 t80 . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.373 8.5 p -137.34 -64.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.398 0 C-N-CA 124.588 1.155 . . . . 0.0 110.724 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -72.76 -38.57 67.29 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -92.88 118.69 31.41 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -136.16 119.28 16.53 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.6 mt 62.56 129.18 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 126.528 1.931 . . . . 0.0 111.843 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -131.96 126.89 35.15 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.272 0.983 . . . . 0.0 109.242 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.48 82.97 1.13 Allowed Glycine 0 N--CA 1.481 1.662 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.01 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.3 t -79.9 -41.51 26.02 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 116.392 -1.766 . . . . 0.0 115.242 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -54.84 -45.2 74.45 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.366 1.894 . . . . 0.0 114.588 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.4 tp -63.52 -70.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 116.134 -1.889 . . . . 0.0 109.254 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.7 t -48.04 -28.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 C-N-CA 126.805 2.042 . . . . 0.0 114.094 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.39 -60.83 2.09 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 114.55 -2.643 . . . . 0.0 106.841 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -36.52 0.11 Allowed 'General case' 0 N--CA 1.505 2.307 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.34 -31.11 60.46 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.32 -31.51 0.08 Allowed 'General case' 0 CA--C 1.591 2.537 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 175.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.6 -53.45 6.54 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 128.33 2.652 . . . . 0.0 114.039 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.27 -55.85 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 116.691 -1.623 . . . . 0.0 109.31 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -61.74 -48.04 82.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.73 2.492 . . . . 0.0 117.73 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.68 108.53 0.25 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 120.667 1.576 . . . . 0.0 111.312 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -36.73 -44.8 0.49 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -126.69 66.01 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 89.73 0.08 OUTLIER Glycine 0 C--N 1.359 1.808 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.66 126.42 37.73 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -129.18 105.27 8.05 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -128.27 -57.06 1.23 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 124.408 1.083 . . . . 0.0 112.579 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.1 t -137.69 126.26 14.57 Favored Pre-proline 0 CA--C 1.583 2.215 0 CA-C-O 113.115 -3.326 . . . . 0.0 109.928 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -64.46 141.22 73.08 Favored 'Trans proline' 0 C--N 1.395 2.988 0 CA-C-N 127.683 3.78 . . . . 0.0 114.89 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -129.14 114.59 16.52 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.985 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.7 t80 . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.0 m -149.64 110.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.263 20.1 t-20 -122.6 -66.0 1.06 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.204 1.002 . . . . 0.0 111.211 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -125.72 -67.2 0.9 Allowed 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 116.73 -1.605 . . . . 0.0 109.259 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -94.41 123.71 37.98 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.594 1.543 . . . . 0.0 107.355 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -132.38 103.25 6.1 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.1 t -132.16 126.1 32.83 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.1 -74.7 1.28 Allowed Glycine 0 N--CA 1.483 1.786 0 O-C-N 124.07 0.856 . . . . 0.0 114.579 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.3 p -46.28 -29.33 1.58 Allowed 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 121.893 4.035 . . . . 0.0 121.893 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -45.74 -48.55 15.26 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.36 -72.62 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 116.283 -1.817 . . . . 0.0 110.359 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.385 4.8 p -51.39 -26.8 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.1 -60.26 2.37 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 114.488 -2.672 . . . . 0.0 106.753 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.46 -37.47 0.13 Allowed 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 122.952 4.427 . . . . 0.0 122.952 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.47 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.52 -31.06 62.03 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.324 0.1 OUTLIER -39.32 -30.01 0.05 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.618 3.562 . . . . 0.0 120.618 175.759 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.1 5.99 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 128.25 2.62 . . . . 0.0 113.53 -177.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 93.1 t -80.32 -58.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 CA-C-O 116.881 -1.533 . . . . 0.0 108.271 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 t -65.02 -43.08 93.61 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.71 127.71 4.06 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 120.292 1.406 . . . . 0.0 110.546 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -39.72 -37.87 0.58 Allowed 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -73.38 -40.29 64.46 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 116.468 -1.729 . . . . 0.0 113.845 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 91.78 1.04 Allowed Glycine 0 C--N 1.361 1.95 0 CA-C-N 120.47 1.486 . . . . 0.0 109.463 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -94.73 99.33 11.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -143.33 120.09 11.2 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -98.35 115.16 27.86 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 m -136.57 113.4 10.13 Favored Pre-proline 0 CA--C 1.587 2.371 0 CA-C-O 114.039 -2.886 . . . . 0.0 105.006 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.31 142.68 27.23 Favored 'Trans proline' 0 C--N 1.395 2.993 0 CA-C-N 126.842 3.479 . . . . 0.0 113.205 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm 59.93 135.96 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 126.874 2.07 . . . . 0.0 112.201 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.782 179.991 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . 0.268 43.1 p90 . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 117.111 -1.424 . . . . 0.0 113.358 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 m -94.5 109.8 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -129.83 -48.65 1.14 Allowed 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 69.26 126.78 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 127.264 2.225 . . . . 0.0 110.017 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 61.48 123.59 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 126.637 1.975 . . . . 0.0 111.836 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.4 mt -98.37 118.37 34.88 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.5 m -108.39 127.52 53.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.923 0.889 . . . . 0.0 108.791 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.72 -91.54 0.08 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.5 p -78.87 -46.94 17.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.531 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -46.35 -45.11 17.46 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 121.71 2.05 . . . . 0.0 115.472 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -63.65 -70.9 0.19 Allowed 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.161 -1.876 . . . . 0.0 109.626 177.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.402 ' HA ' HD11 ' A' ' 15' ' ' LEU 0.263 4.8 t -47.43 -28.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.919 0 CA-C-O 115.85 -2.024 . . . . 0.0 114.282 179.473 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.1 -60.3 2.35 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.248 -2.787 . . . . 0.0 106.872 173.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -35.1 0.08 Allowed 'General case' 0 N--CA 1.508 2.428 1 N-CA-C 123.476 4.621 . . . . 0.0 123.476 -178.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.44 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -76.68 -31.74 57.46 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -179.015 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.333 0.1 OUTLIER -39.09 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.488 0 N-CA-C 120.724 3.602 . . . . 0.0 120.724 175.851 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.93 -52.39 7.92 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 128.235 2.614 . . . . 0.0 113.342 -177.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -80.31 -56.25 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-O 117.053 -1.451 . . . . 0.0 107.96 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.7 p -51.81 -35.1 42.96 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 119.912 3.301 . . . . 0.0 119.912 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.99 110.96 2.41 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -39.86 -37.3 0.54 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -72.9 -39.4 66.38 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 116.306 -1.807 . . . . 0.0 114.162 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.42 87.66 1.27 Allowed Glycine 0 C--N 1.36 1.904 0 CA-C-N 120.562 1.528 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -112.95 113.86 26.09 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -143.02 118.4 10.27 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -134.36 119.35 18.53 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 26.7 m -132.17 113.31 14.65 Favored Pre-proline 0 CA--C 1.587 2.367 0 CA-C-O 114.112 -2.851 . . . . 0.0 104.974 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -68.71 140.74 47.69 Favored 'Trans proline' 0 C--N 1.395 3.006 0 CA-C-N 126.771 3.454 . . . . 0.0 114.395 -176.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -83.16 -62.44 1.59 Allowed 'General case' 0 CA--C 1.572 1.824 0 CA-C-O 116.722 -1.608 . . . . 0.0 111.39 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 CA-C-N 120.376 1.444 . . . . 0.0 109.916 -179.857 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 CA-C-O 118.949 -0.917 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.3 p -76.03 -32.99 59.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -55.05 -48.56 73.3 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 121.59 1.995 . . . . 0.0 114.474 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.9 tp -63.37 -70.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 116.202 -1.856 . . . . 0.0 109.633 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.1 t -48.66 -27.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.971 0 C-N-CA 126.738 2.015 . . . . 0.0 114.06 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -74.33 -60.7 2.15 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 114.445 -2.693 . . . . 0.0 106.847 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.53 -36.51 0.11 Allowed 'General case' 0 N--CA 1.506 2.356 1 N-CA-C 123.182 4.512 . . . . 0.0 123.182 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.55 -31.26 59.98 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.802 2.89 . . . . 0.0 118.802 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.31 -29.71 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 175.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.4 -54.66 5.5 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.241 2.616 . . . . 0.0 113.172 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 99.3 t -80.51 -59.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 116.859 -1.543 . . . . 0.0 108.056 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.3 m -68.72 -46.29 69.32 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.26 177.58 51.95 Favored Glycine 0 C--N 1.36 1.868 0 CA-C-N 120.464 1.483 . . . . 0.0 114.552 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.24 72.46 1.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 123.627 1.679 . . . . 0.0 112.158 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -164.99 -41.64 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 128.043 2.537 . . . . 0.0 108.974 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.3 82.27 1.68 Allowed Glycine 0 C--N 1.368 2.332 0 CA-C-N 120.288 1.404 . . . . 0.0 113.873 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -143.89 117.12 8.98 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 116.785 -1.578 . . . . 0.0 111.427 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 CA-C-O 118.761 -1.022 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.5 p -70.38 -31.01 68.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 118.262 2.69 . . . . 0.0 118.262 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -58.12 -49.56 76.55 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 121.417 1.917 . . . . 0.0 114.126 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.6 -72.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 115.389 -2.243 . . . . 0.0 108.869 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 12.6 m -48.42 -28.02 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 11.7 mm-40 -80.09 -27.34 39.28 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 114.195 -2.812 . . . . 0.0 112.819 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.11 72.15 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.486 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.28 -30.84 66.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.692 3.219 . . . . 0.0 119.692 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.345 0.0 OUTLIER -39.34 -29.85 0.05 Allowed 'General case' 0 CA--C 1.59 2.483 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 176.495 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.35 -53.45 6.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 129.046 2.938 . . . . 0.0 114.344 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.21 -55.78 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 116.613 -1.66 . . . . 0.0 109.187 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -63.24 -47.35 82.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.61 148.55 4.92 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 120.41 1.459 . . . . 0.0 112.437 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -42.01 -36.71 1.18 Allowed 'General case' 0 N--CA 1.511 2.597 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -71.91 -42.22 66.97 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 116.486 -1.721 . . . . 0.0 113.593 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.66 -178.09 53.83 Favored Glycine 0 C--N 1.36 1.898 0 CA-C-N 120.208 1.367 . . . . 0.0 114.67 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -126.95 -31.33 2.64 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . 0.338 90.6 m-85 . . . . . 0 N--CA 1.504 2.27 0 C-N-CA 126.72 2.008 . . . . 0.0 111.935 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.5 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.3 m -74.17 -33.8 63.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -54.74 -49.22 71.36 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 121.756 2.071 . . . . 0.0 114.699 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.28 -72.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 115.283 -2.294 . . . . 0.0 108.964 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 11.4 m -47.85 -28.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.2 -27.51 38.83 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 114.216 -2.802 . . . . 0.0 112.6 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.15 -36.58 72.1 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 120.134 3.383 . . . . 0.0 120.134 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.12 -30.34 64.96 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.482 3.141 . . . . 0.0 119.482 -178.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.3 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.588 2.416 0 N-CA-C 120.35 3.463 . . . . 0.0 120.35 176.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.96 -54.87 5.2 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 128.847 2.859 . . . . 0.0 114.013 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -80.39 -54.2 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 116.716 -1.612 . . . . 0.0 109.452 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -60.99 -48.17 83.06 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.1 101.19 0.18 Allowed Glycine 0 C--N 1.36 1.865 0 CA-C-N 120.757 1.617 . . . . 0.0 111.711 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -38.92 -45.48 1.19 Allowed 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -120.04 66.65 0.82 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.47 -80.95 0.06 OUTLIER Glycine 0 C--N 1.359 1.837 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.2 t80 63.89 96.75 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 126.676 1.991 . . . . 0.0 111.553 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 . . . . . 0 N--CA 1.486 1.334 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.493 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.885 0 CA-C-O 121.899 0.721 . . . . 0.0 114.252 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -77.53 -31.71 53.56 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -58.66 -51.27 70.66 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 121.727 2.058 . . . . 0.0 113.679 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 tp -56.67 -43.04 80.03 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 116.877 -1.535 . . . . 0.0 114.865 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.6 -41.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 115.476 -2.202 . . . . 0.0 109.742 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.298 39.7 mt-10 -64.9 -29.21 70.15 Favored 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 123.053 2.66 . . . . 0.0 113.826 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.85 63.15 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.461 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.08 -29.8 62.05 Favored 'General case' 0 N--CA 1.485 1.309 1 N-CA-C 124.499 4.999 . . . . 0.0 124.499 -176.49 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -61.07 -29.9 70.02 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 mt -72.47 -46.95 52.46 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 126.646 1.978 . . . . 0.0 113.721 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.256 95.6 t -80.44 -59.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.269 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -65.63 -45.7 82.04 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 117.026 2.232 . . . . 0.0 117.026 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.59 114.94 1.7 Allowed Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.609 1.55 . . . . 0.0 110.066 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -40.49 -41.09 1.36 Allowed 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 117.649 2.462 . . . . 0.0 117.649 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -73.04 -38.15 66.61 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 116.333 -1.794 . . . . 0.0 114.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 89.53 1.28 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 120.519 1.509 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -97.47 105.57 17.74 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 t80 . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 179.849 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.347 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 m -71.3 -30.57 66.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -58.87 -51.64 69.16 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 121.616 2.007 . . . . 0.0 113.57 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.09 -54.79 43.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 116.201 -1.857 . . . . 0.0 112.873 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.4 m -70.14 -30.21 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 CA-C-O 115.736 -2.078 . . . . 0.0 114.749 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.292 40.5 mt-10 -75.53 -29.85 59.58 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 122.342 2.337 . . . . 0.0 112.469 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.6 65.39 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.448 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.59 -29.62 62.51 Favored 'General case' 0 N--CA 1.487 1.409 1 N-CA-C 124.665 5.061 . . . . 0.0 124.665 -176.573 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -61.06 -29.4 69.71 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.3 mt -72.77 -54.05 9.94 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 126.762 2.025 . . . . 0.0 112.497 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.274 93.1 t -81.14 -62.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-O 117.069 -1.444 . . . . 0.0 107.913 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -70.84 -53.48 15.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.16 169.85 12.41 Favored Glycine 0 C--N 1.361 1.919 0 CA-C-N 120.618 1.554 . . . . 0.0 114.095 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -37.64 -36.43 0.17 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 119.182 3.03 . . . . 0.0 119.182 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -65.0 -43.92 90.96 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 116.43 -1.748 . . . . 0.0 115.164 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.0 -129.18 8.88 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-N 120.201 1.364 . . . . 0.0 113.191 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.27 134.42 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.474 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.38 0 CA-C-O 118.924 -0.931 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -80.01 -37.04 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -58.39 -53.53 57.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.483 1.947 . . . . 0.0 113.62 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.21 -50.9 72.27 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 124.943 1.297 . . . . 0.0 113.664 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.292 14.9 t -69.18 -26.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 115.209 -2.329 . . . . 0.0 112.49 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 47.3 mt-10 -80.76 -58.39 3.12 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 123.415 2.825 . . . . 0.0 108.237 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . 0.41 . . -33.6 -34.3 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 1 N-CA-C 125.167 5.247 . . . . 0.0 125.167 -178.351 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -77.37 -37.76 51.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 119.785 3.254 . . . . 0.0 119.785 -176.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.361 0.1 OUTLIER -39.53 -33.62 0.18 Allowed 'General case' 0 CA--C 1.591 2.553 0 N-CA-C 119.822 3.267 . . . . 0.0 119.822 174.879 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.1 -55.22 4.9 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 128.906 2.882 . . . . 0.0 113.938 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.264 99.2 t -80.04 -60.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 CA-C-O 116.947 -1.501 . . . . 0.0 107.813 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -65.11 -45.93 83.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.31 169.0 41.31 Favored Glycine 0 C--N 1.359 1.852 0 CA-C-N 120.117 1.326 . . . . 0.0 114.846 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -39.65 -41.58 1.08 Allowed 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.57 60.82 0.94 Allowed 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 123.704 0.802 . . . . 0.0 109.452 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.34 -122.17 3.83 Favored Glycine 0 C--N 1.359 1.857 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -88.71 135.55 33.45 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.841 0.856 . . . . 0.0 110.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.727 0 CA-C-O 121.788 0.66 . . . . 0.0 114.208 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -74.17 -35.82 64.03 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -53.32 -48.69 68.22 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 121.377 1.899 . . . . 0.0 115.874 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -63.77 -71.02 0.18 Allowed 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 116.309 -1.805 . . . . 0.0 109.307 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.0 t -47.76 -27.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 C-N-CA 126.886 2.074 . . . . 0.0 114.298 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.74 -62.58 1.49 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 114.245 -2.788 . . . . 0.0 106.359 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.45 -34.94 0.07 Allowed 'General case' 0 N--CA 1.506 2.357 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.39 -31.72 60.54 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.331 0.1 OUTLIER -38.72 -34.73 0.16 Allowed 'General case' 0 CA--C 1.589 2.466 0 N-CA-C 120.183 3.401 . . . . 0.0 120.183 175.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.32 -55.05 4.97 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 128.661 2.785 . . . . 0.0 113.941 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 98.9 t -80.06 -60.07 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-O 116.912 -1.518 . . . . 0.0 108.104 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m -63.3 -44.41 95.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.64 135.95 4.37 Favored Glycine 0 C--N 1.361 1.932 0 CA-C-N 120.325 1.42 . . . . 0.0 111.912 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -41.35 -37.0 0.91 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.65 -39.47 67.13 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.963 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.06 87.18 0.55 Allowed Glycine 0 C--N 1.36 1.879 0 CA-C-N 120.496 1.498 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -99.12 96.69 7.96 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.861 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 CA-C-O 118.896 -0.946 . . . . 0.0 112.24 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -79.89 -39.6 30.11 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 116.37 -1.776 . . . . 0.0 115.509 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -55.44 -46.36 76.75 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 121.403 1.911 . . . . 0.0 114.447 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.1 -70.69 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 116.235 -1.84 . . . . 0.0 109.414 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.5 t -48.52 -27.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 126.75 2.02 . . . . 0.0 114.08 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.03 -60.9 2.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 114.423 -2.703 . . . . 0.0 106.914 173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.54 -36.85 0.11 Allowed 'General case' 0 N--CA 1.507 2.389 1 N-CA-C 123.118 4.488 . . . . 0.0 123.118 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 -31.27 61.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.18 -30.52 0.06 Allowed 'General case' 0 CA--C 1.59 2.51 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -51.71 8.42 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 128.44 2.696 . . . . 0.0 113.807 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.252 86.2 t -80.29 -58.2 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 CA-C-O 116.691 -1.623 . . . . 0.0 108.525 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.9 m -63.64 -42.24 98.16 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.84 165.14 14.31 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 120.36 1.436 . . . . 0.0 113.701 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.279 12.7 pt-20 -33.6 -43.94 0.14 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.05 66.41 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.28 159.28 6.38 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 119.448 1.022 . . . . 0.0 115.313 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -89.6 137.39 32.37 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.906 0.882 . . . . 0.0 110.239 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 . . . . . 0 N--CA 1.493 1.679 0 C-N-CA 123.78 0.832 . . . . 0.0 109.253 -179.688 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.278 0 CA-C-O 118.915 -0.936 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 m -76.03 -36.48 59.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -52.09 -48.82 64.54 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 121.547 1.976 . . . . 0.0 115.943 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.54 -70.91 0.2 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 116.211 -1.852 . . . . 0.0 109.361 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.0 t -48.51 -27.81 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.941 0 C-N-CA 126.83 2.052 . . . . 0.0 114.12 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.24 -62.58 1.47 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 114.346 -2.74 . . . . 0.0 106.493 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.38 -35.09 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.454 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.81 -32.24 61.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.33 0.1 OUTLIER -38.56 -35.01 0.16 Allowed 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 120.222 3.416 . . . . 0.0 120.222 175.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.52 -53.81 5.96 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 128.626 2.771 . . . . 0.0 114.802 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 86.3 t -77.88 -57.13 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 116.753 -1.594 . . . . 0.0 109.168 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -60.26 -42.2 94.82 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.12 161.97 12.92 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 120.181 1.355 . . . . 0.0 113.217 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -39.86 -38.36 0.67 Allowed 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -75.5 -39.79 58.0 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.99 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.81 146.32 6.24 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 120.637 1.562 . . . . 0.0 113.209 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -84.7 147.14 27.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.025 0.93 . . . . 0.0 111.545 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 . . . . . 0 N--CA 1.493 1.711 0 C-N-CA 124.024 0.93 . . . . 0.0 109.241 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 CA-C-O 118.702 -1.055 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -69.95 -38.07 76.04 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.259 31.8 p80 -57.56 -51.32 69.96 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-N 121.76 2.073 . . . . 0.0 114.675 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.7 tp -59.23 -71.38 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 115.808 -2.044 . . . . 0.0 108.723 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 t -48.94 -28.55 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.883 0 C-N-CA 126.429 1.892 . . . . 0.0 113.987 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -78.93 -27.07 43.66 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 114.377 -2.725 . . . . 0.0 113.148 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.42 -37.46 71.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 119.837 3.273 . . . . 0.0 119.837 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.65 -31.11 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -178.178 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.339 0.0 OUTLIER -38.86 -28.98 0.03 OUTLIER 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 176.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.8 -52.56 7.76 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.816 2.846 . . . . 0.0 113.12 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.37 -55.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 117.111 -1.423 . . . . 0.0 107.542 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.2 p -56.12 -41.48 75.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 118.873 2.916 . . . . 0.0 118.873 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.05 122.29 2.41 Favored Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -36.02 -43.12 0.31 Allowed 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -125.98 66.78 1.19 Allowed 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 92.07 0.1 OUTLIER Glycine 0 C--N 1.358 1.774 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -92.98 109.45 20.9 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.8 p90 . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 179.396 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.611 0 N-CA-C 112.096 -0.401 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.1 m -73.6 -34.23 64.96 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -52.54 -48.59 66.01 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 121.641 2.019 . . . . 0.0 114.483 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.88 -71.53 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 115.83 -2.033 . . . . 0.0 109.289 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -49.7 -28.44 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 C-N-CA 126.346 1.858 . . . . 0.0 114.127 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.67 -27.22 45.14 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 114.442 -2.694 . . . . 0.0 112.869 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.94 70.86 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 120.055 3.354 . . . . 0.0 120.055 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.488 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.25 -29.97 64.42 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.476 3.139 . . . . 0.0 119.476 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.342 0.1 OUTLIER -39.22 -29.55 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.495 0 N-CA-C 120.345 3.461 . . . . 0.0 120.345 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.88 -53.79 6.16 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 128.963 2.905 . . . . 0.0 113.681 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 95.8 t -80.31 -59.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 116.825 -1.56 . . . . 0.0 107.916 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 64.7 m -68.46 -44.33 75.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.36 171.82 38.16 Favored Glycine 0 C--N 1.36 1.874 0 CA-C-N 120.355 1.434 . . . . 0.0 114.775 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -36.2 -42.41 0.31 Allowed 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -122.59 65.04 0.95 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.05 88.89 0.12 Allowed Glycine 0 C--N 1.359 1.85 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -134.96 119.67 18.27 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.96 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.683 0 CA-C-O 118.877 -0.957 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -72.18 -31.52 66.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -56.55 -49.88 73.53 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.449 1.932 . . . . 0.0 114.198 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.53 -70.78 0.19 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 116.177 -1.868 . . . . 0.0 109.431 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HA ' HD11 ' A' ' 15' ' ' LEU . 5.6 t -48.61 -28.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 C-N-CA 126.823 2.049 . . . . 0.0 113.959 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.05 -60.7 2.14 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 114.319 -2.753 . . . . 0.0 107.18 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.6 0.11 Allowed 'General case' 0 N--CA 1.506 2.362 1 N-CA-C 123.048 4.462 . . . . 0.0 123.048 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.483 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.41 -31.38 60.37 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.32 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.516 0 N-CA-C 120.67 3.582 . . . . 0.0 120.67 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.22 -51.79 8.52 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 128.269 2.628 . . . . 0.0 113.597 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -80.1 -55.71 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-O 117.038 -1.458 . . . . 0.0 107.968 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 94.1 p -51.36 -35.2 37.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.777 3.251 . . . . 0.0 119.777 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.76 103.48 1.55 Allowed Glycine 0 C--N 1.358 1.804 0 CA-C-N 120.071 1.305 . . . . 0.0 110.186 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -38.94 -38.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.457 2.762 . . . . 0.0 118.457 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -74.2 -39.88 62.84 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 116.462 -1.733 . . . . 0.0 113.948 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.45 93.72 0.98 Allowed Glycine 0 C--N 1.361 1.928 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -91.49 117.91 30.11 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.76 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 CA-C-O 118.906 -0.941 . . . . 0.0 113.333 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -61.69 -29.92 70.4 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -57.7 -50.56 72.8 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 121.296 1.862 . . . . 0.0 114.117 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.0 tp -62.46 -72.44 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 115.27 -2.3 . . . . 0.0 108.998 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 12.0 m -47.96 -28.1 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.17 -27.5 38.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 114.035 -2.888 . . . . 0.0 112.585 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -36.82 72.8 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.095 3.369 . . . . 0.0 120.095 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.484 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.17 -30.1 64.66 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.4 -29.65 0.05 Allowed 'General case' 0 CA--C 1.589 2.444 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 176.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.9 -53.2 6.67 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 129.034 2.934 . . . . 0.0 114.181 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -80.3 -55.4 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 116.714 -1.612 . . . . 0.0 108.98 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.5 t -59.42 -40.46 86.78 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.32 101.49 2.42 Favored Glycine 0 C--N 1.357 1.727 0 CA-C-N 120.342 1.428 . . . . 0.0 110.191 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -40.2 -36.22 0.49 Allowed 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -70.81 -39.72 72.91 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 116.395 -1.764 . . . . 0.0 114.382 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.94 84.02 0.35 Allowed Glycine 0 C--N 1.36 1.903 0 CA-C-N 120.644 1.566 . . . . 0.0 110.844 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.02 120.95 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.5 p90 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.835 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -77.17 -38.03 52.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -57.39 -47.94 80.36 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 121.428 1.922 . . . . 0.0 114.144 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.91 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 116.262 -1.828 . . . . 0.0 109.204 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.413 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.1 t -47.95 -27.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 C-N-CA 126.826 2.05 . . . . 0.0 114.04 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -74.3 -61.01 2.01 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 114.434 -2.698 . . . . 0.0 107.156 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.55 0.11 Allowed 'General case' 0 N--CA 1.507 2.375 1 N-CA-C 123.129 4.492 . . . . 0.0 123.129 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.467 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.23 -31.59 60.9 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.757 2.873 . . . . 0.0 118.757 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.24 -29.98 0.05 Allowed 'General case' 0 CA--C 1.59 2.482 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 175.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.32 5.79 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.247 2.619 . . . . 0.0 113.546 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.253 87.0 t -80.32 -57.41 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-O 116.802 -1.57 . . . . 0.0 108.468 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -64.75 -47.21 79.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.63 136.97 4.13 Favored Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.279 1.4 . . . . 0.0 112.363 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -42.47 -35.79 1.15 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -69.13 -38.59 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 116.348 -1.787 . . . . 0.0 114.966 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.66 86.04 0.42 Allowed Glycine 0 C--N 1.36 1.88 0 CA-C-N 120.393 1.451 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -99.18 119.64 38.2 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.6 t80 . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.708 0 CA-C-O 119.316 -0.713 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.9 p -70.01 -32.82 71.18 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -59.9 -48.67 80.75 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 121.437 1.926 . . . . 0.0 113.75 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.67 -50.24 74.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 116.603 -1.665 . . . . 0.0 113.415 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.3 m -73.84 -31.46 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 CA-C-O 115.961 -1.971 . . . . 0.0 113.908 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 48.1 mt-10 -73.82 -29.75 62.32 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 122.081 2.219 . . . . 0.0 112.36 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.62 62.54 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.461 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -68.44 -29.86 68.61 Favored 'General case' 0 N--CA 1.486 1.362 1 N-CA-C 123.941 4.793 . . . . 0.0 123.941 -176.81 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.258 0.9 OUTLIER -61.32 -28.62 69.34 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.22 -50.81 62.52 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 126.213 1.805 . . . . 0.0 113.192 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.262 88.8 t -80.37 -60.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.281 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.8 m -66.67 -41.72 87.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.94 133.14 5.54 Favored Glycine 0 C--N 1.358 1.802 0 CA-C-N 120.335 1.425 . . . . 0.0 111.169 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.26 14.3 pt-20 -33.18 -41.04 0.07 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.58 -41.75 59.95 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.824 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.19 86.49 1.16 Allowed Glycine 0 C--N 1.361 1.951 0 CA-C-N 120.579 1.536 . . . . 0.0 110.848 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -100.55 114.65 28.47 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 t80 . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.894 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 CA-C-O 118.77 -1.016 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.6 m -70.82 -37.55 73.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -57.81 -48.17 80.49 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 121.515 1.961 . . . . 0.0 113.975 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.16 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 116.117 -1.896 . . . . 0.0 109.279 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.8 t -47.95 -28.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 126.785 2.034 . . . . 0.0 114.106 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.5 -60.76 2.13 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.34 -2.743 . . . . 0.0 106.783 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.63 -36.35 0.11 Allowed 'General case' 0 N--CA 1.507 2.407 1 N-CA-C 123.238 4.532 . . . . 0.0 123.238 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.97 -30.82 58.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.02 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.35 -30.14 0.06 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.319 3.451 . . . . 0.0 120.319 175.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 -53.9 6.07 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.256 2.622 . . . . 0.0 113.938 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -80.47 -54.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.743 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.4 m -58.88 -47.14 85.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.3 88.33 0.09 OUTLIER Glycine 0 C--N 1.359 1.832 0 CA-C-N 120.654 1.57 . . . . 0.0 111.251 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -42.57 -42.02 3.23 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -65.93 -33.75 76.54 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -154.7 92.0 0.13 Allowed Glycine 0 C--N 1.356 1.678 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -127.1 115.34 19.0 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 p90 . . . . . 0 N--CA 1.492 1.641 0 C-N-CA 124.29 1.036 . . . . 0.0 108.636 -179.851 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -77.71 -29.97 51.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.254 41.2 p-80 -50.31 -52.0 40.45 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 121.862 2.119 . . . . 0.0 116.647 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.65 -71.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 115.749 -2.072 . . . . 0.0 109.456 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.431 ' HA ' HD11 ' A' ' 15' ' ' LEU 0.299 10.4 m -48.47 -27.22 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.084 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 177.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -75.89 -60.24 2.41 Favored 'General case' 0 CA--C 1.573 1.835 0 CA-C-O 114.432 -2.699 . . . . 0.0 106.689 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.43 -37.41 0.12 Allowed 'General case' 0 N--CA 1.507 2.401 1 N-CA-C 122.845 4.387 . . . . 0.0 122.845 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.474 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.22 -29.72 60.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.332 0.1 OUTLIER -39.06 -35.87 0.25 Allowed 'General case' 0 CA--C 1.595 2.686 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 175.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -52.07 7.8 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 128.926 2.89 . . . . 0.0 111.667 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 11.5 m -70.92 -56.71 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 125.544 1.538 . . . . 0.0 112.518 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.9 m -74.57 -43.42 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.83 110.09 3.46 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -35.61 -40.76 0.18 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.85 -41.5 59.74 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 116.481 -1.723 . . . . 0.0 113.61 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.04 91.44 1.3 Allowed Glycine 0 C--N 1.361 1.938 0 CA-C-N 120.447 1.476 . . . . 0.0 109.763 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -94.47 116.44 28.79 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 179.833 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.685 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.8 p -80.33 -39.51 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -54.55 -48.46 71.99 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 121.491 1.95 . . . . 0.0 114.239 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.7 tp -58.12 -71.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 115.793 -2.051 . . . . 0.0 109.244 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -49.23 -28.59 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 C-N-CA 126.39 1.876 . . . . 0.0 114.272 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.06 -27.39 43.08 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 114.411 -2.709 . . . . 0.0 112.774 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.68 70.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 120.18 3.4 . . . . 0.0 120.18 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.95 -30.53 65.39 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.347 0.1 OUTLIER -39.26 -29.79 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.273 3.434 . . . . 0.0 120.273 176.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.33 -53.21 6.52 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 129.077 2.951 . . . . 0.0 114.408 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.24 -54.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 CA-C-O 116.634 -1.65 . . . . 0.0 109.451 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.0 m -60.08 -45.34 93.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.48 91.24 0.39 Allowed Glycine 0 C--N 1.359 1.829 0 CA-C-N 120.533 1.515 . . . . 0.0 110.586 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -35.78 -42.36 0.25 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.97 -42.47 69.67 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.88 -128.57 4.01 Favored Glycine 0 C--N 1.358 1.75 0 CA-C-N 119.194 0.907 . . . . 0.0 111.081 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 56.51 92.09 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.723 2.009 . . . . 0.0 112.457 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.973 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.3 t -79.9 -41.51 26.02 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 116.392 -1.766 . . . . 0.0 115.242 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -54.84 -45.2 74.45 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.366 1.894 . . . . 0.0 114.588 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.4 tp -63.52 -70.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 116.134 -1.889 . . . . 0.0 109.254 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.7 t -48.04 -28.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 C-N-CA 126.805 2.042 . . . . 0.0 114.094 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.39 -60.83 2.09 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 114.55 -2.643 . . . . 0.0 106.841 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -36.52 0.11 Allowed 'General case' 0 N--CA 1.505 2.307 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.34 -31.11 60.46 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.32 -31.51 0.08 Allowed 'General case' 0 CA--C 1.591 2.537 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 175.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.6 -53.45 6.54 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 128.33 2.652 . . . . 0.0 114.039 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.27 -55.85 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 116.691 -1.623 . . . . 0.0 109.31 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -61.74 -48.04 82.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.73 2.492 . . . . 0.0 117.73 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.68 108.53 0.25 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 120.667 1.576 . . . . 0.0 111.312 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -36.73 -44.8 0.49 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -126.69 66.01 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 89.73 0.08 OUTLIER Glycine 0 C--N 1.359 1.808 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.66 126.42 37.73 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.9 t80 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.675 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.786 0 CA-C-O 119.185 -0.786 . . . . 0.0 114.579 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.3 p -46.28 -29.33 1.58 Allowed 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 121.893 4.035 . . . . 0.0 121.893 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -45.74 -48.55 15.26 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.36 -72.62 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 116.283 -1.817 . . . . 0.0 110.359 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.385 4.8 p -51.39 -26.8 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.1 -60.26 2.37 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 114.488 -2.672 . . . . 0.0 106.753 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.46 -37.47 0.13 Allowed 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 122.952 4.427 . . . . 0.0 122.952 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.47 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.52 -31.06 62.03 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.324 0.1 OUTLIER -39.32 -30.01 0.05 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.618 3.562 . . . . 0.0 120.618 175.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.1 5.99 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 128.25 2.62 . . . . 0.0 113.53 -177.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 93.1 t -80.32 -58.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 CA-C-O 116.881 -1.533 . . . . 0.0 108.271 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 t -65.02 -43.08 93.61 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.71 127.71 4.06 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 120.292 1.406 . . . . 0.0 110.546 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -39.72 -37.87 0.58 Allowed 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -73.38 -40.29 64.46 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 116.468 -1.729 . . . . 0.0 113.845 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 91.78 1.04 Allowed Glycine 0 C--N 1.361 1.95 0 CA-C-N 120.47 1.486 . . . . 0.0 109.463 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -94.73 99.33 11.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 179.897 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.5 p -78.87 -46.94 17.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.531 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -46.35 -45.11 17.46 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 121.71 2.05 . . . . 0.0 115.472 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -63.65 -70.9 0.19 Allowed 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.161 -1.876 . . . . 0.0 109.626 177.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.402 ' HA ' HD11 ' A' ' 15' ' ' LEU 0.263 4.8 t -47.43 -28.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.919 0 CA-C-O 115.85 -2.024 . . . . 0.0 114.282 179.473 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.1 -60.3 2.35 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.248 -2.787 . . . . 0.0 106.872 173.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -35.1 0.08 Allowed 'General case' 0 N--CA 1.508 2.428 1 N-CA-C 123.476 4.621 . . . . 0.0 123.476 -178.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.44 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -76.68 -31.74 57.46 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -179.015 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.333 0.1 OUTLIER -39.09 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.488 0 N-CA-C 120.724 3.602 . . . . 0.0 120.724 175.851 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.93 -52.39 7.92 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 128.235 2.614 . . . . 0.0 113.342 -177.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -80.31 -56.25 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-O 117.053 -1.451 . . . . 0.0 107.96 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.7 p -51.81 -35.1 42.96 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 119.912 3.301 . . . . 0.0 119.912 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.99 110.96 2.41 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -39.86 -37.3 0.54 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -72.9 -39.4 66.38 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 116.306 -1.807 . . . . 0.0 114.162 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.42 87.66 1.27 Allowed Glycine 0 C--N 1.36 1.904 0 CA-C-N 120.562 1.528 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -112.95 113.86 26.09 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 179.812 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.3 t -143.23 103.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 1 N-CA-C 99.868 -4.123 . . . . 0.0 99.868 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -96.41 123.0 39.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -132.87 108.57 9.04 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 103.55 -2.759 . . . . 0.0 103.55 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -141.28 118.07 11.06 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.4 mt -139.81 -55.17 0.55 Allowed 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 124.376 1.07 . . . . 0.0 112.734 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 78.4 p -136.22 132.98 36.58 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.2 1.4 . . . . 0.0 109.598 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.42 86.95 0.13 Allowed Glycine 0 N--CA 1.48 1.625 0 CA-C-O 118.949 -0.917 . . . . 0.0 110.951 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.3 p -76.03 -32.99 59.62 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 117.437 2.384 . . . . 0.0 117.437 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -55.05 -48.56 73.3 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 121.59 1.995 . . . . 0.0 114.474 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.9 tp -63.37 -70.8 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 116.202 -1.856 . . . . 0.0 109.633 177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.1 t -48.66 -27.96 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.971 0 C-N-CA 126.738 2.015 . . . . 0.0 114.06 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -74.33 -60.7 2.15 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-O 114.445 -2.693 . . . . 0.0 106.847 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.53 -36.51 0.11 Allowed 'General case' 0 N--CA 1.506 2.356 1 N-CA-C 123.182 4.512 . . . . 0.0 123.182 -178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.55 -31.26 59.98 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 118.802 2.89 . . . . 0.0 118.802 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.31 -29.71 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 175.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.4 -54.66 5.5 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 128.241 2.616 . . . . 0.0 113.172 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 99.3 t -80.51 -59.52 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.375 0 CA-C-O 116.859 -1.543 . . . . 0.0 108.056 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 65.3 m -68.72 -46.29 69.32 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.831 2.16 . . . . 0.0 116.831 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.26 177.58 51.95 Favored Glycine 0 C--N 1.36 1.868 0 CA-C-N 120.464 1.483 . . . . 0.0 114.552 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.24 72.46 1.76 Allowed 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 123.627 1.679 . . . . 0.0 112.158 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -164.99 -41.64 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 128.043 2.537 . . . . 0.0 108.974 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.3 82.27 1.68 Allowed Glycine 0 C--N 1.368 2.332 0 CA-C-N 120.288 1.404 . . . . 0.0 113.873 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -143.89 117.12 8.98 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -126.63 -58.28 1.33 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 116.785 -1.578 . . . . 0.0 111.427 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -82.05 136.8 35.17 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 120.607 1.549 . . . . 0.0 111.599 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.1 p 64.41 124.19 0.02 OUTLIER Pre-proline 0 N--CA 1.507 2.419 0 CA-C-O 112.956 -3.402 . . . . 0.0 111.802 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.59 144.95 28.94 Favored 'Trans proline' 0 C--N 1.394 2.943 0 CA-C-N 127.491 3.711 . . . . 0.0 113.415 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -130.49 113.24 14.03 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.205 0 O-C-N 124.128 0.893 . . . . 0.0 111.007 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 23.4 t80 . . . . . 0 CA--C 1.563 1.468 0 CA-C-O 116.604 -1.665 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.363 55.3 t -98.63 -96.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -97.89 118.71 35.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.515 1.126 . . . . 0.0 108.509 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -100.57 114.82 28.79 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -134.87 107.05 7.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.3 mt -138.45 -53.33 0.61 Allowed 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 124.358 1.063 . . . . 0.0 113.098 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 84.5 p -113.18 128.57 56.52 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.937 1.295 . . . . 0.0 109.497 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.84 90.03 0.08 OUTLIER Glycine 0 N--CA 1.474 1.224 0 CA-C-O 118.761 -1.022 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 90.5 p -70.38 -31.01 68.07 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 118.262 2.69 . . . . 0.0 118.262 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -58.12 -49.56 76.55 Favored 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 121.417 1.917 . . . . 0.0 114.126 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.6 tp -61.6 -72.35 0.12 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 115.389 -2.243 . . . . 0.0 108.869 177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 12.6 m -48.42 -28.02 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.034 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 11.7 mm-40 -80.09 -27.34 39.28 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 114.195 -2.812 . . . . 0.0 112.819 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.11 72.15 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.018 3.34 . . . . 0.0 120.018 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.486 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.28 -30.84 66.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 119.692 3.219 . . . . 0.0 119.692 -178.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.345 0.0 OUTLIER -39.34 -29.85 0.05 Allowed 'General case' 0 CA--C 1.59 2.483 0 N-CA-C 120.275 3.435 . . . . 0.0 120.275 176.495 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.35 -53.45 6.31 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 129.046 2.938 . . . . 0.0 114.344 -178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.1 t -80.21 -55.78 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 116.613 -1.66 . . . . 0.0 109.187 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -63.24 -47.35 82.84 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 117.35 2.352 . . . . 0.0 117.35 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.61 148.55 4.92 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 120.41 1.459 . . . . 0.0 112.437 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -42.01 -36.71 1.18 Allowed 'General case' 0 N--CA 1.511 2.597 0 N-CA-C 117.754 2.502 . . . . 0.0 117.754 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -71.91 -42.22 66.97 Favored 'General case' 0 CA--C 1.574 1.884 0 CA-C-O 116.486 -1.721 . . . . 0.0 113.593 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.66 -178.09 53.83 Favored Glycine 0 C--N 1.36 1.898 0 CA-C-N 120.208 1.367 . . . . 0.0 114.67 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -126.95 -31.33 2.64 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.501 2.408 . . . . 0.0 117.501 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . 0.338 90.6 m-85 69.96 -68.22 0.21 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 126.72 2.008 . . . . 0.0 111.935 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -157.68 128.96 6.7 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 36.8 p -81.76 129.18 66.21 Favored Pre-proline 0 CA--C 1.584 2.256 0 CA-C-O 114.142 -2.837 . . . . 0.0 110.006 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.4 -28.3 34.78 Favored 'Trans proline' 0 C--N 1.392 2.832 0 N-CA-C 122.067 3.833 . . . . 0.0 122.067 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -143.02 120.09 11.4 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.869 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 . . . . . 0 CA--C 1.563 1.471 0 CA-C-O 116.693 -1.623 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 m -94.24 93.61 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 t30 56.96 115.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 126.973 2.109 . . . . 0.0 112.924 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -126.83 -65.9 0.93 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.8 -1.572 . . . . 0.0 109.516 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -92.48 128.81 38.47 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 120.626 1.557 . . . . 0.0 108.232 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 pp -133.31 140.37 47.39 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 124.34 1.056 . . . . 0.0 109.909 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.9 m -78.21 -45.51 22.82 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.59 -123.31 7.89 Favored Glycine 0 C--N 1.36 1.884 0 CA-C-N 120.568 1.531 . . . . 0.0 110.114 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.3 m -74.17 -33.8 63.59 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -54.74 -49.22 71.36 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 121.756 2.071 . . . . 0.0 114.699 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.4 tp -62.28 -72.38 0.13 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 115.283 -2.294 . . . . 0.0 108.964 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.273 11.4 m -47.85 -28.1 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.063 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.2 -27.51 38.83 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 114.216 -2.802 . . . . 0.0 112.6 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.15 -36.58 72.1 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 120.134 3.383 . . . . 0.0 120.134 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.12 -30.34 64.96 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 119.482 3.141 . . . . 0.0 119.482 -178.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.3 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.588 2.416 0 N-CA-C 120.35 3.463 . . . . 0.0 120.35 176.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.96 -54.87 5.2 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 128.847 2.859 . . . . 0.0 114.013 -178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -80.39 -54.2 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 116.716 -1.612 . . . . 0.0 109.452 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -60.99 -48.17 83.06 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 117.933 2.568 . . . . 0.0 117.933 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 157.1 101.19 0.18 Allowed Glycine 0 C--N 1.36 1.865 0 CA-C-N 120.757 1.617 . . . . 0.0 111.711 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -38.92 -45.48 1.19 Allowed 'General case' 0 N--CA 1.509 2.476 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -120.04 66.65 0.82 Allowed 'General case' 0 CA--C 1.575 1.913 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.47 -80.95 0.06 OUTLIER Glycine 0 C--N 1.359 1.837 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.2 t80 63.89 96.75 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 126.676 1.991 . . . . 0.0 111.553 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -137.28 111.97 8.79 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -134.26 119.8 19.19 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.2 m -95.88 114.23 63.68 Favored Pre-proline 0 CA--C 1.588 2.404 0 CA-C-O 113.967 -2.92 . . . . 0.0 105.539 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -75.27 135.0 18.03 Favored 'Trans proline' 0 C--N 1.395 3.018 0 CA-C-N 126.908 3.503 . . . . 0.0 112.931 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -86.5 -64.1 1.21 Allowed 'General case' 0 CA--C 1.573 1.834 0 CA-C-O 116.677 -1.63 . . . . 0.0 110.485 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 CA-C-N 120.418 1.463 . . . . 0.0 109.907 179.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 . . . . . 0 CA--C 1.563 1.476 0 CA-C-O 116.71 -1.614 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 m -148.72 94.74 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 104.798 -2.297 . . . . 0.0 104.798 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 59.46 117.93 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 126.764 2.026 . . . . 0.0 112.351 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -135.26 116.39 14.35 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.237 -2.134 . . . . 0.0 105.237 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -133.35 111.86 11.14 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.4 mt -144.55 120.99 10.99 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.3 m -93.6 125.72 38.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.755 0.822 . . . . 0.0 109.007 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.1 179.12 32.31 Favored Glycine 0 N--CA 1.484 1.885 0 O-C-N 124.021 0.825 . . . . 0.0 114.252 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -77.53 -31.71 53.56 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.881 2.178 . . . . 0.0 116.881 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -58.66 -51.27 70.66 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 121.727 2.058 . . . . 0.0 113.679 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 50.7 tp -56.67 -43.04 80.03 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 116.877 -1.535 . . . . 0.0 114.865 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.6 -41.41 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 115.476 -2.202 . . . . 0.0 109.742 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.298 39.7 mt-10 -64.9 -29.21 70.15 Favored 'General case' 0 N--CA 1.507 2.378 0 CA-C-N 123.053 2.66 . . . . 0.0 113.826 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.51 -47.85 63.15 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 117.873 2.546 . . . . 0.0 117.873 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.461 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.08 -29.8 62.05 Favored 'General case' 0 N--CA 1.485 1.309 1 N-CA-C 124.499 4.999 . . . . 0.0 124.499 -176.49 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -61.07 -29.9 70.02 Favored 'General case' 0 CA--C 1.582 2.192 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 mt -72.47 -46.95 52.46 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 126.646 1.978 . . . . 0.0 113.721 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.256 95.6 t -80.44 -59.0 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.269 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -65.63 -45.7 82.04 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 117.026 2.232 . . . . 0.0 117.026 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.59 114.94 1.7 Allowed Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.609 1.55 . . . . 0.0 110.066 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -40.49 -41.09 1.36 Allowed 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 117.649 2.462 . . . . 0.0 117.649 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 mtm180 -73.04 -38.15 66.61 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 116.333 -1.794 . . . . 0.0 114.237 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.98 89.53 1.28 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 120.519 1.509 . . . . 0.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -97.47 105.57 17.74 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -137.88 115.65 11.44 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 105.564 -2.014 . . . . 0.0 105.564 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -99.54 114.28 27.2 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.3 m -98.43 107.78 44.01 Favored Pre-proline 0 CA--C 1.585 2.313 0 CA-C-O 114.033 -2.889 . . . . 0.0 104.885 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -79.3 121.81 4.94 Favored 'Trans proline' 0 C--N 1.395 2.986 0 CA-C-N 126.596 3.392 . . . . 0.0 111.801 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -87.07 -57.5 2.94 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 116.696 -1.621 . . . . 0.0 111.209 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.365 1.251 0 CA-C-N 120.844 1.656 . . . . 0.0 109.784 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . 0.266 45.8 p90 . . . . . 0 CA--C 1.562 1.441 0 CA-C-O 117.276 -1.345 . . . . 0.0 113.716 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p -92.24 93.08 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -136.17 121.74 19.55 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.18 0.992 . . . . 0.0 108.561 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -128.31 113.53 15.73 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -81.74 -62.44 1.64 Allowed 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 116.669 -1.634 . . . . 0.0 112.243 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 tp -138.67 117.41 12.28 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.2 p -93.42 129.73 39.47 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 124.256 0.972 . . . . 0.0 109.434 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.88 92.69 0.1 Allowed Glycine 0 N--CA 1.476 1.347 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 m -71.3 -30.57 66.42 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -58.87 -51.64 69.16 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 121.616 2.007 . . . . 0.0 113.57 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.09 -54.79 43.08 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 116.201 -1.857 . . . . 0.0 112.873 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.4 m -70.14 -30.21 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.587 0 CA-C-O 115.736 -2.078 . . . . 0.0 114.749 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.292 40.5 mt-10 -75.53 -29.85 59.58 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-N 122.342 2.337 . . . . 0.0 112.469 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.12 -46.6 65.39 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.448 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -73.59 -29.62 62.51 Favored 'General case' 0 N--CA 1.487 1.409 1 N-CA-C 124.665 5.061 . . . . 0.0 124.665 -176.573 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -61.06 -29.4 69.71 Favored 'General case' 0 CA--C 1.579 2.083 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.3 mt -72.77 -54.05 9.94 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 126.762 2.025 . . . . 0.0 112.497 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.274 93.1 t -81.14 -62.72 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 CA-C-O 117.069 -1.444 . . . . 0.0 107.913 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.6 t -70.84 -53.48 15.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.942 1.831 . . . . 0.0 115.942 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 132.16 169.85 12.41 Favored Glycine 0 C--N 1.361 1.919 0 CA-C-N 120.618 1.554 . . . . 0.0 114.095 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -37.64 -36.43 0.17 Allowed 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 119.182 3.03 . . . . 0.0 119.182 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -65.0 -43.92 90.96 Favored 'General case' 0 CA--C 1.573 1.831 0 CA-C-O 116.43 -1.748 . . . . 0.0 115.164 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.0 -129.18 8.88 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-N 120.201 1.364 . . . . 0.0 113.191 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -138.27 134.42 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -93.13 114.92 27.55 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -79.44 -45.48 19.36 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 25.2 m -92.94 118.38 67.85 Favored Pre-proline 0 CA--C 1.588 2.438 0 CA-C-O 113.889 -2.958 . . . . 0.0 106.408 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -73.29 145.76 39.16 Favored 'Trans proline' 0 C--N 1.394 2.944 0 CA-C-N 126.942 3.515 . . . . 0.0 113.635 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.06 127.66 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 126.518 1.927 . . . . 0.0 111.25 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 O-C-N 124.481 1.113 . . . . 0.0 110.814 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 CA--C 1.564 1.5 0 CA-C-O 116.68 -1.628 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.8 t -145.46 103.72 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 1 N-CA-C 99.761 -4.162 . . . . 0.0 99.761 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -138.88 121.47 16.26 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -103.01 119.79 39.48 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -134.18 114.83 13.51 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.4 tp -134.95 109.48 8.49 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -136.68 130.93 32.87 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.218 1.007 . . . . 0.0 108.97 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.65 84.36 0.07 OUTLIER Glycine 0 N--CA 1.477 1.38 0 O-C-N 124.272 0.983 . . . . 0.0 111.915 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -80.01 -37.04 34.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -58.39 -53.53 57.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.483 1.947 . . . . 0.0 113.62 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 49.8 tp -59.21 -50.9 72.27 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 124.943 1.297 . . . . 0.0 113.664 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.292 14.9 t -69.18 -26.73 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-O 115.209 -2.329 . . . . 0.0 112.49 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 47.3 mt-10 -80.76 -58.39 3.12 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 123.415 2.825 . . . . 0.0 108.237 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . 0.41 . . -33.6 -34.3 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.415 1 N-CA-C 125.167 5.247 . . . . 0.0 125.167 -178.351 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 16' ' ' TYR . 0.8 OUTLIER -77.37 -37.76 51.48 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 119.785 3.254 . . . . 0.0 119.785 -176.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 13' ' ' GLU 0.361 0.1 OUTLIER -39.53 -33.62 0.18 Allowed 'General case' 0 CA--C 1.591 2.553 0 N-CA-C 119.822 3.267 . . . . 0.0 119.822 174.879 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.1 -55.22 4.9 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 128.906 2.882 . . . . 0.0 113.938 -178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.264 99.2 t -80.04 -60.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 CA-C-O 116.947 -1.501 . . . . 0.0 107.813 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -65.11 -45.93 83.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.31 169.0 41.31 Favored Glycine 0 C--N 1.359 1.852 0 CA-C-N 120.117 1.326 . . . . 0.0 114.846 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -39.65 -41.58 1.08 Allowed 'General case' 0 N--CA 1.51 2.538 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -121.57 60.82 0.94 Allowed 'General case' 0 CA--C 1.574 1.893 0 C-N-CA 123.704 0.802 . . . . 0.0 109.452 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.34 -122.17 3.83 Favored Glycine 0 C--N 1.359 1.857 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -88.71 135.55 33.45 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.841 0.856 . . . . 0.0 110.766 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -93.28 124.56 37.35 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -79.42 -56.99 3.92 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.8 p -90.7 124.3 62.71 Favored Pre-proline 0 CA--C 1.583 2.218 0 CA-C-O 114.253 -2.784 . . . . 0.0 107.952 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.79 142.08 68.26 Favored 'Trans proline' 0 C--N 1.397 3.106 0 CA-C-N 127.089 3.567 . . . . 0.0 114.903 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.9 tttp -120.85 -66.7 1.03 Allowed 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 117.166 -1.397 . . . . 0.0 109.104 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.079 0 C-N-CA 126.774 2.03 . . . . 0.0 115.187 -179.853 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 CA--C 1.564 1.508 0 CA-C-O 116.756 -1.592 . . . . 0.0 112.294 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -92.98 119.22 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -94.14 124.79 38.38 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -96.67 123.93 40.5 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -136.49 104.09 5.47 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.3 pp -88.58 140.44 29.46 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 124.002 0.921 . . . . 0.0 110.68 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -133.73 120.8 21.03 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.19 -177.11 49.87 Favored Glycine 0 N--CA 1.482 1.727 0 O-C-N 124.111 0.882 . . . . 0.0 114.208 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -74.17 -35.82 64.03 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 -53.32 -48.69 68.22 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 121.377 1.899 . . . . 0.0 115.874 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.9 tp -63.77 -71.02 0.18 Allowed 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 116.309 -1.805 . . . . 0.0 109.307 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.0 t -47.76 -27.82 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.953 0 C-N-CA 126.886 2.074 . . . . 0.0 114.298 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -74.74 -62.58 1.49 Allowed 'General case' 0 CA--C 1.574 1.867 0 CA-C-O 114.245 -2.788 . . . . 0.0 106.359 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.45 -34.94 0.07 Allowed 'General case' 0 N--CA 1.506 2.357 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.39 -31.72 60.54 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 118.268 2.692 . . . . 0.0 118.268 -179.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.331 0.1 OUTLIER -38.72 -34.73 0.16 Allowed 'General case' 0 CA--C 1.589 2.466 0 N-CA-C 120.183 3.401 . . . . 0.0 120.183 175.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.32 -55.05 4.97 Favored 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 128.661 2.785 . . . . 0.0 113.941 -178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 98.9 t -80.06 -60.07 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 CA-C-O 116.912 -1.518 . . . . 0.0 108.104 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m -63.3 -44.41 95.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.64 135.95 4.37 Favored Glycine 0 C--N 1.361 1.932 0 CA-C-N 120.325 1.42 . . . . 0.0 111.912 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -41.35 -37.0 0.91 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -72.65 -39.47 67.13 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 116.371 -1.776 . . . . 0.0 113.963 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.06 87.18 0.55 Allowed Glycine 0 C--N 1.36 1.879 0 CA-C-N 120.496 1.498 . . . . 0.0 110.419 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -99.12 96.69 7.96 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -145.02 121.65 11.12 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -133.2 116.81 16.67 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.3 p 65.07 125.43 0.02 OUTLIER Pre-proline 0 N--CA 1.508 2.461 0 CA-C-O 112.982 -3.39 . . . . 0.0 111.619 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.85 121.43 6.25 Favored 'Trans proline' 0 C--N 1.395 2.984 0 CA-C-N 127.631 3.761 . . . . 0.0 112.246 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.04 113.71 11.72 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 O-C-N 124.115 0.885 . . . . 0.0 110.758 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 37.5 t80 . . . . . 0 CA--C 1.565 1.537 0 CA-C-O 116.862 -1.542 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.358 9.7 p -76.71 -59.23 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 CA-C-N 120.623 1.556 . . . . 0.0 113.01 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -92.49 122.56 35.04 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -140.24 126.54 19.96 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -79.36 -56.95 3.96 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 116.807 -1.568 . . . . 0.0 112.781 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.7 mt -92.9 124.79 37.14 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 120.419 1.463 . . . . 0.0 107.772 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.0 p -75.43 -46.1 34.78 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.68 84.01 1.39 Allowed Glycine 0 C--N 1.36 1.902 0 CA-C-N 120.535 1.516 . . . . 0.0 112.24 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -79.89 -39.6 30.11 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 116.37 -1.776 . . . . 0.0 115.509 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -55.44 -46.36 76.75 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-N 121.403 1.911 . . . . 0.0 114.447 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.1 -70.69 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 CA-C-O 116.235 -1.84 . . . . 0.0 109.414 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.5 t -48.52 -27.96 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.9 0 C-N-CA 126.75 2.02 . . . . 0.0 114.08 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -74.03 -60.9 2.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 114.423 -2.703 . . . . 0.0 106.914 173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.54 -36.85 0.11 Allowed 'General case' 0 N--CA 1.507 2.389 1 N-CA-C 123.118 4.488 . . . . 0.0 123.118 -178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.481 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.13 -31.27 61.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 118.962 2.949 . . . . 0.0 118.962 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.18 -30.52 0.06 Allowed 'General case' 0 CA--C 1.59 2.51 0 N-CA-C 120.401 3.482 . . . . 0.0 120.401 175.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -51.71 8.42 Favored 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 128.44 2.696 . . . . 0.0 113.807 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.252 86.2 t -80.29 -58.2 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 CA-C-O 116.691 -1.623 . . . . 0.0 108.525 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.9 m -63.64 -42.24 98.16 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.84 165.14 14.31 Favored Glycine 0 N--CA 1.485 1.931 0 CA-C-N 120.36 1.436 . . . . 0.0 113.701 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.279 12.7 pt-20 -33.6 -43.94 0.14 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 119.904 3.298 . . . . 0.0 119.904 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.15 -42.05 66.41 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 74.28 159.28 6.38 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 119.448 1.022 . . . . 0.0 115.313 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -89.6 137.39 32.37 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.906 0.882 . . . . 0.0 110.239 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -86.48 128.06 34.92 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.78 0.832 . . . . 0.0 109.253 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -73.45 -44.56 57.85 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.9 m -90.48 117.37 67.94 Favored Pre-proline 0 CA--C 1.59 2.492 0 CA-C-O 113.802 -2.999 . . . . 0.0 106.823 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.72 144.21 31.04 Favored 'Trans proline' 0 C--N 1.394 2.931 0 CA-C-N 126.894 3.498 . . . . 0.0 113.596 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -85.91 -63.11 1.37 Allowed 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 116.694 -1.622 . . . . 0.0 110.805 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 CA-C-N 120.48 1.491 . . . . 0.0 110.819 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.2 t80 . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.305 40.7 t 85.23 96.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.742 0 N-CA-C 103.204 -2.887 . . . . 0.0 103.204 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -136.05 120.94 18.63 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -138.46 -61.99 0.58 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 116.723 -1.608 . . . . 0.0 110.516 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.252 28.4 p80 -89.78 -57.95 2.68 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 121.17 1.805 . . . . 0.0 113.797 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.6 tp -92.29 121.13 33.5 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 119.874 1.215 . . . . 0.0 107.822 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.3 p -120.24 -50.43 2.24 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 116.442 -1.742 . . . . 0.0 114.419 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.83 87.72 0.07 OUTLIER Glycine 0 C--N 1.359 1.856 0 CA-C-N 120.595 1.543 . . . . 0.0 110.859 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.5 m -76.03 -36.48 59.07 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -52.09 -48.82 64.54 Favored 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 121.547 1.976 . . . . 0.0 115.943 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.9 tp -64.54 -70.91 0.2 Allowed 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 116.211 -1.852 . . . . 0.0 109.361 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.0 t -48.51 -27.81 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.941 0 C-N-CA 126.83 2.052 . . . . 0.0 114.12 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -74.24 -62.58 1.47 Allowed 'General case' 0 CA--C 1.574 1.869 0 CA-C-O 114.346 -2.74 . . . . 0.0 106.493 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.38 -35.09 0.07 Allowed 'General case' 0 N--CA 1.505 2.32 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 -178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.454 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.81 -32.24 61.92 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 118.301 2.704 . . . . 0.0 118.301 -179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.33 0.1 OUTLIER -38.56 -35.01 0.16 Allowed 'General case' 0 CA--C 1.59 2.508 0 N-CA-C 120.222 3.416 . . . . 0.0 120.222 175.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.52 -53.81 5.96 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 128.626 2.771 . . . . 0.0 114.802 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 86.3 t -77.88 -57.13 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 116.753 -1.594 . . . . 0.0 109.168 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.8 t -60.26 -42.2 94.82 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 118.102 2.63 . . . . 0.0 118.102 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 116.12 161.97 12.92 Favored Glycine 0 N--CA 1.485 1.914 0 CA-C-N 120.181 1.355 . . . . 0.0 113.217 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -39.86 -38.36 0.67 Allowed 'General case' 0 N--CA 1.51 2.553 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -75.5 -39.79 58.0 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.99 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.81 146.32 6.24 Favored Glycine 0 C--N 1.363 2.034 0 CA-C-N 120.637 1.562 . . . . 0.0 113.209 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -84.7 147.14 27.07 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.025 0.93 . . . . 0.0 111.545 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -83.12 129.88 35.06 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.024 0.93 . . . . 0.0 109.241 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -84.77 136.71 33.58 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.052 0.941 . . . . 0.0 110.317 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.2 t -133.91 121.75 16.04 Favored Pre-proline 0 CA--C 1.58 2.111 0 CA-C-O 112.962 -3.399 . . . . 0.0 109.099 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -63.86 140.26 72.48 Favored 'Trans proline' 0 C--N 1.396 3.066 0 CA-C-N 127.93 3.868 . . . . 0.0 115.063 -174.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -121.02 114.73 21.93 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.897 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 . . . . . 0 CA--C 1.564 1.518 0 CA-C-O 116.657 -1.64 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 m -148.11 112.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -95.09 121.42 36.7 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -91.54 111.18 22.59 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.027 0.931 . . . . 0.0 108.696 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -85.17 141.87 29.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 124.267 0.979 . . . . 0.0 111.581 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.2 mt 64.44 136.64 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 126.324 1.85 . . . . 0.0 111.86 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 88.9 p -80.66 136.27 36.18 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.942 0.897 . . . . 0.0 112.183 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.01 -82.29 0.04 OUTLIER Glycine 0 N--CA 1.481 1.694 0 CA-C-O 118.702 -1.055 . . . . 0.0 111.805 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -69.95 -38.07 76.04 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 117.532 2.419 . . . . 0.0 117.532 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.259 31.8 p80 -57.56 -51.32 69.96 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-N 121.76 2.073 . . . . 0.0 114.675 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 33.7 tp -59.23 -71.38 0.12 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 115.808 -2.044 . . . . 0.0 108.723 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.0 t -48.94 -28.55 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.883 0 C-N-CA 126.429 1.892 . . . . 0.0 113.987 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -78.93 -27.07 43.66 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 114.377 -2.725 . . . . 0.0 113.148 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.42 -37.46 71.49 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 119.837 3.273 . . . . 0.0 119.837 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.65 -31.11 66.48 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 -178.178 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.339 0.0 OUTLIER -38.86 -28.98 0.03 OUTLIER 'General case' 0 CA--C 1.587 2.387 0 N-CA-C 120.728 3.603 . . . . 0.0 120.728 176.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tp -79.8 -52.56 7.76 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.816 2.846 . . . . 0.0 113.12 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.37 -55.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-O 117.111 -1.423 . . . . 0.0 107.542 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 87.2 p -56.12 -41.48 75.38 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 118.873 2.916 . . . . 0.0 118.873 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 130.05 122.29 2.41 Favored Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -36.02 -43.12 0.31 Allowed 'General case' 0 N--CA 1.513 2.676 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 48.4 ttp180 -125.98 66.78 1.19 Allowed 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.91 92.07 0.1 OUTLIER Glycine 0 C--N 1.358 1.774 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -92.98 109.45 20.9 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -144.28 102.28 3.83 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -97.4 92.67 6.07 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.8 m -142.34 114.89 6.31 Favored Pre-proline 0 CA--C 1.586 2.336 0 CA-C-O 114.202 -2.809 . . . . 0.0 104.827 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -70.15 135.44 29.53 Favored 'Trans proline' 0 C--N 1.394 2.956 0 CA-C-N 126.825 3.473 . . . . 0.0 113.731 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp 64.51 129.22 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 C-N-CA 126.397 1.879 . . . . 0.0 111.086 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 O-C-N 124.174 0.921 . . . . 0.0 111.054 179.874 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 93.9 t -114.68 103.95 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 1 N-CA-C 99.981 -4.081 . . . . 0.0 99.981 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -118.92 126.38 51.63 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -79.08 -50.89 10.32 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 117.195 -1.383 . . . . 0.0 113.063 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 63.21 132.82 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 126.584 1.954 . . . . 0.0 111.716 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . 0.255 13.1 tp 60.11 82.32 0.16 Allowed 'General case' 0 N--CA 1.504 2.238 0 C-N-CA 126.657 1.983 . . . . 0.0 112.354 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 t -97.98 131.97 43.96 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.892 0.877 . . . . 0.0 109.156 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.1 139.69 4.29 Favored Glycine 0 CA--C 1.54 1.611 0 O-C-N 124.23 0.956 . . . . 0.0 112.096 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 56.1 m -73.6 -34.23 64.96 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -52.54 -48.59 66.01 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 121.641 2.019 . . . . 0.0 114.483 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.88 -71.53 0.12 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 115.83 -2.033 . . . . 0.0 109.289 177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.1 t -49.7 -28.44 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 C-N-CA 126.346 1.858 . . . . 0.0 114.127 178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.67 -27.22 45.14 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 114.442 -2.694 . . . . 0.0 112.869 175.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.65 -36.94 70.86 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 120.055 3.354 . . . . 0.0 120.055 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.488 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.25 -29.97 64.42 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.476 3.139 . . . . 0.0 119.476 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.342 0.1 OUTLIER -39.22 -29.55 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.495 0 N-CA-C 120.345 3.461 . . . . 0.0 120.345 176.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.88 -53.79 6.16 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 128.963 2.905 . . . . 0.0 113.681 -178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.26 95.8 t -80.31 -59.67 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 CA-C-O 116.825 -1.56 . . . . 0.0 107.916 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 64.7 m -68.46 -44.33 75.06 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.36 171.82 38.16 Favored Glycine 0 C--N 1.36 1.874 0 CA-C-N 120.355 1.434 . . . . 0.0 114.775 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -36.2 -42.41 0.31 Allowed 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -122.59 65.04 0.95 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.05 88.89 0.12 Allowed Glycine 0 C--N 1.359 1.85 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -134.96 119.67 18.27 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -121.73 120.52 34.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -124.81 -60.91 1.34 Allowed 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.289 1.035 . . . . 0.0 111.955 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.8 p -86.92 131.92 43.51 Favored Pre-proline 0 CA--C 1.582 2.196 0 CA-C-O 114.186 -2.816 . . . . 0.0 109.512 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -74.67 145.19 32.52 Favored 'Trans proline' 0 C--N 1.394 2.958 0 CA-C-N 126.678 3.421 . . . . 0.0 113.678 -174.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -83.7 -60.95 1.96 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 116.705 -1.617 . . . . 0.0 111.804 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 CA-C-N 120.403 1.456 . . . . 0.0 110.905 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 m -96.15 99.59 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -93.19 127.4 38.74 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -95.52 112.77 24.42 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -134.76 122.45 22.15 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -89.85 111.88 23.05 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.133 0.973 . . . . 0.0 108.705 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.5 m -90.79 131.06 36.67 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.369 1.043 . . . . 0.0 110.238 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.13 -85.14 1.43 Allowed Glycine 0 N--CA 1.481 1.683 0 O-C-N 124.26 0.975 . . . . 0.0 111.188 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -72.18 -31.52 66.0 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 117.508 2.41 . . . . 0.0 117.508 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -56.55 -49.88 73.53 Favored 'General case' 0 N--CA 1.504 2.247 0 CA-C-N 121.449 1.932 . . . . 0.0 114.198 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.53 -70.78 0.19 Allowed 'General case' 0 CA--C 1.569 1.679 0 CA-C-O 116.177 -1.868 . . . . 0.0 109.431 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' HA ' HD11 ' A' ' 15' ' ' LEU . 5.6 t -48.61 -28.04 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.882 0 C-N-CA 126.823 2.049 . . . . 0.0 113.959 178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -74.05 -60.7 2.14 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-O 114.319 -2.753 . . . . 0.0 107.18 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.6 0.11 Allowed 'General case' 0 N--CA 1.506 2.362 1 N-CA-C 123.048 4.462 . . . . 0.0 123.048 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.483 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.41 -31.38 60.37 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.327 0.1 OUTLIER -39.32 -29.67 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.516 0 N-CA-C 120.67 3.582 . . . . 0.0 120.67 175.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -80.22 -51.79 8.52 Favored 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 128.269 2.628 . . . . 0.0 113.597 -177.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -80.1 -55.71 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-O 117.038 -1.458 . . . . 0.0 107.968 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 94.1 p -51.36 -35.2 37.48 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 119.777 3.251 . . . . 0.0 119.777 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.76 103.48 1.55 Allowed Glycine 0 C--N 1.358 1.804 0 CA-C-N 120.071 1.305 . . . . 0.0 110.186 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -38.94 -38.09 0.41 Allowed 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 118.457 2.762 . . . . 0.0 118.457 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -74.2 -39.88 62.84 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 116.462 -1.733 . . . . 0.0 113.948 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.45 93.72 0.98 Allowed Glycine 0 C--N 1.361 1.928 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -91.49 117.91 30.11 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -142.61 118.07 10.3 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -95.87 116.05 28.34 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.9 m -134.75 114.65 12.11 Favored Pre-proline 0 CA--C 1.587 2.396 0 CA-C-O 114.048 -2.882 . . . . 0.0 105.13 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.15 145.13 34.56 Favored 'Trans proline' 0 C--N 1.394 2.966 0 CA-C-N 126.857 3.485 . . . . 0.0 113.497 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -140.54 122.48 15.54 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.892 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 44.4 t80 . . . . . 0 CA--C 1.549 0.905 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.371 8.0 p -133.04 -64.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 C-N-CA 124.484 1.114 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -92.57 130.2 38.29 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.799 1.239 . . . . 0.0 108.352 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -93.14 117.92 30.63 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -93.16 132.94 36.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 124.401 1.063 . . . . 0.0 108.657 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.5 mt -92.62 122.32 34.92 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.4 t -75.23 -49.13 20.32 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.39 -78.03 0.11 Allowed Glycine 0 C--N 1.36 1.862 0 CA-C-N 120.789 1.632 . . . . 0.0 113.333 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -61.69 -29.92 70.4 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 119.131 3.011 . . . . 0.0 119.131 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -57.7 -50.56 72.8 Favored 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 121.296 1.862 . . . . 0.0 114.117 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.0 tp -62.46 -72.44 0.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 115.27 -2.3 . . . . 0.0 108.998 177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.278 12.0 m -47.96 -28.1 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.17 -27.5 38.95 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 114.035 -2.888 . . . . 0.0 112.585 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -36.82 72.8 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 120.095 3.369 . . . . 0.0 120.095 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.484 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -72.17 -30.1 64.66 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 119.691 3.219 . . . . 0.0 119.691 -178.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -39.4 -29.65 0.05 Allowed 'General case' 0 CA--C 1.589 2.444 0 N-CA-C 120.324 3.453 . . . . 0.0 120.324 176.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.9 -53.2 6.67 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 129.034 2.934 . . . . 0.0 114.181 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.2 t -80.3 -55.4 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.404 0 CA-C-O 116.714 -1.612 . . . . 0.0 108.98 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.5 t -59.42 -40.46 86.78 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 118.46 2.763 . . . . 0.0 118.46 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.32 101.49 2.42 Favored Glycine 0 C--N 1.357 1.727 0 CA-C-N 120.342 1.428 . . . . 0.0 110.191 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -40.2 -36.22 0.49 Allowed 'General case' 0 N--CA 1.51 2.539 0 N-CA-C 118.352 2.723 . . . . 0.0 118.352 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -70.81 -39.72 72.91 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 116.395 -1.764 . . . . 0.0 114.382 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -111.94 84.02 0.35 Allowed Glycine 0 C--N 1.36 1.903 0 CA-C-N 120.644 1.566 . . . . 0.0 110.844 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -139.02 120.95 15.53 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -132.85 96.75 3.86 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.254 48.9 t80 -124.45 -65.17 1.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 124.423 1.089 . . . . 0.0 110.989 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.0 t -85.84 122.17 72.97 Favored Pre-proline 0 CA--C 1.58 2.125 0 CA-C-O 112.81 -3.471 . . . . 0.0 110.231 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -65.06 140.26 64.8 Favored 'Trans proline' 0 C--N 1.395 2.975 0 CA-C-N 127.794 3.819 . . . . 0.0 114.9 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -97.03 116.66 29.62 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 O-C-N 124.297 0.998 . . . . 0.0 110.993 -179.988 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.304 26.9 t 83.26 95.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.706 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -140.66 122.1 15.04 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 64.89 128.72 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.521 0 C-N-CA 126.484 1.914 . . . . 0.0 110.937 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.4 t60 -93.15 122.54 35.64 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.1 mt -94.0 123.9 37.66 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 85.2 p -87.97 132.03 34.39 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.155 0.909 . . . . 0.0 110.964 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.06 85.88 1.34 Allowed Glycine 0 N--CA 1.482 1.707 0 O-C-N 124.356 1.035 . . . . 0.0 111.506 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -77.17 -38.03 52.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -57.39 -47.94 80.36 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 121.428 1.922 . . . . 0.0 114.144 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.91 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 116.262 -1.828 . . . . 0.0 109.204 176.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.413 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.1 t -47.95 -27.98 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.518 2.973 0 C-N-CA 126.826 2.05 . . . . 0.0 114.04 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -74.3 -61.01 2.01 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 114.434 -2.698 . . . . 0.0 107.156 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.58 -36.55 0.11 Allowed 'General case' 0 N--CA 1.507 2.375 1 N-CA-C 123.129 4.492 . . . . 0.0 123.129 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.467 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.23 -31.59 60.9 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.757 2.873 . . . . 0.0 118.757 -179.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.24 -29.98 0.05 Allowed 'General case' 0 CA--C 1.59 2.482 0 N-CA-C 120.662 3.579 . . . . 0.0 120.662 175.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.32 5.79 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 128.247 2.619 . . . . 0.0 113.546 -177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.253 87.0 t -80.32 -57.41 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-O 116.802 -1.57 . . . . 0.0 108.468 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -64.75 -47.21 79.03 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.882 2.179 . . . . 0.0 116.882 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.63 136.97 4.13 Favored Glycine 0 C--N 1.36 1.872 0 CA-C-N 120.279 1.4 . . . . 0.0 112.363 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -42.47 -35.79 1.15 Allowed 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -69.13 -38.59 78.92 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 116.348 -1.787 . . . . 0.0 114.966 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.66 86.04 0.42 Allowed Glycine 0 C--N 1.36 1.88 0 CA-C-N 120.393 1.451 . . . . 0.0 110.899 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -99.18 119.64 38.2 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -130.61 114.88 15.99 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.26 46.4 t80 -124.03 -64.6 1.12 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 124.342 1.057 . . . . 0.0 111.264 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.5 p -89.1 131.17 41.77 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 114.258 -2.782 . . . . 0.0 108.939 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -65.42 138.01 53.35 Favored 'Trans proline' 0 C--N 1.395 3.014 0 CA-C-N 126.939 3.514 . . . . 0.0 114.829 -176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -98.71 122.13 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.939 179.959 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 48.5 p90 . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 84.5 t -109.81 104.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 1 N-CA-C 100.047 -4.057 . . . . 0.0 100.047 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -73.35 -47.13 44.82 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -88.68 116.26 26.8 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.826 1.25 . . . . 0.0 109.111 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -136.71 114.34 11.09 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 36.1 mt -142.75 116.0 8.96 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.2 p -88.12 134.25 33.81 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.899 0.88 . . . . 0.0 111.266 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.66 132.02 10.95 Favored Glycine 0 CA--C 1.541 1.708 0 O-C-N 124.268 0.98 . . . . 0.0 111.76 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.9 p -70.01 -32.82 71.18 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 118.019 2.6 . . . . 0.0 118.019 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -59.9 -48.67 80.75 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 121.437 1.926 . . . . 0.0 113.75 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.67 -50.24 74.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 116.603 -1.665 . . . . 0.0 113.415 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.266 6.3 m -73.84 -31.46 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.535 0 CA-C-O 115.961 -1.971 . . . . 0.0 113.908 178.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.263 48.1 mt-10 -73.82 -29.75 62.32 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 122.081 2.219 . . . . 0.0 112.36 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.85 -49.62 62.54 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 117.838 2.533 . . . . 0.0 117.838 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.461 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -68.44 -29.86 68.61 Favored 'General case' 0 N--CA 1.486 1.362 1 N-CA-C 123.941 4.793 . . . . 0.0 123.941 -176.81 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.258 0.9 OUTLIER -61.32 -28.62 69.34 Favored 'General case' 0 CA--C 1.581 2.153 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mp -66.22 -50.81 62.52 Favored 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 126.213 1.805 . . . . 0.0 113.192 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.262 88.8 t -80.37 -60.55 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.363 0 CA-C-O 116.767 -1.587 . . . . 0.0 108.281 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.8 m -66.67 -41.72 87.7 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.349 2.351 . . . . 0.0 117.349 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.94 133.14 5.54 Favored Glycine 0 C--N 1.358 1.802 0 CA-C-N 120.335 1.425 . . . . 0.0 111.169 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.26 14.3 pt-20 -33.18 -41.04 0.07 Allowed 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 120.465 3.506 . . . . 0.0 120.465 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.58 -41.75 59.95 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 116.41 -1.757 . . . . 0.0 113.824 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.19 86.49 1.16 Allowed Glycine 0 C--N 1.361 1.951 0 CA-C-N 120.579 1.536 . . . . 0.0 110.848 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -100.55 114.65 28.47 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -138.03 115.91 11.54 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.261 47.0 t80 -127.64 -66.3 0.88 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 124.399 1.08 . . . . 0.0 110.701 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.4 p -89.12 132.74 36.9 Favored Pre-proline 0 CA--C 1.581 2.163 0 CA-C-O 114.296 -2.764 . . . . 0.0 109.271 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.77 148.52 41.43 Favored 'Trans proline' 0 C--N 1.395 2.979 0 CA-C-N 126.671 3.418 . . . . 0.0 113.634 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.328 49.2 mtpt 69.26 -58.37 0.51 Allowed 'General case' 0 N--CA 1.51 2.549 0 C-N-CA 125.95 1.7 . . . . 0.0 113.703 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.27 0 CA-C-N 120.223 1.374 . . . . 0.0 110.491 179.925 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 55.8 p90 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.45 111.63 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 t30 57.79 115.82 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 126.799 2.04 . . . . 0.0 112.467 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -133.76 119.36 19.17 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 105.188 -2.153 . . . . 0.0 105.188 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -88.45 99.87 12.61 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.954 0.902 . . . . 0.0 109.142 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -86.57 138.41 31.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.115 0.966 . . . . 0.0 111.048 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.4 m -88.22 133.09 34.12 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.809 0.844 . . . . 0.0 110.186 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.57 -84.46 0.05 OUTLIER Glycine 0 N--CA 1.479 1.514 0 O-C-N 124.328 1.017 . . . . 0.0 111.616 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.6 m -70.82 -37.55 73.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -57.81 -48.17 80.49 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 121.515 1.961 . . . . 0.0 113.975 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.16 -70.83 0.2 Allowed 'General case' 0 CA--C 1.569 1.694 0 CA-C-O 116.117 -1.896 . . . . 0.0 109.279 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HA ' HD11 ' A' ' 15' ' ' LEU . 4.8 t -47.95 -28.05 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.914 0 C-N-CA 126.785 2.034 . . . . 0.0 114.106 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -74.5 -60.76 2.13 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.34 -2.743 . . . . 0.0 106.783 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.63 -36.35 0.11 Allowed 'General case' 0 N--CA 1.507 2.407 1 N-CA-C 123.238 4.532 . . . . 0.0 123.238 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.97 -30.82 58.75 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -179.02 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.325 0.1 OUTLIER -39.35 -30.14 0.06 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.319 3.451 . . . . 0.0 120.319 175.607 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 -53.9 6.07 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 128.256 2.622 . . . . 0.0 113.938 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.6 t -80.47 -54.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.743 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 55.4 m -58.88 -47.14 85.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 118.491 2.775 . . . . 0.0 118.491 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 144.3 88.33 0.09 OUTLIER Glycine 0 C--N 1.359 1.832 0 CA-C-N 120.654 1.57 . . . . 0.0 111.251 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -42.57 -42.02 3.23 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -65.93 -33.75 76.54 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 117.458 2.392 . . . . 0.0 117.458 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -154.7 92.0 0.13 Allowed Glycine 0 C--N 1.356 1.678 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -127.1 115.34 19.0 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -138.46 123.57 19.12 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.29 1.036 . . . . 0.0 108.636 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -134.81 118.17 16.73 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.8 m -130.02 109.64 16.82 Favored Pre-proline 0 CA--C 1.586 2.349 0 CA-C-O 114.003 -2.903 . . . . 0.0 104.559 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.81 137.04 17.45 Favored 'Trans proline' 0 C--N 1.394 2.956 0 CA-C-N 126.733 3.44 . . . . 0.0 112.682 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? 62.29 129.69 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 C-N-CA 126.481 1.912 . . . . 0.0 111.765 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 O-C-N 124.297 0.998 . . . . 0.0 110.841 179.891 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -137.04 94.38 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.93 124.69 40.06 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -91.74 141.03 29.13 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.008 0.923 . . . . 0.0 109.388 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.6 t60 62.21 95.08 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 126.993 2.117 . . . . 0.0 112.733 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.3 mt -153.24 120.39 5.81 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.9 m -80.9 -56.68 3.96 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 116.609 -1.662 . . . . 0.0 113.324 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.58 177.03 46.12 Favored Glycine 0 C--N 1.362 1.997 0 CA-C-N 120.559 1.527 . . . . 0.0 115.679 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 60.5 m -77.71 -29.97 51.57 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 116.969 2.211 . . . . 0.0 116.969 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . 0.254 41.2 p-80 -50.31 -52.0 40.45 Favored 'General case' 0 N--CA 1.504 2.238 0 CA-C-N 121.862 2.119 . . . . 0.0 116.647 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 41.0 tp -66.65 -71.7 0.19 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 115.749 -2.072 . . . . 0.0 109.456 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.431 ' HA ' HD11 ' A' ' 15' ' ' LEU 0.299 10.4 m -48.47 -27.22 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.084 0 N-CA-C 116.667 2.099 . . . . 0.0 116.667 177.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -75.89 -60.24 2.41 Favored 'General case' 0 CA--C 1.573 1.835 0 CA-C-O 114.432 -2.699 . . . . 0.0 106.689 174.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.43 -37.41 0.12 Allowed 'General case' 0 N--CA 1.507 2.401 1 N-CA-C 122.845 4.387 . . . . 0.0 122.845 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.474 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.22 -29.72 60.37 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 118.632 2.827 . . . . 0.0 118.632 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.332 0.1 OUTLIER -39.06 -35.87 0.25 Allowed 'General case' 0 CA--C 1.595 2.686 0 N-CA-C 118.834 2.902 . . . . 0.0 118.834 175.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -52.07 7.8 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 128.926 2.89 . . . . 0.0 111.667 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.259 11.5 m -70.92 -56.71 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 C-N-CA 125.544 1.538 . . . . 0.0 112.518 179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.9 m -74.57 -43.42 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.83 110.09 3.46 Favored Glycine 0 C--N 1.36 1.908 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -35.61 -40.76 0.18 Allowed 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.85 -41.5 59.74 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-O 116.481 -1.723 . . . . 0.0 113.61 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.04 91.44 1.3 Allowed Glycine 0 C--N 1.361 1.938 0 CA-C-N 120.447 1.476 . . . . 0.0 109.763 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -94.47 116.44 28.79 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -141.95 113.21 7.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . 0.273 45.5 t80 -94.52 -68.38 0.8 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 123.93 0.892 . . . . 0.0 110.845 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.6 p -146.48 117.4 4.75 Favored Pre-proline 0 CA--C 1.581 2.164 0 CA-C-O 114.306 -2.759 . . . . 0.0 106.437 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -78.45 133.49 11.86 Favored 'Trans proline' 0 C--N 1.396 3.055 0 CA-C-N 126.908 3.503 . . . . 0.0 112.396 -176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.426 17.1 ptpt 64.12 -61.55 0.18 Allowed 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-N 119.218 0.917 . . . . 0.0 111.142 -179.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 44.0 t80 . . . . . 0 CA--C 1.566 1.561 0 CA-C-O 116.85 -1.547 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.41 114.55 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -92.75 120.79 33.49 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -94.62 130.49 41.05 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -76.07 -51.57 11.99 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 116.669 -1.634 . . . . 0.0 113.844 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.0 mt -96.88 115.97 28.36 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.4 m -106.02 130.64 53.9 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.833 0.853 . . . . 0.0 109.789 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.53 75.85 1.13 Allowed Glycine 0 N--CA 1.482 1.734 0 CA-C-O 118.674 -1.07 . . . . 0.0 114.685 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.8 p -80.33 -39.51 28.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 115.802 1.778 . . . . 0.0 115.802 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -54.55 -48.46 71.99 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 121.491 1.95 . . . . 0.0 114.239 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.7 tp -58.12 -71.44 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 115.793 -2.051 . . . . 0.0 109.244 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.9 t -49.23 -28.59 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.838 0 C-N-CA 126.39 1.876 . . . . 0.0 114.272 178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -79.06 -27.39 43.08 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 114.411 -2.709 . . . . 0.0 112.774 175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.68 70.85 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 120.18 3.4 . . . . 0.0 120.18 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -71.95 -30.53 65.39 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 119.543 3.164 . . . . 0.0 119.543 -178.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.347 0.1 OUTLIER -39.26 -29.79 0.05 OUTLIER 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.273 3.434 . . . . 0.0 120.273 176.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.33 -53.21 6.52 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 129.077 2.951 . . . . 0.0 114.408 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.24 -54.46 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 CA-C-O 116.634 -1.65 . . . . 0.0 109.451 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.0 m -60.08 -45.34 93.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.48 91.24 0.39 Allowed Glycine 0 C--N 1.359 1.829 0 CA-C-N 120.533 1.515 . . . . 0.0 110.586 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -35.78 -42.36 0.25 Allowed 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.97 -42.47 69.67 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.88 -128.57 4.01 Favored Glycine 0 C--N 1.358 1.75 0 CA-C-N 119.194 0.907 . . . . 0.0 111.081 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.0 t80 56.51 92.09 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 126.723 2.009 . . . . 0.0 112.457 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -99.35 118.04 35.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -98.83 118.36 35.42 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.7 m -96.85 111.34 57.22 Favored Pre-proline 0 CA--C 1.587 2.39 0 CA-C-O 113.982 -2.913 . . . . 0.0 105.369 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.48 137.09 18.18 Favored 'Trans proline' 0 C--N 1.394 2.971 0 CA-C-N 126.697 3.428 . . . . 0.0 112.82 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -85.87 -64.01 1.22 Allowed 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 116.708 -1.615 . . . . 0.0 110.633 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.106 0 CA-C-N 120.354 1.434 . . . . 0.0 110.766 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 52.6 t80 . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.373 8.5 p -137.34 -64.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.398 0 C-N-CA 124.588 1.155 . . . . 0.0 110.724 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -72.76 -38.57 67.29 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -92.88 118.69 31.41 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -136.16 119.28 16.53 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 26.6 mt 62.56 129.18 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 126.528 1.931 . . . . 0.0 111.843 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.6 p -131.96 126.89 35.15 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.272 0.983 . . . . 0.0 109.242 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.48 82.97 1.13 Allowed Glycine 0 N--CA 1.481 1.662 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.01 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.3 t -79.9 -41.51 26.02 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 116.392 -1.766 . . . . 0.0 115.242 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -54.84 -45.2 74.45 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.366 1.894 . . . . 0.0 114.588 178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 34.4 tp -63.52 -70.89 0.19 Allowed 'General case' 0 CA--C 1.569 1.69 0 CA-C-O 116.134 -1.889 . . . . 0.0 109.254 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HA ' HD11 ' A' ' 15' ' ' LEU . 3.7 t -48.04 -28.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.519 2.986 0 C-N-CA 126.805 2.042 . . . . 0.0 114.094 178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.39 -60.83 2.09 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 114.55 -2.643 . . . . 0.0 106.841 174.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -36.52 0.11 Allowed 'General case' 0 N--CA 1.505 2.307 1 N-CA-C 123.185 4.513 . . . . 0.0 123.185 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.458 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -75.34 -31.11 60.46 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 118.828 2.899 . . . . 0.0 118.828 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.328 0.1 OUTLIER -39.32 -31.51 0.08 Allowed 'General case' 0 CA--C 1.591 2.537 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 175.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.6 -53.45 6.54 Favored 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 128.33 2.652 . . . . 0.0 114.039 -178.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.1 t -80.27 -55.85 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.353 0 CA-C-O 116.691 -1.623 . . . . 0.0 109.31 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -61.74 -48.04 82.52 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.73 2.492 . . . . 0.0 117.73 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.68 108.53 0.25 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 120.667 1.576 . . . . 0.0 111.312 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -36.73 -44.8 0.49 Allowed 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 116.839 2.163 . . . . 0.0 116.839 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -126.69 66.01 1.26 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 89.73 0.08 OUTLIER Glycine 0 C--N 1.359 1.808 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -92.66 126.42 37.73 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -129.18 105.27 8.05 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -128.27 -57.06 1.23 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 124.408 1.083 . . . . 0.0 112.579 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 15.1 t -137.69 126.26 14.57 Favored Pre-proline 0 CA--C 1.583 2.215 0 CA-C-O 113.115 -3.326 . . . . 0.0 109.928 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -64.46 141.22 73.08 Favored 'Trans proline' 0 C--N 1.395 2.988 0 CA-C-N 127.683 3.78 . . . . 0.0 114.89 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -129.14 114.59 16.52 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 104.682 -2.34 . . . . 0.0 104.682 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.985 179.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . . 43.7 t80 . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.0 m -149.64 110.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . 0.263 20.1 t-20 -122.6 -66.0 1.06 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.204 1.002 . . . . 0.0 111.211 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -125.72 -67.2 0.9 Allowed 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 116.73 -1.605 . . . . 0.0 109.259 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -94.41 123.71 37.98 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 120.594 1.543 . . . . 0.0 107.355 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -132.38 103.25 6.1 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.1 t -132.16 126.1 32.83 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.1 -74.7 1.28 Allowed Glycine 0 N--CA 1.483 1.786 0 O-C-N 124.07 0.856 . . . . 0.0 114.579 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.3 p -46.28 -29.33 1.58 Allowed 'General case' 0 N--CA 1.494 1.735 1 N-CA-C 121.893 4.035 . . . . 0.0 121.893 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -45.74 -48.55 15.26 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.36 -72.62 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 116.283 -1.817 . . . . 0.0 110.359 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.385 4.8 p -51.39 -26.8 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -75.1 -60.26 2.37 Favored 'General case' 0 CA--C 1.574 1.875 0 CA-C-O 114.488 -2.672 . . . . 0.0 106.753 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.46 -37.47 0.13 Allowed 'General case' 0 N--CA 1.505 2.317 1 N-CA-C 122.952 4.427 . . . . 0.0 122.952 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.47 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -74.52 -31.06 62.03 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 119.033 2.975 . . . . 0.0 119.033 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.324 0.1 OUTLIER -39.32 -30.01 0.05 Allowed 'General case' 0 CA--C 1.59 2.494 0 N-CA-C 120.618 3.562 . . . . 0.0 120.618 175.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.48 -54.1 5.99 Favored 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 128.25 2.62 . . . . 0.0 113.53 -177.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.255 93.1 t -80.32 -58.04 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 CA-C-O 116.881 -1.533 . . . . 0.0 108.271 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.4 t -65.02 -43.08 93.61 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.71 127.71 4.06 Favored Glycine 0 C--N 1.359 1.821 0 CA-C-N 120.292 1.406 . . . . 0.0 110.546 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -39.72 -37.87 0.58 Allowed 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -73.38 -40.29 64.46 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 116.468 -1.729 . . . . 0.0 113.845 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.14 91.78 1.04 Allowed Glycine 0 C--N 1.361 1.95 0 CA-C-N 120.47 1.486 . . . . 0.0 109.463 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -94.73 99.33 11.44 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -143.33 120.09 11.2 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -98.35 115.16 27.86 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.8 m -136.57 113.4 10.13 Favored Pre-proline 0 CA--C 1.587 2.371 0 CA-C-O 114.039 -2.886 . . . . 0.0 105.006 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -75.31 142.68 27.23 Favored 'Trans proline' 0 C--N 1.395 2.993 0 CA-C-N 126.842 3.479 . . . . 0.0 113.205 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm 59.93 135.96 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 126.874 2.07 . . . . 0.0 112.201 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.782 179.991 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . . . . . . . . 0.268 43.1 p90 . . . . . 0 CA--C 1.562 1.407 0 CA-C-O 117.111 -1.424 . . . . 0.0 113.358 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 m -94.5 109.8 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -129.83 -48.65 1.14 Allowed 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.522 1.675 . . . . 0.0 115.522 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 69.26 126.78 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 C-N-CA 127.264 2.225 . . . . 0.0 110.017 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 61.48 123.59 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 126.637 1.975 . . . . 0.0 111.836 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 40.4 mt -98.37 118.37 34.88 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.5 m -108.39 127.52 53.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.923 0.889 . . . . 0.0 108.791 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.72 -91.54 0.08 OUTLIER Glycine 0 N--CA 1.474 1.18 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.5 p -78.87 -46.94 17.49 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 116.308 -1.806 . . . . 0.0 115.531 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -46.35 -45.11 17.46 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 121.71 2.05 . . . . 0.0 115.472 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.3 tp -63.65 -70.9 0.19 Allowed 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.161 -1.876 . . . . 0.0 109.626 177.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.402 ' HA ' HD11 ' A' ' 15' ' ' LEU 0.263 4.8 t -47.43 -28.41 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.517 2.919 0 CA-C-O 115.85 -2.024 . . . . 0.0 114.282 179.473 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -75.1 -60.3 2.35 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 114.248 -2.787 . . . . 0.0 106.872 173.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -36.69 -35.1 0.08 Allowed 'General case' 0 N--CA 1.508 2.428 1 N-CA-C 123.476 4.621 . . . . 0.0 123.476 -178.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.44 ' H ' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -76.68 -31.74 57.46 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -179.015 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . 0.333 0.1 OUTLIER -39.09 -29.59 0.04 OUTLIER 'General case' 0 CA--C 1.59 2.488 0 N-CA-C 120.724 3.602 . . . . 0.0 120.724 175.851 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.93 -52.39 7.92 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 128.235 2.614 . . . . 0.0 113.342 -177.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -80.31 -56.25 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 CA-C-O 117.053 -1.451 . . . . 0.0 107.96 178.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 89.7 p -51.81 -35.1 42.96 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 119.912 3.301 . . . . 0.0 119.912 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.99 110.96 2.41 Favored Glycine 0 C--N 1.358 1.767 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -39.86 -37.3 0.54 Allowed 'General case' 0 N--CA 1.51 2.555 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 -179.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -72.9 -39.4 66.38 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 116.306 -1.807 . . . . 0.0 114.162 178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.42 87.66 1.27 Allowed Glycine 0 C--N 1.36 1.904 0 CA-C-N 120.562 1.528 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -112.95 113.86 26.09 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -143.02 118.4 10.27 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -134.36 119.35 18.53 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 26.7 m -132.17 113.31 14.65 Favored Pre-proline 0 CA--C 1.587 2.367 0 CA-C-O 114.112 -2.851 . . . . 0.0 104.974 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -68.71 140.74 47.69 Favored 'Trans proline' 0 C--N 1.395 3.006 0 CA-C-N 126.771 3.454 . . . . 0.0 114.395 -176.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -83.16 -62.44 1.59 Allowed 'General case' 0 CA--C 1.572 1.824 0 CA-C-O 116.722 -1.608 . . . . 0.0 111.39 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 CA-C-N 120.376 1.444 . . . . 0.0 109.916 -179.857 . . . . . . . . 0 0 . 1 stop_ save_